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ABSTRACT 
 
 This thesis presents the development of new catalysts for the palladium-catalyzed N-
tert-prenylation of indoles, the rhodium-catalyzed endo- and enantioselective hydroacylation 
of ortho-allylbenzaldehydes, studies toward the rhodium-catalyzed intramolecular 
hydroacylation of 1,2-disubstituted alkenes, and the first examples of the rhodium-catalyzed, 
enantioselective hydroacylation of 1,1,2-trisubstituted alkenes.  
Chapter II discusses the development of three distinct protocols for the synthesis of 
N-tert-prenylindoles using indole, (η6-indole)Cr(CO)3, and indoline nucleophiles. These 
reactions occur in the presence of the same palladium catalyst prepared in situ from readily 
available precursors and require loadings of the palladium catalyst that are up to ten times 
less than required for previously reported direct N-tert-prenylations of indoles.  These 
methods for palladium-catalyzed N-tert-prenylation generate N-tert-prenylindoles with a 
range of electronic character in high yields (up to 94%) with high tert-prenyl-to-n-prenyl 
selectivity (up to 12:1). 
Chapter III describes the development of a rhodium catalyst for endo- and 
enantioselective hydroacylation of ortho-allylbenzaldehydes. A catalyst generated from 
[Rh(COD)Cl]2, (R)-DTBM-Segphos and NaBARF promotes the enantioselective 
hydroacylation reactions and minimizes the formation of byproducts from competitive alkene 
isomerization and ene/dehydration pathways. These rhodium-catalyzed processes generate 
the 3,4-dihydronaphthalen-1(2H)-one products in moderate-to-high yields (49-91%) with 
excellent enantioselectivities (96-99% ee). 
 
 
x 
Chapter IV describes studies toward the intramolecular hydroacylation of 1,2-
disubstituted alkenes as well as the first examples of catalytic, enantioselective 
hydroacylation of 1,1,2-trisubstituted alkenes. The intramolecular hydroacylation of 1,2-
disubstituted alkenes is facilitated by a cationic rhodium complex and generates the indanone 
products in high yields (up to 94%). However, the α-center is prone to epimerization and 
results in racemic mixtures of the bicyclic products.  
In contrast, the rhodium-catalyzed intramolecular hydroacylation of 1,1,2-
trisubstituted alkenes generates highly enantioenriched, polycyclic architectures. The DFT 
and mechanistic studies presented are consistent with a reaction pathway that includes 
intramolecular alkene hydroacylation and α-epimerization. This reaction sequence enables 
the hydroacylation of 2-(cyclohex-1-en-1-yl)benzaldehydes to form hexahydro-9H-fluoren-9-
ones in moderate to high yields (68-91%) with high enantioselectivities (up to 99% ee) and 
diastereoselectivities (typically >20:1). 
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CHAPTER I 
INTRODUCTION 
 Transition-metal catalysis has been well established as an essential component of 
modern synthetic organic chemistry.[1] This broad research area encompasses chemical 
transformations such as cross-coupling processes, metathesis reactions, polymerizations, 
oxidative functionalizations, C-H activation chemistry, allylic substitutions, and 
hydrofunctionalization reactions, among others.[1] Advances in transition metal-catalyzed 
processes have contributed to a fundamental understanding of the mechanisms and catalytic 
principles that govern these reactions and have enabled the development of improved 
catalysts for many regio- and enantioselective chemical transformations. In this thesis, 
fundamental principles of transition-metal catalysis will be applied to the development of 
new catalysts for allylic substitution and hydrofunctionalization reactions including a 
palladium catalyst for the N-tert-prenylation of indoles, a rhodium catalyst for the endo- and 
enantioselective hydroacylation of ortho-allylbenzaldehydes and a rhodium catalyst for the 
intramolecular hydroacylation of higher order alkenes.  
 N-tert-prenylindoles are a unique class of prenylated indoles that incorporate the tert-
prenyl moiety through a C-N bond. Compounds with this general architecture and analogues 
containing oxidized prenyl moieties exhibit an array of medicinal properties distinct from 
structures that incorporate the linear (n-prenyl) isomer.[2-3] However, traditional methods for 
the synthesis of N-tert-prenylindoles involve multiple nonstrategic redox steps and the use of 
heavily prefunctionalized starting materials (Scheme 1).[4-7]  
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Scheme 1: Methods for the synthesis of N-tert-prenylindoles 
The only direct method for the synthesis of N-tert-prenylindoles was reported by 
Baran and co-workers and requires high loadings of the palladium catalyst (20-40 mol%) as 
well as an excess of silver and copper co-oxidants (2.0-2.5 equiv).[6] This thesis presents a 
method for the direct synthesis of N-tert-prenylindoles with a broad range of electronic 
character via palladium-catalyzed allylic substitution.[8] These reactions require significantly 
lower catalyst loadings than previously reported direct N-tert-prenylations of indoles, and 
occur without the use of precious metal co-oxidants.  
 Intramolecular alkene hydroacylation is a valuable strategy to generate a wide variety 
of carbocyclic and heterocyclic ketones.[9] These reactions can be promoted by transition-
metal or N-heterocyclic carbene (NHC) catalysts. NHC-catalyzed hydroacylations occur with 
exo-selectivity whereas transition metal-catalyzed hydroacylations can occur with either exo- 
or endo-selectivity. ortho-Allylbenzaldehydes are one class of substrates that highlights the 
two potential regiochemical outcomes of intramolecular alkene hydroacylations. Exo-
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selective hydroacylations of these substrates have been well explored and both racemic and 
enantioselective variants have been reported.[10-11] However, only one example of endo-
selective hydroacylation of ortho-allylbenzaldehyde substrates has been reported.[12] Douglas 
and co-workers reported the rhodium-catalyzed hydroacylation of 2-(2-
methylallyl)benzaldehyde that requires a chelating additive and results in a racemic product 
(Scheme 2).  
 
 
Scheme 2: ortho-Allylbenzaldehydes as hydroacylation substrates. 
 
This thesis describes the development of a rhodium catalyst for the endo- and 
enantioselective hydroacylation of ortho-allylbenzaldehydes.[13] This rhodium-catalyzed 
process generates the 3,4-dihydronaphthalen-1(2H)-one products with high 
enantioselectivities and mitigates the formation of byproducts resulting from alkene 
isomerization and ene/dehydration pathways through catalyst design.  
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Since the initial report of alkene hydroacylation in 1972,[14] terminal and 1,1-
disubstituted alkenes have remained the most common substrates used in intramolecular 
alkene hydroacylations to generate a variety of ketone products (Scheme 3a).  
 
Scheme 3: Hydroacylations of terminal, 1,1-disubstituted and higher order alkenes. 
However, intramolecular alkene hydroacylations of higher order alkenes are quite 
rare.[12, 15-16] Morehead reported a single example of the rhodium-catalyzed hydroacylation of 
ethyl (E)-3-(2-formylphenyl)acrylate that required 5 days to reach 90% conversion (Scheme 
3b).[15] Douglas proposed that exo-selective hydroacylation of a 1,2-disubstituted alkene 
occurs following isomerization of 2-homoallylbenzaldehyde in the presence of a rhodium 
catalyst.[12] This thesis presents studies toward the hydroacylation of 1,2-disubstituted 
alkenes and discusses efforts made to address challenges in the development of an 
enantioselective version of this reaction. This thesis also describes the first examples of 
catalytic, enantioselective hydroacylations of 1,1,2-trisubstituted alkenes. DFT and 
mechanistic studies are consistent with an alkene hydroacylation/α-epimerization reaction 
sequence for these catalytic processes. A cationic rhodium complex promotes the 
hydroacylation of 2-(cyclohex-1-en-1-yl)benzaldehyde to generate hexahydro-9H-fluoren-9-
ones in high yields and enantioselectivities.  
R
O
H
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O
R
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O
R
R
Rh or Co catalyst
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Thesis Organization 
 This thesis is comprised of five chapters that contain both work that has been 
published in peer-reviewed journals and research results that are in preparation for 
publication. Chapter I serves to introduce transition-metal catalysis and catalytic methods 
development in the context of prenylation and hydroacylation reactions. Chapters II and III 
are adapted from papers published in Organic Letters and have been modified to include data 
that was not integrated into the published work. Modifications to these chapters also serve to 
describe the details of this research in greater depth. Chapter IV discusses research results 
that are currently in preparation for submission to Angewandte Chemie International Edition. 
This chapter also describes results that will not be included in the published manuscript. 
Chapter V serves as a general summary and conclusion of the presented research and 
proposes strategies to address the limitations that remain in some of the research projects 
described.  
 Chapter II describes the palladium-catalyzed synthesis of N-tert-prenylindoles and is 
modified version from a paper published in Organic Letters in 2013. The work included in 
this chapter encompasses the development of three distinct protocols for the synthesis of N-
tert-prenylindoles by palladium-catalyzed allylic substitution using indole, (η6-
indole)Cr(CO)3, and indoline nucleophiles. This catalytic method facilitates the synthesis of 
N-tert-prenylindoles with a range of electronic character and substitution. This work was 
accomplished in collaboration with Ryan Van Zeeland, also of the Stanley group. The author 
of this thesis is responsible for the synthesis and characterization of all indole, indoline, N-
tert-prenylindole and N-tert-prenylindolines prepared, as well as the identification of reaction 
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conditions for this catalytic method. Ryan Van Zeeland is responsible for the synthesis and 
characterization of all chromium-containing compounds described.  
 Chapter III describes the rhodium-catalyzed hydroacylation of ortho-
allylbenzaldehydes and is modified from a paper published in Organic Letters in 2015. This 
chapter discusses the development of a cationic rhodium catalyst that facilitates the endo- 
and enantioselective hydroacylation of ortho-allylbenzaldehydes to generate 3,4-
dihydronaphthalen-1(2H)-ones. This work was accomplished in collaboration with Adam C. 
Schmidt, an undergraduate researcher in the Stanley Lab. Adam assisted in initial evaluation 
of reaction conditions for the rhodium-catalyzed hydroacylation and synthesis of the parent 
2-(2-methylallyl)benzaldehyde substrate. The author of this thesis is responsible for 
optimization of this catalytic system, as well as the synthesis and characterization of all 
compounds described.  
 Chapter IV discusses the development of a rhodium catalyst for the intramolecular 
hydroacylation of higher order alkenes. The chapter contains modified sections of a paper in 
preparation for submission to Angewandte Chemie International Edition, as well as 
additional data that will not be included in the submitted manuscript. This chapter discusses 
efforts toward the development of a rhodium catalyst for the hydroacylation of 1,2-
disubstituted alkenes and presents the first examples of the enantioselective hydroacylation 
of 1,1,2-trisbustituted alkenes. DFT studies to model the catalytic reaction sequence and 
kinetics experiments are also described. This work was accomplished in collaboration with 
Prof. Joseph Scanlon as well as undergraduate students Brian P. Schumacher and Eugene A. 
Schneider of Ripon College. Prof. Scanlon, Brian and Eugene performed the theoretical 
computational work to identify the catalytic intermediates and potential energy surface for 
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the reactions described. The author of this thesis is responsible for the experimental 
mechanistic work, as well as the synthesis and characterization of all compounds described.  
 Chapter V discusses general conclusions from the work presented and proposes new 
directions for the continuation of this research in the Stanley lab. 
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CHAPTER II 
PALLADIUM-CATALYZED SYNTHESIS OF N-TERT-PRENYLINDOLES 
 
Adapted from a paper published in Organic Letters[1] 
Kirsten F. Johnson, Ryan Van Zeeland, Levi M. Stanley 
Abstract 
Three distinct protocols for the synthesis of N-tert-prenylindoles are described using 
indole, (η6-indole)Cr(CO)3, and indoline nucleophiles in the presence of the same palladium 
catalyst prepared in situ from readily available precursors.  These reactions require loadings 
of the palladium catalyst that are up to ten times less than required for previously reported 
direct N-tert-prenylations of indoles.  These methods for palladium-catalyzed N-tert-
prenylation generate N-tert-prenylindoles with a range of electronic character in high yields 
(up to 94%) with high tert-prenyl-to-n-prenyl selectivity (up to 12:1). 
Introduction 
Prenylated indoles are found in structurally diverse fungal, plant, and bacterial natural 
products[2-3] and have been the focus of many recent synthetic[4-12] and biosynthetic 
studies.[13-17] The diversity of these natural products stems from nature’s ability to 
incorporate the prenyl group throughout the indole core as either an n-prenyl (prenyl) or tert-
prenyl (reverse prenyl) moiety.  Synthetic chemists have developed a variety of methods to 
prepare both prenylated and tert-prenylated indoles that exhibit promising medicinal 
properties.[2-17] Despite these efforts, the synthetic methodology necessary to access certain 
classes of tert-prenylated indoles remains underdeveloped. 
N-tert-Prenylated indoles (Figure 1) are a unique class of prenylated indoles in which 
the prenyl group is linked to the indole core through a carbon-nitrogen bond.  N-tert-
 10 
Prenylindoles and analogues containing oxidized prenyl moieties exhibit an array of 
medicinal properties including activation of insulin receptors, cytotoxicitiy toward cancer 
cell lines, as well as anti-inflammatory, antimycobacterial, and antifungal activities.[18-22] 
 
 
Figure 1: Representative N-tert-prenylindole natural products. 
Current synthetic routes to N-tert-prenylated indoles involve 1) multiple non-strategic 
redox steps, 2) the use of pre-functionalized starting materials, or 3) high loadings of a 
precious metal catalyst and metal co-oxidants (Scheme 1). The traditional, four-step synthetic 
sequence to generate N-tert-prenylated indoles was reported by Sugiyama and co-workers in 
2001 and includes reduction of the indole to an indoline, Cu(I)-catalyzed propargylic 
substitution, partial reduction of the alkyne to an alkene, and oxidation of the N-tert-
prenylindoline to the corresponding indole.[23-26] In 2007, Willis and co-workers reported a 
tandem Pd-catalyzed synthesis of N-tert-prenylindoles from 2-methyl-3-butene-2-amine and 
2-bromo-β-chlorostyrenes by a sequence of arylamination and alkenyl amination.[27] In 2011, 
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Nishikawa and co-workers reported the N-tert-prenylation of methyl indole-3-acetate by 
alkylation with the dicobalthexacarbonyl complex of 2-methyl-3-butyn-2-ol in the presence 
of TMSOTf, followed by reduction and decomplexation with n-Bu3SnH.[28] 
  
Scheme 1: Strategies for the synthesis of N-tert-prenylindoles. 
Prior to the studies reported in this thesis, only one direct method for the N-tert-
prenylation of indoles had been reported.  In 2009, Baran and co-workers reported the direct 
synthesis of N-tert-prenylindoles by Pd-mediated C−H functionalization of 2-methyl-2-
butene with indoles.[29] The direct C−H functionalization 2-methyl-2-butene enables the 
synthesis of N-tert-prenylindoles from a broad array of readily accessible indoles, but the 
synthetic utility and practicality of this strategy remains limited because high loadings of the 
palladium catalyst (20-40 mol %) and a silver co-oxidant (2.0-2.5 equiv) are required.  
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Results and Discussion 
   At the outset of this project, we sought to develop a strategy to generate N-tert-
prenylindoles with a range of electronic properties that minimize the number of non-strategic 
redox steps and employ practical loadings of catalyst precursors.  We aimed to identify a 
method for the synthesis of N-tert-prenylindoles through a palladium-catalyzed allylic 
alkylation approach (Scheme 2).[30-31] 
 
Scheme 2: Proposed scheme for the Pd-catalyzed N-tert-prenylation of indoles 
To establish the viability of our allylic substitution strategy, we conducted reactions 
of tert-butyl (2-methylbut-3-en-2-yl) carbonate with indole-3-carboxaldehyde in the presence 
of Cs2CO3 and catalysts generated from a variety of palladium precursors and bisphosphine 
ligands (Table 1). We found that palladium complexes of bisphosphine ligands with wide 
natural bite angles catalyze the N-prenylation of indole-3-carboxaldehyde 1a with high tert-
prenyl:n-prenyl selectivity (9:1 to 13:1) (entries 1-5).  We observed traces of the N-
allylindole product generated from nucleophilic attack of the allylpalladium(II) species from 
[Pd(η3-allyl)Cl]2. In order to prevent formation of this byproduct we evaluated alternative 
palladium precursors and found that [Pd(η3-prenyl)Cl]2 was a suitable precatalyst (entries 6 
and 7). We then evaluated a range of solvents for the N-prenylation of indole-3-
carboxaldehyde 1a and found that CH2Cl2 and PhCN generated the N-tert-prenylindole 
product with the best combination of yield and selectivity (entries 7-11). Attempts to 
X Pd(0)catalyst PdII
N
H
R1
R2
base
attack at the more
substituted carbon
N
R1
R2
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completely remove PhCN from the reaction mixture resulted in significant loss of the N-
prenylindole products so we chose to use CH2Cl2 for further evaluation of the reaction 
conditions. The reaction of 1a with 2.00 equivalents of tert-butyl (2-methylbut-3-en-2-yl) 
carbonate 2 in the presence of a catalyst generated from [Pd(η3-prenyl)Cl]2 and Xantphos at 0 
°C occurred with high tert-prenyl:n-prenyl selectivity (12:1) and 3a was isolated in 76% as a 
single regioisomer (Entry 14).  
Table 1: Study of reaction conditions for the N-tert-prenylation of 1a with 2.a 
 
 
Entry Equiv 2 Ligand Pd source (mol %) Solvent Temp. 
(° C) 
Yieldb 
(%) 
3a:4ab 
1 1.00 DPPF [Pd(η3-allyl)Cl]2 (2) CH2Cl2 rt 59 9:1 
2 1.00 DPEPhos [Pd(η3-allyl)Cl]2 (2) CH2Cl2 rt 53 10:1 
3 1.00 DPPPent [Pd(η3-allyl)Cl]2 (2) CH2Cl2 rt 58 11:1 
4 1.00 rac-BINAP [Pd(η3-allyl)Cl]2 (2) CH2Cl2 rt 52 9:1 
5 1.00 Xantphos [Pd(η3-allyl)Cl]2 (2) CH2Cl2 rt 68 13:1 
6 1.00 Xantphos Pd2(dba)3 (2) CH2Cl2 rt 58 8:1 
7 1.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) CH2Cl2 rt 62 9:1 
8 1.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) THF rt 50 9:1 
9 1.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) MeCN rt 61 8:1 
10 1.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) PhCN rt 69 10:1 
11 1.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) Dioxane rt 59 9:1 
12 1.50 Xantphos [Pd(η3-prenyl)Cl]2 (2) CH2Cl2 rt 88 10:1 
13 2.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) CH2Cl2 rt 99 10:1 
14 2.00 Xantphos [Pd(η3-prenyl)Cl]2 (2) CH2Cl2 0 99 (76)c 12:1 
aReactions run on a 0.500 mmol scale and full experimental procedure is given in the Experimental section of 
this thesis chapter. bDetermined by 1H NMR of the crude reaction mixture using 1,3,5-trimethoxybenzene as an 
internal standard. cIsolated yield of 3a. 
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H
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We then evaluated these conditions for palladium-catalyzed N-tert-prenylation in 
reactions of a series of indoles containing electron-withdrawing groups at either the 3-
position or the 5-position with carbonate 2.  The data from these experiments are summarized 
in Table 2.  As shown in entries 1-4, 3-substituted indoles 1a-1d (R1 = CHO, C(O)Me, 
CO2Me, or CN) reacted with carbonate 2 to form N-tert-prenylindoles 3a-3d in good-to-
excellent yield with 10:1 or greater regioselectivity (3:4).  N-tert-Prenylindoles 3a and 3b 
were isolated in 76% and 65% yield as single constitutional isomers.  In contrast, N-tert-
prenylindoles 3c and 3d were not readily separable from the N-n-prenyl isomers 4c and 4d.  
These products were isolated as 12:1 mixtures of the N-tert-prenylindole and N-n-
prenylindole isomers. 
Table 2: Scope of Pd-Catalyzed N-tert-Prenylation of Indoles.a 
 
Entry 1 R1 R2 3 Yield 3 + 4 (%)b 3:4c 
1 1a CHO H 3a 76d 12:1 
2 1b C(O)Me H 3b 65d 10:1 
3 1c CO2Me H 3c 90 12:1 
4 1d CN H 3d 94 12:1 
5e 1e H CN 3e 40 7:1 
6e 1f H NO2 3f 62 7:1 
aReactions run on a 0.500 mmol scale and full experimental procedure is given in the Experimental section of 
this thesis chapter. bIsolated yield of 3 + 4. cDetermined by 1H NMR spectroscopy of the crude reaction mixture. 
cIsolated yield of 3. dReactions run at room temperature. 
The presence of electron-withdrawing substitution at the 3-position of the indole core 
is not a strict requirement under our reaction conditions.  Reactions of 5-cyanoindole 1e and 
5-nitroindole 1f with carbonate 2 occurred to form mixtures of N-prenylindole products 3e-f 
and 4e-f in 40% and 62% yield with 7:1 tert-prenyl:n-prenyl selectivity (entries 5 and 6).  
N
H
R1 [Pd(η3-prenyl)Cl]2 (2 mol %)
Xantphos (4 mol %)OBoc
Cs2CO3
CH2Cl2, 0 °C
+
N
R1
1a-f 2 3a-f
R2 R
2
N
R1
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+
4a-f
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However, reactions of indoles lacking electron-withdrawing substitutents and reactions of 2-
substituted indoles did not form N-prenylindole products.  
The disparate reactivity of indoles with and without electron-withdrawing 
substituents suggested that indolate anions of the electron-deficient indoles were primarily 
responsible for nucleophilic attack on a prenylpalladium(II) intermediate.  Thus, the 
difference in relative acidity of the indole N−H is likely responsible for the difference in 
reactivity between more acidic, electron-deficient indoles and less acidic, electron-rich 
indoles.[32] Since η6-coordination of metal carbonyl complexes to arenes is known to increase 
the acidity of benzylic C-H bonds,[33-40] we hypothesized that η6-coordination of a metal 
carbonyl complex to the indole core would similarly increase the acidity of the indole N−H 
bond by reducing the electron density in the indole π-system. 
We prepared a series of (η6-indole)Cr(CO)3 complexes of electron-rich indoles and 
evaluated their reactivity as nucleophiles in Pd-catalyzed prenylation reactions.  Reactions of 
(η6-indole)Cr(CO)3 complexes of indoles 5a-g with carbonate 2 are summarized in Table 3.  
Table 3: Scope of Pd-Catalyzed N-tert-Prenylation of (η6-indole)Cr(CO)3 Complexes.a
 
Entry 5 R1 R2 3 Yield 3 + 4 (%)b 3:4c 
1 5a H H 3g 86 8:1 
2 5b Me H 3h 75 8:1 
3 5c CH2CO2Me H 3i 78 9:1 
4 5d H 4-OMe 3j 78 7:1 
5 5e H 5-OMe 3k 51 8:1 
6 5f H 6-OMe 3l 72 7:1 
7 5g H 7-OMe 3m 46 <1:20 
aReactions run on a 0.250 mmol scale and full experimental procedure is given in the Experimental section of 
this thesis chapter. bIsolated yield of 3 + 4. cDetermined by 1H NMR spectroscopy of the crude reaction mixture. 
Cr(CO)3
N
H
R1
R2
1) [Pd(η3-prenyl)Cl]2 (2 mol %)
    Xantphos (4 mol %)
    Cs2CO3, CH2Cl2, rt
OBoc
+
5a-g 2
2) DDQ, MeCN, 0 °C
N
R1
3g-m
R2
N
R1
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+
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 As shown in entries 1-3, (η6-indole)Cr(CO)3 complexes prepared from indole, 3-
methylindole and methyl indole-3-acetate (5a-c) reacted with carbonate 2 to form N-tert-
prenylindoles 3g-3i after oxidative decomplexation with DDQ.  These one-pot, two-step 
transformations gave the N-tert-prenylindoles 3g-i and N-n-prenylindoles 4g-i in 62-86% 
yield with 6:1 to 9:1 tert-prenyl:n-prenyl selectivity. Reactions of (η6-indole)Cr(CO)3 
complexes prepared from 4-MeO-, 5-MeO-, and 6-MeO-indole also occurred in moderate to 
good yields with high tert-prenyl:n-prenyl selectivities (entries 4-6).  The reactions of (η6-
indole)Cr(CO)3 complexes 5d-f with 2 and subsequent decomplexation of the Cr(CO)3 unit 
generated N-tert-prenylindoles 3j-l and N-n-prenylindoles 4j-l in 51-78% yield and 7:1 to 8:1 
tert-prenyl:n-prenyl selectivity.  In contrast, the prenylation of (η6-7-MeO-indole)Cr(CO)3 5g 
with 2 occurred with >20:1 selectivity favoring the N-n-prenylindole isomer 4m (entry 7). 
We propose that substitution at the 7-position of the indole core increases steric volume near 
the nucleophilic nitrogen of the indolate species and inhibits attack at the more substituted 
end of the prenylpalladium(II) intermediate. Nucleophilic attack instead occurs at the less 
substituted end of the prenylpalladium(II) species resulting in formation of the N-n-
prenylindole isomer 4m. 
The synthesis of N-tert-prenylindoles from electron-rich indole precursors is enabled 
by the markedly different electronic properties of the corresponding (η6-indole)Cr(CO)3 
complexes.  However, the utility of these complexes is inherently limited by the need for 
stoichiometric quantities of chromium.  Furthermore, the synthesis of (η6-indole)Cr(CO)3 
complexes from indoles containing even weakly deactivating groups is challenging.  For 
example, standard procedures for synthesis of (η6-indole)Cr(CO)3 complexes generated (η6-
5-bromoindole)Cr(CO)3 in less than 5% yield.  
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We hypothesized that the increased nucleophilicity of the indoline nitrogen would 
enable us to synthesize N-tert-prenylindoles with a greater range of electronic character after 
oxidation of the N-tert-prenylindoline intermediate. We evaluated this hypothesis by 
conducting the reaction of a series of indoline derivatives with carbonate 2 (Table 3).[41] 
Indoline, 3-methylindoline, methyl indoline-3-acetate, and 3-phenylindoline react with 
carbonate 2 to form 3g-i and 3n after oxidation of the intermediate N-tert-prenylindolines 
with MnO2 (entries 1-4).  The reactions occur with 5:1 to 6:1 tert-prenyl:n-prenyl selectivity, 
and the N-tert-prenylindolines are readily separated from the linear regioisomer.  N-tert-
prenylindoles 3g-i and 3n were isolated in 43-80% yield over two steps. Reactions of 4-
MeO-, 5-MeO-, and 6-MeO-indolines with 2 occurred with 2:1 to 4:1 selectivity and 
subsequent oxidation generated N-tert-prenylindoles 3j-l in 26-60% yield (entries 6-8). 
Table 4: Scope of Pd-Catalyzed N-tert-Prenylation of Indolines.a
 
Entry 6 R1 R2 7:8b Yield 7 (%) 3 Yield 3 
(%)c 
Yield 3 
(%)d 
1 6a H H 6:1 83 3g 96 80 
2 6b Me H 5:1 59 3h 97 57 
3 6c CH2CO2Me H 5:1 56 3i 77 43 
4 6d Ph H 5:1 61 3n 92 47 
5 6e (CH2)2NPhth H 4:1 50 3o 94 47 
6 6f H 4-OMe 4:1 58 3j 93 54 
7 6g H 5-OMe 2:1 26 3k 99 26 
8 6h H 6-OMe 5:1 61 3l 98 60 
9 6i H 5-Br 5.5:1 74 3p 87 64 
aReactions run on a 0.500 mmol scale and full experimental procedure is given in the Experimental section of 
this thesis chapter bRatio of N-tert-prenylindoline:N-tert-prenylindoline determined by 1H NMR spectroscopy of 
the crude reaction mixture. cIsolated yield of 3 for the oxidation of 7 by MnO2. dIsolated yield of 3 over two 
steps. 
N
H
R1
 [Pd(η3-prenyl)Cl]2 
(2 mol %)
 Xantphos (4 mol %)
 Cs2CO3, CH2Cl2, rtOBoc+ N
R1
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R2 R
2
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The sequence of N-prenylation of indolines followed by oxidation to the 
corresponding indoles allowed us to form N-tert-prenylindoles that were not accessible via 
the approaches shown in Tables 2 and 3.  Reactions of a protected tryptamine derivative, 3-
phenylindole, and 5-bromoindole with carbonate 2 either did not occur in high yields or the 
corresponding (η6-indole)Cr(CO)3 complexes were difficult to isolate.  However, reactions of 
3-phenylindoline 6d, indoline 6e (R1 = (CH2)2NPhth), and 5-bromoindoline 6i with 2 
occurred with 4:1 to 5.5:1 tert-prenyl:n-prenyl selectivity (entries 4, 5 and 9). The N-
prenylindoline isomers were cleanly separable at the indoline oxidation state and oxidation of 
the isomerically pure N-tert-prenylindolines by MnO2 generated N-tert-prenylindoles 3n-p in 
47-64% yield over the two steps.    
Conclusions 
In summary, we have developed three strategies based on palladium-catalyzed allylic 
alkylation reactions to generate N-tert-prenylindoles. In the presence of the same palladium 
catalyst, good yields and high regioselectivities are observed for three distinct classes of 
nucleophiles.  Direct N-tert-prenylations of electron-deficient indoles and indolines occur 
readily, while N-tert-prenylations of electron-rich indoles are facilitated by complexation 
with chromium.  Straightforward procedures for oxidative decomplexation of the chromium 
carbonyl fragment from the (η6-N-tert-prenylindole)Cr(CO)3 intermediates and oxidation of 
the N-tert-prenylindolines provide access to electron-rich N-tert-prenylindoles in moderate to 
good yields.  Thus, N-tert-prenylindoles with a broad range of substitution and electronic 
character can be accessed through these complementary approaches.  
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Experimental 
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques.  All reactions 
were performed under an atmosphere of nitrogen unless otherwise stated.  All glassware for 
moisture sensitive reactions was dried at 140 °C in an oven.  THF and CH2Cl2 were degassed 
by purging with argon for 45 minutes and dried with a solvent purification system by passing 
through a one-meter column of activated alumina.  Anhydrous n-dibutylether, acetonitrile, 
benzonitrile, and 1,4-dioxane were purchased from Sigma-Aldrich.  Flash column 
chromatography was performed on Fisher brand silica gel 60 (230-400 mesh) using 
hexanes/ethyl acetate, hexanes/ether, or hexanes/dichloromethane mixtures.  Products were 
visualized on TLC by UV light or by staining with KMnO4.   
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer.  NMR spectra 
were acquired on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State 
University Chemical Instrumentation Facility.  Chemical shifts are reported in ppm relative 
to a residual solvent peak (CDCl3 = 7.26 ppm for 1H and 77.36 ppm for 13C; C6D6 = 7.16 for 
1H and 128.06 for 13C).  Coupling constants are reported in hertz.    
Materials. Indole-3-carboxaldehyde 1a, 3-acetylindole 1b, methyl indole-3-
carboxylate 1c, 3-cyanoindole 1d, indole, 3-methylindole, 3-indoleacetic acid, and 
tryptamine were purchased from Sigma-Aldrich and used with out further purification. 5-
Cyanoindole 1e and 5-nitroindole 1f were purchased from TCI and used without further 
purification. 4-Methoxyindole, 5-methoxyindole, 6-methoxyindole, and 7-methoxyindole 
were purchased from AK Scientific and used without further purification. 5-Bromoindole 
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was purchased from Frontier Scientific and used without further purification. Methyl indole-
3-acetate was synthesized according to a literature procedure from 3-indoleacetic acid.[42] 3-
Phenylindole was synthesized according to a literature procedure from 2-phenylacetaldehyde 
and phenylhydrazine.[43]  N-Phthalimidotryptamine was synthesized according to a literature 
procedure from tryptamine and phthalic anhydride.[44]  tert-Butyl (2-methylbut-3-en-2-yl) 
carbonate was prepared according to a literature procedure from 2-methylbut-3-en-2-ol and 
Boc2O.[12] 
[Pd(η3-allyl)Cl]2, Pd2(dba)3, and PdCl2 were purchased from Strem and used without 
further purification.  [Pd(η3-prenyl)Cl]2 was synthesized from PdCl2 and 1-chloro-3-methyl-
2-butene according to a literature procedure.[45] DPEPhos (oxydi-2,1-
phenylene)bis(diphenylphosphine) and rac-BINAP (2,2’-bis(diphenylphosphino)-1,1’-
binaphthalene) were purchased from Strem and used without further purification.  DPPPent 
(1,5-bis(diphenylphosphino)pentane), DPPF (1,1-bis(diphenylphosphino)ferrocene, 
Xantphos (4,5-bis(diphenylphosphino)-9,9-dimethylxanthene) and Cs2CO3 were purchased 
from Sigma-Aldrich and used without further purification.  
Identification of Reaction Conditions for the N-tert-Prenylation of Indoles (Table 1) 
 
 
 
In a nitrogen-filled dry-box, indole-3-carboxaldehyde 1a (72.5 mg, 0.500 mmol, 1.00 
equiv), Cs2CO3 (162 mg, 0.500 mmol, 1.00 equiv), ligand (0.020 mmol, 0.040 equiv), and 
the Pd source (0.010 mmol, 0.020 equiv.) were added to a 1-dram vial.  tert-Butyl (2-
methylbut-3-en-2-yl) carbonate 2 (0.500-1.00 mmol, 2.00 equiv) was added to a second 1-
dram vial. Both vials were sealed with a PFTE/silicone-lined septum cap and removed from 
N
H
CHO Pd source (2 mol%)
ligand (4 mol %)OBoc
Cs2CO3 (1 equiv)
solvent, temp
+ N
CHO
N
CHO
+
1a 2 3a 4a
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the dry-box.  The mixture of 1a, Cs2CO3, and catalyst precursors was suspended in CH2Cl2 
(1.5 mL).  Carbonate 2 was dissolved in CH2Cl2 (1 mL). The vials were allowed to stir for 5 
minutes at the appropriate temperature. The solution of tert-butyl (2-methylbut-3-en-2-yl) 
carbonate 2 was then added to the suspension of 1a, Cs2CO3, and catalyst precursors. The 
reaction mixture was allowed to stir at the reaction temperature (2-20 h) until the 
consumption of carbonate 2 was observed by TLC analysis. The reaction mixture was filtered 
through a pad of silica (eluting with Et2O).  The crude reaction mixture was concentrated 
under reduced pressure.  CDCl3 (0.5-0.7 mL) was added to dissolve the crude reaction 
mixture, and 1,3,5-trimethoxybenzene (28.6 mg, 0.170 mmol) was added as an internal 
standard.  The ratio of N-tert-prenylindole 3a:N-n-prenylindole 4a and the combined yield of 
N-tert-prenylindole 3a and N-n-prenylindole 4a was then determined by 1H NMR 
spectroscopy. For Table 1, entry 14 the crude reaction mixture was purified by flash column 
chromatography (1:1 hexane:Et2O) to yield 3a (80.6 mg, 0.377 mmol). 
N-tert-Prenylation of Indoles 1a-f (Table 2) 
 
General Procedure A: In a nitrogen-filled dry-box, the appropriate indole 1 (0.500 
mmol, 1.00 equiv), Cs2CO3 (163 mg, 0.500 mmol, 1.00 equiv), Xantphos (11.6 mg, 0.020 
mmol, 0.040 equiv), and [Pd(η3-prenyl)Cl]2 (4.2 mg, 0.010 mmol, 0.020 equiv.) were added 
to a 1-dram vial.  tert-Butyl (2-methylbut-3-en-2-yl) carbonate 2 (186 mg, 1.00 mmol, 2.00 
equiv) was added to a second 1-dram vial. Both vials were sealed with a PFTE/silicone-lined 
septum cap and removed from the dry-box.  The mixture of 1, Cs2CO3, and catalyst 
N
H
R1 [Pd(η3-prenyl)Cl]2 (2 mol %)
Xantphos (4 mol %)OBoc
Cs2CO3
CH2Cl2, 0 °C
+
N
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2
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precursors was suspended in CH2Cl2 (1.5 mL).  Carbonate 2 was dissolved in CH2Cl2 (1 mL). 
The vials were cooled to 0 °C and allowed to stir for 5 minutes. The solution of tert-butyl (2-
methylbut-3-en-2-yl) carbonate 2 was then added to the suspension of 1, Cs2CO3, and 
catalyst precursors. The reaction mixture was allowed to stir at the reaction temperature (4-24 
h) until the consumption of carbonate 2 was observed by TLC analysis. The reaction mixture 
was filtered through a pad of silica (eluting with EtOAc).  The crude reaction mixture was 
concentrated under reduced pressure.  CDCl3 (0.5-0.7 mL) was added to dissolve the crude 
reaction mixture, and the ratio of N-tert-prenylindole 3:N-n-prenylindole 4 was determined 
by 1H NMR spectroscopy. The crude reaction mixture was purified by flash column silica gel 
chromatography (hexane:EtOAc or hexane:Et2O) to yield 3a and 3b as single isomers and 
isomeric mixtures of 3c-f + 4c-f. 
 1-(2-Methylbut-3-en-2-yl)-1H-indole-3-carbaldehyde[29] (3a): Prepared 
according to General Procedure A from indole-3-carboxaldehyde 1a (72.5 mg, 
0.500 mmol) (reaction time = 4 h). 1H NMR spectroscopy showed a 12:1 N-
tert-prenylindole 3a:N-n-prenylindole 4b ratio. The mixture was purified by 
flash column chromatography (1:1 hexane:EtOAc) to yield 3a (80.6 mg, 0.377 mmol, 76%) 
as an off-white amorphous solid. Rf  0.16 (80:20 hexane:EtOAc)  1H NMR (400 MHz, 
CDCl3): δ 9.98 (s, 1H), 8.31 (d, J = 7.2 Hz, 1H), 7.90 (s, 1H), 7.53 (d, J = 8.0 Hz, 1H), 7.29 - 
7.18 (m, 2H), 6.10 (dd, J = 17.6, 10.8 Hz, 1H), 5.27 (d, J = 10.8 Hz, 1H), 5.19 (d, J = 17.6 
Hz, 1H), 1.79 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 184.9, 142.7, 136.8, 136.6, 126.9, 
123.4, 122.8, 122.2, 117.7, 115.1, 114.8, 60.7, 28.1. HRMS (ESI) calcd. for C14H16NO+ 
[M+H]+ 214.1226, found 214.1226. 
N
O H
3a
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 1-(1-(2-Methylbut-3-en-2-yl)-1H-indol-3-yl)ethanone (3b): Prepared 
according to General Procedure A from 3-acetylindole 1b (79.6 mg, 0.500 
mmol) (reaction time = 24 h). 1H NMR spectroscopy showed a 10:1 N-tert-
prenylindole 3b:N-n-prenylindole 4b ratio. The crude material was purified by 
flash column chromatography (1:1 hexane:EtOAc) to yield 3b (73.7 mg, 0.324 mmol, 65%) 
as a off-white amorphous solid. Rf  0.19 (80:20 hexane:EtOAc)  1H NMR (400 MHz, 
CDCl3): δ 8.41 (d, J = 7.6 Hz, 1H), 7.94 (s, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.26 (dd, J = 8.4, 
7.6 Hz, 1H), 7.20 (dd, J = 8.4, 7.6 Hz, 1H), 6.12 (dd, J = 17.6, 10.8 Hz, 1H), 5.28 (d, J = 10.8 
Hz, 1H), 5.20 (d, J = 17.6 Hz, 1H), 2.54 (s, 3H), 1.81 (s, 6H). 13C NMR (100 MHz, CDCl3): 
δ 193.3, 143.0, 136.4, 132.7, 127.9, 122.73, 122.68, 122.4, 116.6, 114.9, 114.6, 60.4, 28.2, 
28.0. HRMS (ESI) calcd. for C15H18NO+ [M+H]+ 228.1383, found 228.1383. 
 Methyl 1-(2-methylbut-3-en-2-yl)-1H-indole-3-carboxylate[29] (3c): 
Prepared according to General Procedure A from methyl indole-3-
carboxylate 1c (87.6 mg, 0.500 mmol) (reaction time = 22 h). 1H NMR 
spectroscopy showed a 12:1 N-tert-prenylindole 3c:N-n-prenylindole 4c ratio. 
The mixture was purified by flash column chromatography (1:1 hexane:Et2O) to yield a 
mixture of 3c and 4c (109.1 mg, 0.448 mmol, 90%) as a colorless oil. Rf  0.47 (1:1 
hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 8.19 (d, J = 8.0 Hz, 1H), 8.01 (s, 1H), 7.51 
(d, J = 8.4 Hz, 1H), 7.22 (dd, J = 8.0, 8.4 Hz, 1H), 7.16 (dd, J = 8.0. 8.4 Hz, 1H), 6.08 (dd, J 
= 17.6, 10.8 Hz, 1H), 5.23 (d, J = 10.8 Hz, 1H), 5.15 (d, J = 17.6 Hz, 1H), 3.89 (s, 3H), 1.75 
(s, 6H). 13C NMR (100 MHz, CDCl3): δ 165.9, 143.2, 136.1, 132.3, 128.2, 122.2, 121.9, 
121.8, 114.7, 114.7, 106.5, 60.4, 51.2, 28.2. HRMS (ESI) calcd. for C15H18NO2+ [M+H]+ 
244.1332, found 244.1333. 
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 1-(2-Methylbut-3-en-2-yl)-1H-indole-3-carbonitrile (3d): Prepared 
according to General Procedure A from 3-cyanoindole 1d (71.1 mg, 0.500 
mmol) (reaction time = 22 h). 1H NMR spectroscopy showed a 12:1 N-tert-
prenylindole 3d:N-n-prenylindole 4d ratio. The mixture was purified by flash column 
chromatography (1:1 hexane:Et2O) to yield a mixture of 3d and 4d (99.6 mg, 0.474 mmol, 
94%) as a colorless oil. Rf  0.41 (80:20 hexane:Et2O)  1H NMR (400 MHz, CDCl3): δ 7.45 (s, 
1H), 7.42 - 7.35 (m, 1H), 7.25 - 7.17 (m, 1H), 6.94 - 6.85 (m, 2H), 5.74 (dd, J = 17.4, 10.6 
Hz, 1H), 4.94 (d, J = 10.6 Hz, 1H), 4.83 (d, J = 17.4 Hz, 1H), 1.42 (s, 6H). 13C NMR (100 
MHz, CDCl3): δ 142.6, 134.9, 132.8, 129.4, 123.2, 122.1, 120.1, 116.4, 115.1, 110.9, 85.5, 
60.9, 28.1. HRMS (ESI) calcd. for C14H15N2+ [M+H]+ 211.1230, found 211.1229. 
1-(2-Methylbut-3-en-2-yl)-1H-indole-5-carbonitrile (3e): Prepared 
according to General Procedure A from 5-cyanoindole 1e (71.1 mg, 0.500 
mmol) (reaction time = 22 h at room temperature). 1H NMR spectroscopy 
showed a 7:1 N-tert-prenylindole 3e:N-n-prenylindole 4e ratio. The mixture was purified by 
flash column chromatography (1:1 hexane:Et2O) to yield a mixture of 3e and 4e (41.6 mg, 
0.198 mmol, 40%) as a colorless oil. Rf  0.47 (1:1 hexane:EtOAc) 1H NMR (400 MHz, 
CDCl3): δ 7.95 (s, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.42 (d, J = 3.2 Hz, 1H), 7.32 (d, J = 8.4 Hz, 
1H), 6.56 (d, J = 3.2 Hz, 1H), 6.11 (dd, J = 17.6, 10.8 Hz, 1H), 5.26 (d, J = 10.8 Hz, 1H), 
5.16 (d, J = 17.6 Hz, 1H), 1.76 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 143.5, 137.1, 129.9, 
127.7, 126.7, 123.7, 121.1, 114.7, 114.5, 102.4, 102.0, 60.0, 28.2. HRMS (ESI) calcd. for 
C14H15N2+ [M+H]+ 211.1230, found 211.1230. 
 1-(2-Methylbut-3-en-2-yl)-5-nitro-1H-indole (3f): Prepared according 
to General Procedure A from 5-nitroindole 1f (81.1 mg, 0.500 mmol) 
N
CN
3d
N
O2N
3f
N
NC
3e
 25 
(reaction time = 24 h at room temperature). 1H NMR spectroscopy showed a 7:1 N-tert-
prenylindole 3f:N-n-prenylindole 4f ratio. The mixture was purified by flash column 
chromatography (1:1 hexane:Et2O) to yield a mixture of 3f and 4f (71.8 mg, 0.312 mmol, 
62%) as a light yellow amorphous solid. Rf  0.59 (1:1 hexane:EtOAc) 1H NMR (400 MHz, 
CDCl3): δ 8.53 (d, J = 1.2 1H), 7.98 (d, J = 9.2, 1.2 Hz, 1H), 7.53 (d, J = 9.2 Hz, 1H), 7.44 
(d, J = 3.2 Hz, 1H), 6.64 (d, J = 3.2 Hz, 1H), 6.11 (dd, J = 17.2, 10.4 Hz, 1H), 5.27 (d, J = 
10.4 Hz, 1H), 5.16 (d, J = 17.2 Hz, 1H), 1.76 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 143.4, 
141.4, 138.4, 129.5, 128.7, 118.2, 116.4, 114.6, 113.7, 103.6, 60.2, 28.2. HRMS (ESI) calcd. 
for C13H15N2O2+ [M+H]+ 231.1128, found 231.1128. 
Synthesis of (η6-Indole)Cr(CO)3 Complexes 5a-g 
 
General Procedure B: In a nitrogen-filled dry-box, the appropriate indole 1g-m (2.00-
15.0 mmol), Cr(CO)6 (1.42-1.78 equiv), n-dibutylether (40 mL) and THF (4 mL) were added 
to an oven-dried Schlenk flask (100 mL).  The flask was sealed, removed from the dry-box, 
placed under a positive pressure of nitrogen and equipped with a reflux condenser.  Positive 
pressure of nitrogen gas was maintained throughout the reaction by a nitrogen line equipped 
to the top of the condenser.  The reaction mixture was heated at reflux (oil bath temperature = 
145 °C) for 48 h.  The resulting yellow/orange solution was allowed to cool to room 
temperature under nitrogen then filtered through a short plug of silica gel. The filtrate was 
concentrated under reduced pressure (70 °C water bath temp) to remove excess Cr(CO)6 and 
n-dibutylether.  The resulting yellow/orange solid was recrystallized from hexane:EtOAc to 
afford (η6-indole)Cr(CO)3 complexes 5a-g.  
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 (η6-Indole)Cr(CO)3[46] (5a): Prepared according to General Procedure B 
from indole (1.20 g, 10.2 mmol) and Cr(CO)6 (3.20 g, 14.5 mmol, 1.42 
equiv). The crude product was purified by recrystallization from 
hexane:EtOAc to yield 5a (1.99 g, 7.84 mmol, 73%) as a yellow crystalline solid. Mp = 123-
125 °C (decomposition). 1H NMR (600 MHz, CDCl3) δ 7.84 (br s, 1H), 7.23 (app s, 1H), 
6.41 (app s, 1H), 6.36 (d, J = 6.6 Hz, 1H), 6.12 (d, J = 6.6 Hz, 1H), 5.40 (t, J = 6.6 Hz, 1H), 
5.12 (t, J = 6.6 Hz, 1H). 13C NMR (150 MHz, C6D6) δ 235.0, 130.0, 115.5, 104.0, 100.6, 
90.5, 88.6, 87.4, 78.4. IR: λmax 1847, 1941, 2848, 2916, 3428. HRMS (ESI) calcd. for 
C11H7CrNO3+ [M+H]+ 253.9904, found 253.9901. 
 (η6-3-Methyl-1H-indole)Cr(CO)3[47] (5b): Prepared according to General 
Procedure B from 3-methylindole (1.00 g, 7.62 mmol) and Cr(CO)3 (3.00 
g, 13.6 mmol, 1.78 equiv). The crude product was purified by 
recrystallization from hexane:EtOAc and to yield 5b (1.44 g, 5.39 mmol, 73%) as a yellow 
crystalline solid. 1H NMR (600 MHz, CDCl3) δ 7.59 (br s, 1H), 6.96 (s, 1H), 6.27 (d, J = 6.0 
Hz, 1H), 6.09 (d, J = 6.0 Hz, 1H), 5.41 (t, J = 6.0 Hz, 1H), 5.11 (t, J = 6.0 Hz, 1H), 2.26 (s, 
3H). Mp = 121-123 °C (decomposition).  1H NMR (600 MHz, C6D6) δ 5.94 (app s, 1H), 5.82 
(br s, 1H), 5.58 (d, J = 3.4, 1H), 5.24 (d, J = 3.4, 1H), 4.73 (app s, 1H), 4.41 (app s, 1H), 1.86 
(s, 3H). 13C NMR (150 MHz, C6D6) δ 235.4, 128.4, 126.9, 116.5, 113.6, 100.4, 90.8, 87.5, 
87.0, 79.0, 9.1. IR: λmax 1848, 1933, 2849, 2917, 3428. HRMS (ESI) calcd. for C12H9CrNO3+ 
[M+H]+ 268.0060, found 268.0061.  
 (η6-Methyl 2-(1H-indol-3-yl)acetate)Cr(CO)3 (5c): Prepared 
according to General Procedure B from methyl indole-3-acetate 
(0.380 g, 2.01 mmol) and Cr(CO)3 (0.750 g, 3.41 mmol, 1.70 equiv). 
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The crude product was purified by recrystallization from hexane:EtOAc and to yield 5c 
(0.291 g, 0.895 mmol, 45%) as a yellow crystalline solid. Mp = 124-126 °C (decomposition).  
1H NMR (600 MHz, CDCl3) δ 7.80 (br s, 1H), 7.18 (s, 1H), 6.33 (app s, 1H), 6.08 (app s, 
1H), 5.41 (app s, 1H), 5.11 (app s, 1H), 3.77 (s, 3H), 3.68 (s, 2H). 13C NMR (150 MHz, 
C6D6) δ 234.9, 170.6, 128.34, 116.0, 110.1, 99.7, 90.6, 87.5, 87.0, 78.4, 51.7, 30.5. IR: λmax 
1721, 1849, 1943, 2848, 2916, 3416. HRMS (ESI) calcd. for C14H11CrNO5+ [M+H]+ 
326.0115, found 326.0122. 
 (η6-4-Methoxy-1H-indole)Cr(CO)3 (5d): Prepared according to General 
Procedure B from 4-methoxyindole (1.00 g, 2.92 mmol) and Cr(CO)3 (1.70 
g, 5.10 mmol, 1.75 equiv). The crude product was purified by 
recrystallization from hexane:EtOAc and to yield 5d (0.256 g, 0.904 mmol, 31%) as a yellow 
crystalline solid. Mp = 132-134 °C (decomposition). 1H NMR (600 MHz, CDCl3) δ 7.86 (br 
s, 1H), 7.21 (app s, 1H), 6.63 (app s, 1H), 5.74 (app s, 1H), 5.46 (app s, 1H), 4.88 (app s, 
1H), 3.97 (s, 3H). 1H NMR (600 MHz, C6D6) δ 6.39 (app s, 1H), 6.14 (app s, 1H), 6.02 (br s, 
1H), 4.92 (app s, 1H), 4.80 (app s, 1H), 4.08 (app s, 1H), 3.27 (s, 3H). 13C NMR (150 MHz, 
C6D6) δ 235.4, 139.7, 129.2, 118.1, 102.8, 95.4, 90.1, 73.0, 69.6, 55.7. IR: λmax 1815, 1841, 
1929, 3437. HRMS (ESI) calcd. for C12H9CrNO4+ [M+H]+ 284.0009, found 284.0009. 
 (η6-5-Methoxy-1H-indole)Cr(CO)3 (5e): Prepared according to General 
Procedure B from 5-methoxyindole (0.650 g, 4.42 mmol) and Cr(CO)3 
(1.46 g, 6.63 mmol, 1.50  equiv). The crude product was purified by 
recrystallization from hexane:EtOAc and to yield 5e (0.591 g, 2.09 mmol, 46%) as a yellow 
crystalline solid. Mp = 133-135 °C (decomposition). 1HMR (600MHz, CDCl3) δ 6.15 (s, 
1H), 6.63 (app s, 1H), 5.74 (app s, 1H), 5.46 (app s, 1H), 4.88 (app s, 1H), 3.11 (s, 3H). 
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1HMR (600MHz, C6D6) 6.15 (app s, 1H), 5.83 (app s, 1H), 5.72 (br s, 1H), 5.41 (app s, 1H), 
5.30 (app s, 1H), 4.79 (app s, 1H), 3.11 (s, 3H). 13C NMR (150 MHz, C6D6) δ 235.4, 138.7, 
131.2, 109.5, 103.4, 102.1, 79.5, 79.2, 71.8, 55.6. IR: λmax 1849, 1933, 2849, 2916, 2961, 
3445. HRMS (ESI) calcd. for C12H9CrNO4+ [M+H]+ 284.0009, found 284.0013.  
 (η6-6-Methoxy-1H-indole)Cr(CO)3 (5f): Prepared according to General 
Procedure B from 6-methoxyindole (0.500 g, 3.40 mmol) and Cr(CO)3 
(1.12 g, 5.09 mmol, 1.50 equiv). The crude product was purified by 
recrystallization from hexane:EtOAc and to yield 5f (0.202 g, 0.713 mmol, 21%) as a yellow 
crystalline solid. Mp = 131-133 °C (decomposition).  1H NMR (600 MHz, CDCl3) δ 7.70 (br 
s, 1H), 7.16 (s, 1H), 6.42 (d, J = 6.6 Hz, 1H), 6.31 (s, 1H), 5.95 (s, 1H), 5.04 (d, J = 6.6 Hz, 
1H), 3.78 (s, 3H). 1H NMR (600MHz, C6D6) δ 6.18 (s, 1H), 5.90 (br s, 1H), 5.77 (s, 1H), 
5.76 (d, J = 6.6 Hz, 1H), 5.21 (s, 1H), 4.41 (d, J = 6.6 Hz, 1H), 3.17 (s, 1H). 13C NMR (150 
MHz, C6D6) δ 235.5, 141.2, 129.5, 117.7, 104.3, 95.4, 87.9, 75.6, 65.8, 55.4. IR: λmax 1834, 
1877, 1934, 3114, 3146, 3359, 3418. HRMS (ESI) calcd. for C12H9CrNO4+ [M+H]+ 
284.0009, found 284.0013.  
 (η6-7-Methoxy-1H-indole)Cr(CO)3 (5g): Prepared according to General 
Procedure B from 7-methoxyindole (0.500 g, 3.40 mmol) and Cr(CO)3 
(1.12 g, 5.09 mmol, 1.50 equiv). The crude product was purified by 
recrystallization from hexane:EtOAc and to yield 5g (0.505 g, 1.78 mmol, 53 %) as a yellow 
crystalline solid. Mp = 116-118 °C (decomposition). 1H NMR (400MHz, CDCl3) δ 8.2 (br s, 
1H), 7.32 (app s,1H), 6.49 (app s, 1H), 5.81 (d, J = 6.4 Hz, 1H), 5.23 (t, J = 6.4, 1H) 5.07 (d, 
J = 6.4, 1H), 3.99 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 235.1, 132.6, 131.3, 108.8, 104.3, 
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88.6, 82.5, 77.4, 72.2, 56.7. IR: λmax 1825, 1936, 2848, 2916, 3405. HRMS (ESI) calcd. for 
C12H9CrNO4+ [M+H]+ 284.0009, found 284.0011. 
 
N-tert-Prenylation of (η6-Indole)Cr(CO)3 Complexes 5a-g (Table 3) 
 
General Procedure C: In a nitrogen-filled dry-box, the appropriate (η6-indole)Cr(CO)3 
complex 5 (0.250 mmol, 1.00 equiv), Cs2CO3 (81.2 mg, 0.250 mmol, 1.00 equiv), Xantphos 
(5.79 mg, 0.010 mmol, 0.020 equiv), and [Pd(η3-prenyl)Cl]2 (2.11 mg, 0.005 mmol, 0.010 
equiv.) were added to a 1-dram vial.  tert-Butyl (2-methylbut-3-en-2-yl) carbonate 2 (93.1 
mg, 0.500 mmol, 2.00 equiv) was added to a second 1-dram vial. Both vials were sealed with 
a PFTE/silicone-lined septum cap and removed from the dry-box. The mixture of 5, Cs2CO3, 
and catalyst precursors was suspended in CH2Cl2 (1.5 mL).  Carbonate 2 was dissolved in 
CH2Cl2 (1 mL). The vials were allowed to stir for 5 minutes. The solution of tert-butyl (2-
methylbut-3-en-2-yl) carbonate 2 was then added to the suspension of 5, Cs2CO3, and 
catalyst precursors. The reaction mixture was allowed to stir at room temperature (2-6 h) 
until the consumption of carbonate 2 was observed by TLC analysis.  The solvent was 
removed under reduced pressure.  The residue was taken up in CH3CN (3 mL), cooled to 0 
°C, and DDQ (85.0 mg, 0.750 mmol, 1.50 equiv) was added.  The reaction mixture was 
allowed to stir at 0 °C for 2-6 h.  The reaction progress was monitored by TLC analysis.  
When the reaction was judged to be complete, the solvent was removed under reduced 
pressure.  The resulting residue was taken up in Et2O, filtered through a short plug of silica 
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gel (eluting with Et2O), and concentrated under reduced pressure. CDCl3 (0.5 - 0.7 mL) was 
added to dissolve the crude reaction mixture and the ratio of N-tert-prenylindole 3:N-n-
prenylindole 4 was determined by 1H NMR spectroscopy. The crude reaction mixture was 
purified by flash column silica gel chromatography (hexane:EtOAc or hexane:Et2O) to yield 
isomeric mixtures of 3g-m + 4g-m. 
1-(2-Methylbut-3-en-2-yl)-1H-indole[25-26] (3g): Prepared according to 
General Procedure C from (η6-indole)Cr(CO)3 (63.3 mg, 0.250 mmol) 
(reaction time = 3 h). 1H NMR spectroscopy showed an 8:1 N-tert-prenylindole 
3g:N-n-prenylindole 4g ratio. The crude material was purified by flash chromatography (95:5 
hexane:Et2O) to yield a mixture of 3g and 4g (39.9 mg, 0.215 mmol, 86%) as a colorless oil. 
Rf  0.64 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.71 - 7.66 (m, 1H), 7.61 - 
7.55 (m, 1H), 7.36 (d, J = 2.0 Hz, 1H), 7.22 - 7.10 (m, 2H), 6.55 (d, J = 2.6 Hz, 1H), 6.21 
(dd, J = 17.2, 10.8 Hz, 1H), 5.28 (d, J = 10.8 Hz, 1H), 5.22 (d, J = 17.2 Hz, 1H), 1.81 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 144.5, 135.6, 130.3, 125.3, 121.2, 120.9, 119.4, 114.1, 113.8, 
100.9, 59.3, 28.2 HRMS (ESI) calcd. for C13H16N+ [M+H]+186.1277, found 186.1279.  
3-Methyl-1-(2-methylbut-3-en-2-yl)-1H-indole (3h): Prepared according to 
General Procedure C from (η6-3-methyl-1H-indole)Cr(CO)3 (70.6 mg, 0.250 
mmol) (reaction time = 2 h). 1H NMR spectroscopy showed an 8:1 N-tert-
prenylindole 3h:N-n-prenylindole 4h ratio. The crude material was purified by 
flash chromatography (95:5 hexane:Et2O) to yield a mixture of 3h and 4h (37.3 mg, 0.187 
mmol, 75%) as a colorless oil. Rf  0.64 (80:20 hexane:EtOAc) 1H NMR (400 MHz, CDCl3): 
δ 7.65 - 7.59 (m, 1H), 7.57 - 7.50 (m, 1H), 7.20 - 7.09 (m, 3H), 6.20 (dd, J = 18.0, 11.2 Hz, 
1H), 5.25 (d, J = 11.2 Hz, 1H), 5.21 (d, J = 18.0 Hz, 1H), 2.38 (s, 3H), 1.78 (s, 6H). 13C 
N
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NMR (100 MHz, CDCl3): δ 144.8, 135.9, 130.4, 123.1, 120.9, 119.2, 118.7, 113.9, 113.6, 
109.7, 59.0, 28.2, 10.0. HRMS (ESI) calcd. for C14H18N+ [M+H]+ 200.1434, found 200.1435.  
Methyl 2-(1-(2-methylbut-3-en-2-yl)-1H-indol-3-yl)acetate (3i): 
Prepared according to General Procedure C from (η6-methyl 2-(1H-indol-
3-yl)acetate)Cr(CO)3 (85.1 mg, 0.250 mmol) (reaction time = 2 h). 1H 
NMR spectroscopy showed a 9:1 N-tert-prenylindole 3i:N-n-prenylindole 
4i ratio. The crude material was purified by flash chromatography (70:30 hexane:Et2O) to 
yield a mixture of 3i and 4i (50.3 mg, 0.195 mmol, 78%) as a colorless oil. Rf  0.51 (80:20 
hexane:EtOAc) 1H NMR (400 MHz, CDCl3): δ 7.62 (m, 1H), 7.52 (m, 1H), 7.30 (s, 1H), 
7.18 - 7.08 (m, 2H), 6.16 (dd, J = 17.6, 11.0 Hz, 1H), 5.23 (d, J = 11.0, 1H), 5.20 (d, J = 17.8 
Hz, 1H), 3.79 (s, 2H), 3.72 (s, 3H), 1.77 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 173.0, 
144.5, 135.8, 129.4, 124.4, 121.2, 119.31, 119.25, 114.1, 113.8, 106.5, 59.3, 52.2, 31.6, 28.2. 
HRMS (ESI) calcd, for C16H20NO2+ [M+H]+ 258.1489, found 258.1491. 
4-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3j): Prepared according to 
General Procedure C from (η6-4-methoxy-1H-indole)Cr(CO)3 (74.6 mg, 0.250 
mmol) (reaction times = 6 h). 1H NMR spectroscopy showed a 7:1 N-tert-
prenylindole 3j:N-n-prenylindole 4j ratio. The crude material was purified by 
flash chromatography (95:5 hexane:Et2O) to yield a mixture of 3j and 4j (41.8 mg, 0.194 
mmol, 78%) as a colorless oil. Rf  0.53 (80:20 hexane:EtOAc) 1H NMR (400 MHz, CDCl3): 
δ 7.25 (d, J = 3.2 Hz, 1H), 7.19 (d, J = 8.0 Hz, 1H), 7.07 (app t, J = 8.0 Hz, 1H), 6.63 (d, J = 
3.2 Hz, 1H), 6.53 (d, J = 8.0 Hz, 1H), 6.18 (dd, J = 17.6, 10.4 Hz, 1H), 5.24 (d, J = 10.4 Hz, 
1H), 5.18 (d, J = 17.6 Hz, 1H), 3.98 (s, 3H), 1.78 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 
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153.6, 144.5, 137.0, 123.9, 121.6, 120.9, 113.7, 107.7, 99.2, 98.0, 59.4, 55.6, 28.3. HRMS 
(ESI) calcd. for C14H18NO+ [M+H]+ 216.1383, found 216.1381. 
5-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3k): Prepared 
according to General Procedure C from (η6-5-methoxy-1H-
indole)Cr(CO)3 (74.6 mg, 0.250 mmol) (reaction time = 5 h). 1H NMR 
spectroscopy showed an 8:1 N-tert-prenylindole 3k:N-n-prenylindole 4k ratio. The crude 
material was purified by flash chromatography (95:5 hexane:Et2O) to yield a mixture of 3k 
and 4k (27.4 mg, 0.127 mmol, 51%) as a colorless oil. Rf  0.35 (80:20 hexane:EtOAc) 1H 
NMR (400 MHz, CDCl3): δ 7.44 (d, J = 9.2 Hz, 1H), 7.30 (d, J = 2.4 Hz, 1H), 7.11 (d, J = 
2.4 Hz, 1H), 6.82 (dd, J = 9.2, 2.8 Hz, 1H), 6.44 (d, J = 2.8 Hz, 1H), 6.16 (dd, J = 17.6, 10.8 
Hz, 1H), 5.24 (d, J = 10.8 Hz, 1H), 5.18 (d, J = 17.6 Hz, 1H), 3.87 (s, 3H), 1.76 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 153.9, 144.5, 130.9, 130.7, 125.9, 114.7, 113.8, 111.3, 102.6, 
100.5, 59.2, 56.0, 28.2. HRMS (ESI) calcd. for C14H18NO+ [M+H]+ 216.1383, found 
216.1385.  
6-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3l): Prepared 
according to General Procedure C from (η6-6-methoxy-1H-
indole)Cr(CO)3 (74.6 mg, 0.250 mmol) (reaction time = 5 h). 1H NMR 
spectroscopy showed a 7:1 N-tert-prenylindole 3l:N-n-prenylindole 4l ratio. The crude 
material was purified by flash chromatography (95:5 hexane:Et2O) to yield a mixture of 3l 
and 4l (39.0 mg, 0.181 mmol, 73%) as a colorless oil. Rf  0.54 (80:20 hexane:EtOAc) 1H 
NMR (400 MHz, CDCl3): δ 7.52 (d, J = 8.4 Hz, 1H), 7.23 (d, J = 3.2 Hz, 1H), 7.07 (d, J = 
1.6 Hz, 1H), 6.80 (dd, J = 8.4, 1.6 Hz, 1H), 6.45 (d, J = 3.2 Hz, 1H), 6.18 (dd, J = 17.6, 10.4 
Hz, 1H), 5.27 (d, J = 10.4 Hz, 1H), 5.22 (d, J = 17.6 Hz, 1H), 3.85 (s, 3H), 1.77 (s, 6H). 13C 
N
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NMR (100 MHz, CDCl3): δ 155.4, 144.5, 136.3, 124.7, 124.3, 121.5, 113.7, 108.9, 100.8, 
98.3, 59.2, 56.0, 28.0. HRMS (ESI) calcd. for C14H18NO+ [M+H]+ 216.1383, found 
216.1379.  
7-Methoxy-1-(3-methylbut-2-en-1-yl)-1H-indole (4m): Prepared 
according to General Procedure C from (η6-7-methoxy-1H-indole)Cr(CO)3 
(74.6 mg, 0.250 mmol) (reaction time = 5 h). 1H NMR spectroscopy showed 
a <1:20 N-tert-prenylindole 3m:N-n-prenylindole 4m ratio. The crude material was purified 
by flash chromatography (95:5 hexane:Et2O) to yield the linear isomer 4m (24.5 mg, 0.114 
mmol, 46%) as a colorless oil. Rf  0.68 (80:20 hexane:EtOAc) 1H NMR (400 MHz, CDCl3): 
δ 7.22 (d, J = 8.0 Hz, 1H), 7.02 (d, J = 2.8 Hz, 1H), 6.99 (t, J = 8.0 Hz, 1H), 6.63 (d, J = 8.0 
Hz, 1H), 6.45 (d, J = 2.8 Hz, 1H), 5.43 (t, J = 7.0 Hz, 1H), 5.04 (d, J = 7.0 Hz, 2H), 3.94 (s, 
3H), 1.81 (s, 3H), 1.75 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 148.0, 135.0, 131.2, 128.5, 
126.0, 122.4, 119.9, 114.1, 102.6, 101.7, 55.7, 47.0, 26.0, 18.3. HRMS (ESI) calcd. for 
C14H18NO+ [M+H]+ 216.1383, found 216.1383.  
Synthesis of Indolines 6b-i 
 
General Procedure D: To a stirred solution of indole 1h, 1j-m (2.38 – 6.79 mmol) in 
acetic acid (4–15 mL) was added NaBH3CN (5.96-17.0 mmol, 2.50 equiv). The reaction was 
let stir at room temperature and reaction progress was monitored by TLC analysis. The 
reaction mixture was diluted with H2O, basified to pH ~9 using NaOH pellets and extracted 
using EtOAc (3x). The combined organic layers were washed with H2O, saturated NaCl 
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solution, dried over Na2SO4, filtered and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography (hexane:EtOAc) to yield products 6b 
and 6f-i. 
 
General Procedure E: To a stirred solution of indole 1i, 1n-o (1.38 – 2.64 mmol) in 
trifluoroacetic acid (3–6 mL) at 50 °C was added Et3SiH (2.76-5.29 mmol, 2.00 equiv) and 
the reaction was heated for 48 h and reaction progress was monitored by TLC analysis. The 
reaction mixture was cooled to room temperature, diluted with H2O, basified to pH ~9 using 
a saturated solution of NaHCO3 and extracted using CHCl3 (3x). The combined organic 
layers were washed dried over MgSO4, filtered and concentrated under reduced pressure. The 
crude product was purified by flash column chromatography (hexane:EtOAc) to yield 
products 6c–e. 
 3-Methyl-1H-indoline[48] (6b): Prepared according to General Procedure D 
from 3-methyl-1H-indole (0.500 g, 3.81 mmol), NaBH3CN (0.600 g, 9.53 mmol, 
2.50 equiv) and 8 mL acetic acid (reaction time = 4.5 h) and monitored by TLC. 
The crude product was purified by flash column silica gel chromatography (80:20 
hexane:EtOAc) to yield 6b (0.394 g, 2.96 mmol, 78%) as a brown/red oil. Rf  0.40 (80:20 
hexane:EtOAc) 1H NMR (400 MHz, CDCl3): δ 7.32 (app d, J = 7.6 Hz, 1H), 7.27 (ddd, J = 
7.6, 7.6, 1.2 Hz, 2H), 6.99 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 6.81 (app d, J = 7.6 Hz, 1H), 3.87 
(br s, 1H), 3.82 (t, J = 8.8 Hz, 1H), 3.61 - 3.49 (m, 1H), 3.24 (t, J = 8.8 Hz, 1H), 1.54 (d, J = 
6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 151.3, 134.2, 127.1, 123.2,118.4, 109.3, 55.3, 
36.5, 18.6. HRMS (ESI) calcd. for C9H12N+ [M+H]+ 134.0963, found 134.0965.  
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 Methyl 2-(indolin-3-yl)acetate[49] (6c): Prepared according to General 
Procedure E from methyl 2-(1H-indol-3-yl)acetate (0.50 g, 2.64 mmol), 
Et3SiH (0.59 mL, 5.29 mmol, 2.00 equiv) and 4 mL trifluoroacetic acid 
(reaction time = 48 h at 50 °C). The crude product was dried on a vacuum 
line at 40 °C to remove unreacted Et3SiH and yield 6c (0.303 g, 1.58 mmol, 60%) as a brown 
oil. Rf  0.13 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.11 - 7.02 (m, 2H), 6.72 
(ddd, J = 7.6, 7.6,1.2 Hz, 1H), 6.65 (app d, J = 7.6 Hz, 1H), 3.79 (t, J = 8.8 Hz, 2H), 3.74 (s, 
1H), 3.72 (s, 3H), 3.27 (dd, J = 8.8, 6.0 Hz, 1H), 2.78 (dd, J = 16.0, 6.0 Hz, 1H), 2.58 (dd, J 
= 16.0, 8.8 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 173.1, 151.5, 131.5, 128.3, 124.2, 
119.0, 110.0, 53.7, 52.0, 39.0, 38.8. HRMS (ESI) calcd. for C11H14NO2+ [M+H]+ 192.1019, 
found 192.1019.  
 3-Phenyl-1H-indoline[50-51] (6d): Prepared according to General Procedure E 
from 3-phenyl-1H-indole (0.500 g, 2.57 mmol), Et3SiH (0.570 mL, 5.15 mmol, 
2.00 equiv) and 6 mL trifluoroacetic acid (reaction time = 48 h). The crude 
product was dried on a vacuum line at 40 °C to remove unreacted Et3SiH and yield 6d (0.356 
g, 1.82 mmol, 71%) as a light brown oil. Rf  0.37 (80:20 hexane:EtOAc)  1H NMR (400 
MHz, CDCl3): δ 7.33 - 7.18 (m, 5H), 7.09 - 7.02 (m,  1H), 6.89 (m, 1H), 6.69 (m, 2H), 4.46 
(t, J = 9.2 Hz, 1H), 3.90 (t, J = 9.2 Hz, 1H), 3.89 (br s, 1H), 3.47 (t, J = 9.2 Hz, 1H). 13C 
NMR (100 MHz, CDCl3): δ 151.8, 143.8, 132.7, 128.9, 128.5, 128.1, 127.0, 125.3, 119.4, 
110.1, 57.0, 49.0. HRMS (ESI) calcd. for C14H14N+ [M+H]+ 196.1121, found 196.1119.  
2-(2-(Indolin-3-yl)ethyl)isoindoline-1,3-dione[52] (6e): Prepared 
according to General Procedure E from 2-(2-(1H-indol-3-
yl)ethyl)isoindoline-1,3-dione (0.400 g, 1.38 mmol), Et3SiH (0.310 mL, 
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2.76 mmol, 2.00 equiv) and 3 mL trifluoroacetic acid (reaction time = 48 h). The crude 
product was purified by flash column chromatography (60:40 hexane:EtOAc) to yield 6e 
(0.281 g, 0.96 mmol, 70%) as a tan amorphous solid. Rf  0.31 (80:20 hexane:EtOAc)  1H 
NMR (400 MHz, CDCl3): δ 7.87 - 7.80 (m, 2H), 7.75 - 7.67 (m, 2H), 7.15 (app d, J = 7.6 Hz, 
1H), 7.01 (app t, J = 7.6 Hz, 1H), 6.70 (ddd, J = 7.6, 7.6, 0.8 Hz, 2H), 6.63 (app d, J = 7.6 
Hz, 1H), 3.84 - 3.74 (m, 3H), 3.33 - 3.25 (m, 2H), 2.27 - 2.16 (m, 1H), 1.99 - 1.88 (m, 1H), 
1.26 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 168.7, 151.5, 134.3, 132.4, 132.1, 128.0, 124.2, 
123.6, 119.1, 110.0, 53.3, 40.0, 36.4, 33.0. HRMS (ESI) calcd. for C18H17N2O2+ [M+H]+ 
293.1285, found 293.1286. 
4-Methoxy-1H-indoline[53] (6f): Prepared according to General Procedure D 
from 4-methoxy-1H-indole (0.500 g, 3.40 mmol), NaBH3CN (0.530 g, 8.49 
mmol, 2.50 equiv) and 7 mL acetic acid (reaction time = 3 h). The crude product 
was purified by flash column chromatography (80:20 hexane:EtOAc) to yield 6f 
(0.332 g, 2.22 mmol, 65%) as an opaque oil. Rf  0.28 (80:20 hexane:EtOAc)  1H NMR (400 
MHz, CDCl3): δ 7.01 (d, J = 8.0 Hz, 1H), 6.32 (d, J = 8.0 Hz, 2H), 3.97 (br s, 1H), 3.83 (s, 
3H), 3.57 (t, J = 8.4 Hz, 2H), 3.00 (t, J = 8.4 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 156.7, 
153.4, 128.9, 116.1, 103.6, 102.0, 55.5, 47.7, 27.1. HRMS (ESI) calcd. for C9H12NO+ 
[M+H]+ 150.0913, found 150.0913. 
5-Methoxy-1H-indoline[54-55] (6g): Prepared according to General 
Procedure D from 5-methoxy-1H-indole (1.00 g, 6.79 mmol), NaBH3CN 
(1.07 g, 17.0 mmol, 2.50 equiv) and 14 mL acetic acid (reaction time = 2 
h). The crude product was purified by flash column chromatography (80:20 hexane:EtOAc) 
to yield 6g (0.766 g, 5.13 mmol, 76%) as a brown/red oil. Rf  0.16 (80:20 hexane:EtOAc)  1H 
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NMR (400 MHz, CDCl3): δ 6.78 (s, 1H), 6.65 - 6.55 (m, 2H), 3.75 (s, 3H), 3.52 (t, J = 8.4 
Hz, 2H), 3.52 (br s, 1H), 3.01 (t, J = 8.4 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 153.6, 
145.6, 131.3, 112.3, 111.7, 110.2, 56.1, 48.0, 30.6. HRMS (ESI) calcd. for C9H12NO+ 
[M+H]+ 150.0913, found 150.0913.  
6-Methoxy-1H-indoline[56] (6h): Prepared according to General Procedure 
D from 6-methoxy-1H-indole (0.350 g, 2.38 mmol), NaBH3CN (0.370 g, 
5.95 mmol, 2.50 equiv) and 5 mL acetic acid (reaction time = 2 h). The 
crude product was purified by flash column chromatography (80:20 hexane:EtOAc) to yield 
6h (0.326 g, 2.19 mmol,, 92%) as a brown/red oil. Rf  0.26 (80:20 hexane:EtOAc) 1H NMR 
(400 MHz, CDCl3): δ 7.02 (d, J = 8.0 Hz, 1H), 6.33 - 6.22 (m, 2H), 3.92 (br s, 1H), 3.77 (s, 
3H), 3.55 (t, J = 8.2 Hz, 2H), 2.98 (t, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 159.9, 
153.1, 124.7, 121.7, 103.4, 96.4, 55.4, 48.0, 29.1. HRMS (ESI) calcd. for C9H12NO+ [M+H]+ 
150.0913, found 150.0912. 
5-Bromo-1H-indoline[57] (6i): Prepared according to General Procedure D 
from 5-bromo-1H-indole (0.500 g, 2.55 mmol), NaBH3CN (0.400 g, 6.38 
mmol, 2.50 equiv) and 5 mL acetic acid (reaction time = 2 h). The crude 
product was purified by flash column chromatography (80:20 hexane:EtOAc) to yield 6i 
(0.469 g, 3.14 mmol, 93%) as a brown/red oil. Rf  0.29 (80:20 hexane:EtOAc) 1H NMR (400 
MHz, CDCl3): δ 6.69 (d, J = 2.0 Hz, 1H), 6.59 (dd, J = 8.4, 2.0 Hz, 1H), 5.99 (d, J = 8.4 Hz, 
1H), 3.16 (br s, 1H), 3.04 (t, J = 8.6 Hz, 2H), 2.50 (t, J = 8.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 150.9, 132.1, 130.1, 127.8, 110.9, 110.4, 47.8, 30.0. HRMS (ESI) calcd. for 
C8H9BrN+ [M+H]+ 197.9913, observed 197.9914. 
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N-tert-Prenylation of Indolines 6a-i (Table 4) 
 
 
 
General Procedure F: In a nitrogen-filled dry-box, the appropriate indoline 6 (0.500 
mmol, 1.00 equiv), Cs2CO3 (163 mg, 0.500 mmol, 1.00 equiv), Xantphos (11.6 mg, 0.020 
mmol, 0.040 equiv), and [Pd(η3-prenyl)Cl]2 (4.21 mg, 0.010 mmol, 0.020 equiv.) were added 
to a 1-dram vial.  tert-Butyl (2-methylbut-3-en-2-yl) carbonate 2 (186 mg, 1.00 mmol, 2.00 
equiv) was added to a second 1-dram vial. Both vials were sealed with a PFTE/silicone-lined 
septum cap and removed from the dry-box.  The mixture of 1, Cs2CO3, and catalyst 
precursors was suspended in CH2Cl2 (1.5 mL).  Carbonate 2 was dissolved in CH2Cl2 (1 mL). 
The vials were cooled to 0 °C and allowed to stir for 5 minutes. The solution of tert-butyl (2-
methylbut-3-en-2-yl) carbonate 2 was then added to the suspension of 1, Cs2CO3, and 
catalyst precursors. The reaction mixture was allowed to stir at the reaction temperature (1.5-
2 h) until the consumption of carbonate 2 was observed by TLC analysis. The reaction 
mixture was filtered through a pad of silica (eluting with EtOAc) and the crude reaction 
mixture was concentrated under reduced pressure.  CDCl3 (0.5-0.7 mL) was added to 
dissolve the crude reaction mixture, and the ratio of N-tert-prenylindoline 7a-i:N-n-
prenylindoline 8a-i was determined by 1H NMR spectroscopy. The crude reaction mixture 
was purified by flash column chromatography (hexane:Et2O) to yield 7a-d and 7f-i as single 
constitutional isomers and an isomeric mixture of 7e + 8e. N-tert-prenylindoline 7a-i (0.125-
0.200 mmol, 1.00 equiv) was then added to a scintillation vial, dissolved in 4 mL CH2Cl2 and 
MnO2 (5.00 equiv) was added. The reaction mixture was heated to 50 °C for 24 - 48 hours in 
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the sealed vial. The reaction mixture was cooled to room temperature, filtered through a pad 
of celite (eluting with EtOAc) and concentrated under reduced pressure to yield products 3g-l 
and 3n-p. 
1-(2-Methylbut-3-en-2-yl)indoline[25-26] (7a): Prepared according to General 
Procedure F from 1H-indoline (59.6 mg, 0.500 mmol) (reaction time = 2 h). 1H 
NMR spectroscopy showed a 6:1 N-tert-prenylindoline 7a:N-n-prenylindoline 
8a ratio. The crude material was purified by flash chromatography (98:2 hexane:Et2O) to 
yield 7a (77.5 mg, 0.414 mmol, 83%) as a colorless oil. Rf  0.42 (80:20 hexane:EtOAc)  1H 
NMR (400 MHz, CDCl3): δ 7.11 (d, J = 7.6 Hz, 1H), 7.00 (t, J = 7.6 Hz, 1H), 6.84 (d, J = 7.6 
Hz, 1H), 6.68 (t, J = 7.6 Hz, 1H), 6.18 (dd, J = 17.6, 10.8 Hz, 1H), 5.28 (d, J = 17.6 Hz, 1H), 
5.18 (d, J = 10.8 Hz, 1H), 3.47 (t, J = 8.4 Hz, 2H), 2.95 (t, J = 8.4 Hz, 2H), 1.39 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 151.0, 147.32, 131.7, 126.7, 124.5, 117.5, 112.4, 111.4, 57.6, 
49.3, 28.4, 24.3. HRMS (ESI) calcd. for C13H18N+ [M+H]+ 188.1434, observed 188.1435.  
1-(2-Methylbut-3-en-2-yl)-1H-indole[25-26] (3g): Prepared according to 
General Procedure F from 7a (37.5 mg, 0.200 mmol) and MnO2 (87.0 mg, 
1.00 mmol, 5.00 equiv) and heated for 24 h. Pure isomer 3g was isolated as a 
colorless oil (36.1 mg, 0.195 mmol, 96%). Experimental data matches values for Table 3, 
entry 1.  
 3-Methyl-1-(2-methylbut-3-en-2-yl)-1H-indoline (7b): Prepared according 
to General Procedure F from 6b (66.6 mg, 0.500 mmol) (reaction time = 2 h) 
1H NMR spectroscopy showed a 5:1 N-tert-prenylindoline 7b:N-n-
prenylindoline 8b. The crude material was purified by flash chromatography (98:2 
hexane:Et2O) to yield 8b (59.6 mg, 0.296 mmol, 59%) as a colorless oil. Rf  0.65 (80:20 
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hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.07 (app d, J = 7.2 Hz, 1H), 7.01 (app t, J = 
8.8 Hz, 1H), 6.83 (app d, J = 8.0 Hz, 1H), 6.70 (ddd, J = 7.2, 7.2, 0.8 Hz, 1H), 6.17 (dd, J = 
17.6, 10.8 Hz, 1H), 5.27 (dd, J = 17.6, 1.2 Hz, 1H), 5.17 (dd, J = 10.8, 1.2 Hz, 1H), 3.66 (t, J 
= 8.4 Hz, 1H), 3.33 - 3.19 (m, 1H), 2.99 (t, J = 8.4 Hz, 1H), 1.40 (s, 3H), 1.37 – 1.32 (d, J = 
6.8, 3H), 1.36 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 150.6, 147.3, 136.6, 126.9, 123.1, 
117.5, 112.4, 111.4, 57.4, 34.7, 26.8, 22.0, 18.6. HRMS (ESI) calcd. for C14H20N+ [M+H]+ 
202.1590, found 202.1591. 
3-Methyl-1-(2-methylbut-3-en-2-yl)-1H-indole (3h): Prepared according to 
General Procedure F from 7b (40.3 mg, 0.200 mmol) and MnO2 (87.0 mg, 
1.00 mmol, 5.00 equiv) and heated for 24 h. Pure isomer 3h was isolated as a 
colorless oil (38.5 mg, 0.193 mmol, 97%). Experimental data matches values for Table 3, 
entry 2. 
 Methyl 2-(1-(2-methylbut-3-en-2-yl)-1H-indolin-3-yl)acetate (7c): 
Prepared according to General Procedure F from 6c (95.6 mg, 0.500 
mmol) (reaction time = 1.5 h). 1H NMR spectroscopy showed a 5:1 N-tert-
prenylindoline 7c:N-n-prenylindoline 8c. The crude material was purified 
by flash chromatography on silica gel (98:2 hexane:Et2O) to yield 7c (73.2 mg, 0.282 mmol, 
56%) as a colorless oil. Rf  0.51 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.03 
-7.01 (app d, J = 7.2 Hz, 1 H), 7.00 - 6.96 (app t, J = 8.0, 1H), 6.79 (app d, J = 8.0 Hz, 1H), 
6.64 (app t, J = 7.2 Hz, 1H), 6.10 (dd, J = 17.6, 10.8 Hz, 1H), 5.22 (dd, J = 17.6, 1.0 Hz, 1H), 
5.13 (d, J = 10.8, 1.0 Hz, 1H), 3.73 (s, 3H), 3.69 (t, J = 8.4 Hz, 1H), 3.63 - 3.52 (m, 1H), 3.15 
(dd, J = 8.6, 6.0 Hz, 1H), 2.79 (dd, J = 16.4, 6.0 Hz, 1H), 2.58 (dd, J = 16.4, 8.6 Hz, 1H), 
1.34 (s, 3H), 1.33 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 173.3, 150.6, 147.0, 133.4, 127.6, 
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123.6, 117.5, 112.6, 111.7, 57.4, 55.4, 52.0, 38.9, 36.6, 24.8, 24.1. HRMS (ESI) calcd. for 
C16H22NO2+ [M+H]+ 260.1645, found 260.1646. 
Methyl 2-(1-(2-methylbut-3-en-2-yl)-1H-indol-3-yl)acetate (3i): 
Prepared according to General Procedure F from 7c (51.9 mg, 0.200 
mmol) and MnO2 (87.0 mg, 1.00 mmol, 5.00 equiv) and heated for 48 h. 
Pure isomer 3i was isolated as a colorless oil (39.6 mg, 0.154 mmol, 
77%). Experimental data matches values for Table 3, entry 3. 
 1-(2-Methylbut-3-en-2-yl)-3-phenyl-1H-indoline (7d): Prepared according 
to General Procedure F from 6d (97.6 mg, 0.500 mmol) (reaction time = 2 h). 
1H NMR spectroscopy showed a 5:1 N-tert-prenylindoline 7d:N-n-
prenylindoline 7d. The crude material was purified by flash chromatography (98:2 
hexane:Et2O) to yield 7d (80.8 mg, 0.307 mmol, 61%) as a colorless oil. Rf  0.68 (80:20 
hexane:EtOAc). 1H NMR (400 MHz, CDCl3): δ 7.26 (m, 4H), 7.24 – 7.16 (m, 1H), 6.95 (app 
t, J = 8.0 Hz, 1H), 6.82 (app d, J = 8.0 Hz, 1H), 6.79 (app d, J = 8.0 Hz, 1H), 6.57 (app t, J = 
8.0 Hz, 1H), 6.11 (dd, J = 17.6, 10.4 Hz, 1H), 5.21 (dd, J = 17.6, 0.8 Hz, 1H), 5.10 (dd, J = 
10.4, 0.8 Hz, 1H), 4.29 (t, J = 8.8 Hz, 1H), 3.80 (t, J = 8.8 Hz, 1H), 3.30 (t, J = 8.8 Hz, 1H), 
1.31 (s, 3H), 1.30 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 151.0, 147.1, 144.0, 134.6, 128.8, 
128.6, 127.3, 127.0, 124.9, 117.9, 112.6, 111.8, 58.7, 57.7, 47.0, 26.6, 22.4. HRMS (ESI) 
calcd. for C19H22N+ [M+H]+.264.1747, found 264.1745. 
 1-(2-Methylbut-3-en-2-yl)-3-phenyl-1H-indole (3n): Prepared according to 
General Procedure F from 7d (52.7 mg, 0.200 mmol) and MnO2 (87.0 mg, 1.00 
mmol, 5.00 equiv) and heated for 24 h. Pure isomer 3n was isolated as a 
colorless oil (48.3 mg, 0.185 mmol, 92%). 1H NMR (400 MHz, CDCl3): δ 7.79 - 7.72 (m, 
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1H), 7.47 (m, 2H), 7.42 - 7.35 (m, 1H), 7.28 - 7.20 (m, 3H), 7.14 - 7.04 (m, 1H), 7.00 - 6.92 
(m, 2H), 5.99 (dd, J = 17.0, 10.2 Hz, 1H), 5.06 (dd, J = 10.2, 0.8 Hz, 1H), 5.02 (dd, J = 17.0, 
0.8 Hz, 1H), 1.60 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 144.3, 136.4, 136.2, 129.0, 128.0, 
127.8, 126.0, 123.4, 121.4, 120.2, 120.0, 116.5, 114.4, 114.0, 59.6, 28.3. HRMS (ESI) calcd. 
for C19H20N+ [M+H]+ 262.1590, found 262.1591.  
2-(2-(1-(2-Methylbut-3-en-2-yl)indolin-3-yl)ethyl)isoindoline-1,3-dione 
(7e): Prepared according to General Procedure F from 6e (146 mg, 0.500 
mmol) (reaction time = 3 h). 1H NMR spectroscopy showed a 4:1 N-tert-
prenylindoline 7e:N-n-prenylindoline 8e. The crude material was purified 
by flash chromatography (98:2 hexane:Et2O) to yield 7e (89.5 mg, 0.248 mmol, 50%) as a 
colorless oil. Rf  0.43 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.89 - 7.82 (m, 
2H), 7.76 - 7.68 (m, 2H), 7.13 - 7.03 (m, 2H), 6.95 (t, J = 7.7 Hz, 1H), 6.77 (d, J = 8.0 Hz, 
1H), 6.64 (dt, J = 12.9, 7.4 Hz, 1H), 6.50 (d, J = 7.8 Hz, 1H), 6.10 (dd, J = 17.6, 10.8 Hz, 
1H), 5.20 (dd, 17.6, 0.8 Hz, 1H), 5.12 (dd, J = 10.8, 0.8 Hz, 1H), 3.84 – 3.78 (m, 2H), 3.72 - 
3.66 (m, 1H), 3.24 - 3.01 (m, 2H), 2.29 - 2.18 (m, 1H), 1.96 - 1.85 (m, 1H), 1.35 (s, 3H), 1.34 
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 168.7, 150.6, 147.1, 134.3, 134.0, 132.5, 127.3, 
123.6, 123.5, 117.6, 112.5, 111.6, 57.5, 55.1, 37.6,36.4, 32.9, 25.6, 23.4, HRMS (ESI) calcd, 
for C23H24N2O2+ [M+H]+ 361.1911, found 361.1917.  
2-(2-(1-(2-Methylbut-3-en-2-yl)-1H-indol-3-yl)ethyl)isoindoline-1,3-
dione (3o): Prepared according to General Procedure F from 7e (45.7 mg, 
0.125 mmol) and MnO2 (87.0 mg, 1.00 mmol, 5.00 equiv) and heated for 
24 h. Pure isomer 3o was isolated as a yellow/orange oil (42.2 mg, 0.118 
mmol, 94%). Rf  0.21 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 7.86 – 7.83 (m, 
N
NPhth
7e
N
NPhth
3o
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2H), 7.77 - 7.68 (m, 3H), 7.51 - 7.47 (m, 1H), 7.20 (s, 1H), 7.14 - 7.08 (m, 2H), 6.13 (dd, J = 
17.2, 10.8 Hz, 1H), 5.21 (d, J = 10.8 Hz, 1H), 5.14 (d, J = 17.2 Hz, 1H), 4.01 (dd, J = 7.6 Hz, 
7.4 Hz, 2H), 3.15 (dd, J = 7.6 Hz, 7.4 Hz, 2H), 1.72 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 
168.6, 144.5, 135.9, 134.1, 132.6, 129.5, 123.6, 123.4, 121.1, 119.3, 119.1, 114.0, 113.7, 
110.4, 59.2, 38.9, 28.2, 24.8. HRMS (ESI) calcd. for C23H23N2O2+ [M+H]+ 359.1754, found 
359.1757.  
4-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indoline (7f): Prepared according 
to General Procedure F from 6f (74.6 mg, 0.500 mmol) (reaction time = 2 h). 
1H NMR spectroscopy showed a 4:1 N-tert-prenylindoline 7f:N-n-
prenylindoline 8f. The crude material was purified by flash chromatography (98:2 
hexane:Et2O) to yield 7f (63.1 mg, 0.290 mmol, 58%) as a colorless oil. Rf  0.53 (80:20 
hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 6.95 (t, J = 7.2 Hz, 1H), 6.52 (d, J = 7.2 Hz, 
1H), 6.27 (d, J = 7.2 Hz, 1H), 6.14 (dd, J = 17.6, 10.8 Hz, 1H), 5.23 (d, J = 17.6 Hz, 1H), 
5.13 (d, J = 10.8 Hz, 1H), 3.82 (s, 3H), 3.47 (t, J = 8.4 Hz, 2H), 2.88 (t, J = 8.4 Hz, 2H), 1.35 
(s, 6H). 13C NMR (100 MHz, CDCl3): δ 156.1, 152.7, 147.5, 128.0, 112.3, 107.7, 105.5, 
100.9, 57.7, 55.5, 49.6, 25.1, 24.5. HRMS (ESI) calcd. for C14H20NO+ [M+H]+ 218.1539, 
found 218.1545. 
4-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3j): Prepared according to 
General Procedure F from 7f (43.5 mg, 0.200 mmol) and MnO2 (87.0 mg, 
1.00 mmol, 5.00 equiv) and heated for 24 h. Pure isomer 3j was isolated as a 
colorless oil (40.2 mg, 0.186 mmol, 93%). Experimental data matches values 
for Table 3, entry 4. 
N
OMe
3j
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5-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indoline (7g): Prepared 
according to General Procedure F from 6g (74.6 mg, 0.500 mmol) 
(reaction time = 2 h) 1H NMR spectroscopy showed a 2:1 N-tert-
prenylindoline 7g:N-n-prenylindoline 8g. The crude material was purified by flash 
chromatography (98:2 hexane:Et2O) to yield 7g (28.4 mg, 0.131 mmol, 26%) as a colorless 
oil. Rf  0.32 (80:20 hexane:EtOAc) 1H NMR (400 MHz, CDCl3): δ 6.72 (d, J = 8.8 Hz, 1H), 
6.71 (s, 1H), 6.52 (dd, J = 8.4, 2.8 Hz, 1H), 6.12 (dd, J = 17.4, 10.8 Hz, 1H), 5.22 (d, J = 17.4 
Hz, 1H), 5.12 (d, J = 10.8 Hz, 1H), 3.73 (s, 3H), 3.37 (t, J = 8.0 Hz, 2H), 2.88 (t, J = 8.0 Hz, 
2H), 1.31 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 152.7, 147.6, 145.2, 133.4, 112.4, 111.8 
(2C), 111.2, 57.7, 56.1, 49.7, 28.8, 24.1. HRMS (ESI) calcd. for C14H20NO+ [M+H]+ 
218.1539, found 218.1537. 
5-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3k): Prepared 
according to General Procedure F from 7g (43.5 mg, 0.200 mmol) and 
MnO2 (87.0 mg, 1.00 mmol, 5.00 equiv) and heated for 24 h. Pure 
isomer 3k was isolated as a colorless oil (43.4 mg, 0.200 mmol, 99%). Experimental data 
matches values for Table 3, entry 5. 
6-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indoline (7h): Prepared 
according to General Procedure F from 6h (74.6 mg, 0.500 mmol) 
(reaction time = 2 h). 1H NMR spectroscopy showed a 5:1 N-tert-
prenylindoline 7h:N-n-prenylindoline 8h. The crude material was purified by flash 
chromatography (98:2 hexane:Et2O) to yield 7h (66.2 mg, 0.305 mmol, 61%) as a colorless 
oil. Rf  0.54 (80:20 hexane:EtOAc)  1H NMR (400 MHz, CDCl3): δ 6.95 (d, J = 8.0 Hz, 1H), 
6.45 (s, 1H), 6.24 - 6.07 (m, 2H), 5.25 (d, J = 17.6 Hz, 1H), 5.16 (d, J = 10.8 Hz, 1H), 3.74 
N
MeO
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(s, 3H), 3.46 (t, J = 8.0 Hz, 2H), 2.86 (t, J = 8.0 Hz, 2H), 1.36 (s, 6H). 13C NMR (100 MHz, 
CDCl3): δ 159.4, 152.2, 147.3, 124.2, 113.7, 112.5, 101.1, 99.3, 55.6, 49.9, 27.9, 27.5, 24.3. 
HRMS (ESI) calcd. for C14H20NO+ [M+H]+ 218.1539, found 218.1539.  
6-Methoxy-1-(2-methylbut-3-en-2-yl)-1H-indole (3l): Prepared 
according to General Procedure F from 7h (43.5 mg, 0.200 mmol) and 
MnO2 (87.0 mg, 1.00 mmol, 5.00 equiv) and heated for 24 h. Pure 
isomer 3l was isolated as a colorless oil (42.3 mg, 0.196 mmol, 98%). Experimental data 
matches values for Table 3, entry 6. 
5-Bromo-1-(2-methylbut-3-en-2-yl)-1H-indoline (7i): Prepared 
according to General Procedure F from 6i (99.0 mg, 0.500 mmol) (reaction 
time = 1.5 h). 1H NMR spectroscopy showed a 5.5:1 N-tert-prenylindoline 
7i:N-n-prenylindoline 8i. The crude material was purified by flash chromatography (98:2 
hexane:Et2O) to yield 7i (98.0 mg, 0.368 mmol, 74%) as a colorless oil. Rf  0.59 (80:20 
hexane:EtOAc) 1H NMR (400 MHz, CDCl3): δ 7.14 (app s, 1H), 7.03 (dd, J = 8.8, 2.0, Hz, 
1H), 6.65 (d, J = 8.4 Hz, 1H), 6.08 (dd, J = 17.6, 11.6 Hz, 1H), 5.22 (d, J = 17.6 Hz, 1H), 
5.15 (d, J = 11.6 Hz, 1H), 3.44 (t, J = 8.4 Hz, 2H), 2.89 (t, J = 8.4 Hz, 2H), 1.33 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 150.1, 146.7, 134.1, 129.3, 127.3, 112.8, 112.6, 109.2, 57.6, 
49.5, 28.1, 24.3. HRMS (ESI) calcd. for C13H17BrN+ [M+H]+ 266.0539, found 266.0540. 
5-Bromo-1-(2-methylbut-3-en-2-yl)-1H-indole (3p): Prepared according 
to General Procedure G from 7i (53.2 mg, 0.200 mmol) and MnO2 (87.0 
mg, 1.00 mmol, 5.00 equiv) and heated for 24 h. Pure isomer 3p was 
isolated as a colorless oil (46.1 mg, 0.175 mmol, 87%). Rf  0.59 (80:20 hexane:EtOAc).  1H 
NMR (400 MHz, CDCl3): δ 7.75 (d, J = 1.6 Hz, 1H), 7.40 (app d, J = 8.8 Hz, 1H), 7.31 (d, J 
NMeO
3l
N
Br
3p
N
Br
7i
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= 3.2 Hz, 1H), 7.20 (dd, J = 8.8, 1.6 Hz, 1H), 6.43 (dd, J = 3.2, 0.8 Hz, 1H), 6.12 (dd, J = 
17.6, 11.2 Hz, 1H), 5.24 (d, J = 11.2 Hz, 1H), 5.15 (d, J = 17.6 Hz, 1H), 1.75 (s, 6H). 13C 
NMR (100 MHz, CDCl3): δ 144.0, 134.2, 132.0, 126.6, 123.7, 123.6, 115.4, 114.2, 112.9, 
100.5, 59.6, 28.2. HRMS (ESI) calcd. for C13H15BrN+ [M+H]+ 264.0382, found 264.0379.  
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CHAPTER III 
 
RHODIUM-CATALYZED, ENANTIOSELECTIVE HYDROACYLATION OF 
ORTHO-ALLYLBENZALDEHYDES 
 
Adapted from a paper published in Organic Letters[1] and highlighted in SYNFACTS 
 
Kirsten F. Johnson, Adam C. Schmidt, Levi M. Stanley
 
Abstract 
 
The development of a rhodium catalyst for endo- and enantioselective hydroacylation 
of ortho-allylbenzaldehydes is described. A catalyst generated in situ from [Rh(COD)Cl]2, 
(R)-DTBM-Segphos and NaBARF promotes the enantioselective hydroacylation reactions 
and minimizes the formation of byproducts from competitive alkene isomerization and 
ene/dehydration pathways. These rhodium-catalyzed processes generate the 3,4-
dihydronaphthalen-1(2H)-one products in moderate-to-high yields (49-91%) with excellent 
enantioselectivities (96-99% ee). 
Introduction 
 
The development of new catalysts has rendered intramolecular alkene hydroacylation 
a valuable strategy to generate a wide variety of carbocyclic and heterocyclic ketones.[2-25] 
These transformations, which involve the formal insertion of an aldehyde C-H bond into an 
alkene, can be promoted by transition metal or N-heterocyclic carbene (NHC) catalysts. The 
selection of transition metal or NHC catalysts for enantioselective intramolecular 
hydroacylations is often dictated by the desired regiochemical outcome of the reaction.  
Intramolecular olefin hydroacylations promoted by NHC-catalysts occur with exo selectivity 
(formal Markovnikov selectivity),[4-11] while transition metal-catalyzed hydroacylations can 
occur with either endo selectivity (formal anti-Markovnikov selectivity)[12-22] or exo 
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selectivity.[23-25] The potential for complementary regioselectivity makes possible the 
synthesis of two distinct ketone products from the same substrate.  
 
Figure 1: Hydroacylations of ortho-allylbenzaldehydes. 
 
ortho-Allylbenzaldehydes are a class of substrates that highlights the two potential 
regiochemical outcomes of alkene hydroacylation.  Douglas and co-workers reported the 
endo-selective hydroacylation of ortho-allylbenzaldehydes that occur in the presence of an 
achiral rhodium catalyst to form racemic 3,4-dihydronaphthalene-1(2H)-ones (Figure 1a).[26] 
The complementary exo-selective processes occur in the presence of an achiral nickel 
catalyst to form racemic 2,3-dihydro-1H-inden-1-ones (Figure 1b).[27] In 2015, Glorius and 
co-workers reported the first catalytic, exo- and enantioselective hydroacylations of ortho-
allylbenzaldehydes to form 2,3-dihydro-1H-inden-1-ones containing an all-carbon quaternary 
stereogenic center (Figure 1c).[28] However, an endo- and enantioselective variant of the 
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hydroacylation of ortho-allylbenzaldehydes had not been reported prior to the work 
described in this thesis chapter. 
In 2014, we reported enantioselective hydroacylation of N-allyllindole-2-
carboxaldehydes and N-allylpyrrole-2-carboxaldehydes to generate six-membered ketone 
products with exclusive endo selectivity.[29] These reactions occur in the presence of rhodium 
complexes containing a chiral bisphosphine ligand and a weakly coordinating counteranion. 
We envisioned that a related cationic rhodium catalyst would promote the endo-selective 
hydroacylation of ortho-allylbenzaldehydes to form 3,4-dihydronaphthalen-1(2H)-ones with 
high enantioselectivities (Figure 2). 
 
Figure 2: Proposed reaction scheme for endo- and enantioselective hydroacylation of ortho-
allylbenzaldehydes. 
 
We envisioned that this reaction could proceed through the accepted mechanism for 
transition metal-catalyzed olefin hydroacylation reactions, and we expected to encounter the 
same challenges of catalyst activity described in previous reports (Figure 3).[2, 30-31] The 
standard hydroacylation mechanism involves oxidative addition to the aldehyde C-H bond to 
generate an acylmetal(III) hydride intermediate. This species must be sufficiently stabilized 
to prevent a reaction sequence including decarbonylation and reductive elimination that 
inactivates the transition metal catalyst.[14-15, 30-31] The productive reaction pathway proceeds 
with migratory insertion of the olefin into the metal-hydride bond of the acylmetal(III) 
hydride species. Finally, reductive elimination generates the ketone product and regenerates 
the active metal catalyst. Previous mechanistic studies on transition metal-catalyzed olefin 
hydroacylation have found that reductive elimination is the turnover-limiting step in these 
O
R
chiral
non-racemic
Rh catalyst
O
R
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processes.[2-3, 30-31] We hypothesized that a cationic rhodium complex could facilitate the 
hydroacylation of ortho-allylbenzaldehydes and proper tuning of the steric and electronic 
properties of this catalyst could improve catalyst activity by increasing the rate of reductive 
elimination. 
 
 
Figure 3: Catalytic cycle for transition metal-catalyzed olefin hydroacylation.
   
Results and Discussion 
To assess the feasibility of endo- and enantioselective hydroacylation of ortho-
allylbenzaldehydes, we evaluated the reaction of 2-(2-methylallyl)benzaldehyde 1a in the 
presence of a catalyst generated from [Rh(COD)Cl]2, (R)-BINAP, and AgBF4 (Scheme 1). 
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Scheme 1: Rh-catalyzed hydroacylation of 2-(2-methylallyl)benzaldehyde 1a 
 
This reaction formed the desired hydroacylation product 2a in 41% yield with 91% 
ee, but we also observed formation of the alkene isomerization product 3a in 8% yield and 2-
methylnaphthalene 4 in 47% yield. Although transition metal-catalyzed hydroacylation 
reactions often require high catalyst loadings to overcome competitive decarbonylation,[14-18, 
30-31] decarbonylation of 1a was not observed under these conditions.  
 
Figure 4: Catalytic cycle for the Rh-catalyzed hydroacylation of ortho-allylbenzaldehydes. 
The formation of 2-methylnaphthalene 4 from the reaction of 1a was unexpected and 
has not been described in the context of alkene hydroacylation. However, the formation of 
substituted naphthalene derivatives from ortho-allylbenzaldehydes is known to occur by a 
sequence of Lewis acid-catalyzed intramolecular ene reaction and dehydration.[32] To 
evaluate whether the silver salt used to generate the active catalyst promotes the formation of 
4, 2-(2-methylallyl)benzaldehyde 1a was exposed to 5 mol % AgBF4 in the absence of 
[Rh(COD)Cl]2 and the bisphosphine ligand (Scheme 2). This reaction generated 4 in 91% 
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yield and demonstrates that AgBF4 is a non-innocent additive under our catalytic reaction 
conditions. 
 
Scheme 2: Ag(I)-catalyzed ene/dehydration of 2-(2-methylallyl)benzaldehyde 
To effect counteranion exchange and enable the in situ generation of the active, 
cationic rhodium complex while mitigating the silver-catalyzed ene/dehydration pathway, we 
employed sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate (NaBARF) in place of 
AgBF4.[33-35] We hypothesized the absence of Ag(I) would eliminate the formation of 4.  To 
test this hypothesis, we evaluated the hydroacylation of 1a in the presence of a catalyst 
generated from [Rh(COD)Cl]2, (R)-BINAP, and NaBARF (Scheme 3). The reaction occurred 
to form the ketone product 2a in 77% yield and the alkene isomerization product 3a in 23% 
yield.  The formation of 2-methylnaphthalene 4 was not observed. 
 
Scheme 3: Hydroacylation of ortho-allylbenzaldehyde 1a using a NaBARF additive  
Although this in situ generated catalyst eliminates the ene reaction/dehydration 
pathway to 4, the enhanced cationic character of this rhodium complex increases the rate of 
alkene isomerization relative to the rate of alkene hydroacylation.[36-44] The ratio of 
hydroacylation to isomerization is 5.1:1 when the catalyst contains the tetrafluoroborate 
counteranion; the ratio decreases to 3.3:1 when the catalyst contains the tetraarylborate 
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counteranion. We conducted a deuterium isotope incorporation experiment to confirm the 
mechanism by which this olefin isomerization occurs (Scheme 4). The reaction of d-1a in the 
presence of a catalyst generated from [Rh(COD)Cl]2, rac-BINAP, and NaBARF formed the 
hydroacylation product d-2a with deuterium incorporation exclusively at the β-position, as 
expected for the hydroacylation product. The olefin isomerization product d-3 was found to 
contain deuterium exclusively at the aldehyde carbon. Thus, isomerization of 1a does not 
occur via endocyclic β-hydride elimination as has been recently reported for the rhodium-
catalyzed isomerization of 4-pentenals to 3-pentenals.[45]  
 
Scheme 4: Rh-catalyzed hydroacylation of d-1a. 
We hypothesized that the steric and electronic properties of the chiral bisphosphine 
ligand could be leveraged to improve the rate of alkene hydroacylation relative to the rate of 
alkene isomerization. Rhodium catalysts with less cationic character should attenuate the 
rates of both alkene isomerization and alkene hydroacylation.[14-15, 36-44] However, 
bisphosphine ligands with bulky aryl substituents on phosphorous should significantly 
increase the overall rate of alkene hydroacylation relative to the rate of alkene isomerization 
by increasing the rate of the turnover-limiting reductive elimination to form the ketone 
product.[46-50] 
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Table 1: Identification of catalysts for hydroacylation of 2-(2-methylallyl)benzaldehyde 1a 
 
aYield determined by 1H NMR spectroscopy with dibromomethane as the internal standard. bIsolated yield of 2a 
is shown in parentheses. cDetermined by chiral HPLC analysis. dDetermined by 1H NMR spectroscopy of the 
crude reaction mixture. e[Rh(COD)2]BF4 (5 mol %) used in place of [Rh(COD)Cl]2 and NaBARF. 
f[Rh(COD)2]BARF (5 mol %) used in place of [Rh(COD)Cl]2 and NaBARF. 
 
To evaluate the impact of steric and electronic properties of the ligand, we conducted 
hydroacylations of 1a with catalysts derived from a series of bisphosphine ligands with 
axially chiral backbones (Table 1). The rhodium(I) complexes of (R)-MeO-Biphep L2 and 
(R)-Segphos L3, which are more electron-rich than the complex derived from (R)-BINAP 
L1, catalyze the reaction of 1a with improved ratios of hydroacylation to isomerization (4.7:1 
and 5.0:1) relative to the rhodium(I) complex of L1 (compare entries 2 and 3 with entry 1). 
O O
+
O
1a 2a 3a
[Rh(COD)Cl]2 (2.5 mol %)
Ligand (5 mol %)
NaBARF (5 mol %)
1,4-dioxane
100 °C, 6 h
PPh2
PPh2
L1: (R)-BINAP
PPh2
PPh2
O
O
O
O
MeO
MeO
PPh2
PPh2
L3: (R)-SegphosL2: (R)-MeO-Biphep
PAr2
PAr2
O
O
O
O
MeO
MeO
PAr2
PAr2
L5:
(R)-DTBM-Segphos
L4: 
(R)-DTBM-MeO-Biphep
Ar = t-Bu
t-Bu
OMe
Entry Ligand Yield 2a (%)a,b ee 2a (%)c Yield 3 (%)a Ratio 2a:3ad 
1 L1 77 (56) 87 23 3.3:1 
2 L2 75 (75) 90 16 4.7:1 
3 L3 80 (72) 88 16 5.0:1 
4 L4 80 (80) 99 9 8.9:1 
5 L5 85 (81) 98 8 10.7:1 
6e L5 65(63) 99 10 6.5:1 
7f L5 50(52) 99 5 10.0:1 
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We then conducted hydroacylations of 1a in the presence of rhodium catalysts prepared from 
ligands containing bulky, electron-rich 3,5-di-tert-butyl-4-methoxyphenyl substituents on 
phosphorous. The hydroacylation of 1a occurs with an 8.9:1 ratio of hydroacylation to 
isomerization when the reaction is run in the presence of the rhodium(I) complex of (R)-
DTBM-MeO-Biphep L4, and ketone product 2a is isolated in 80% yield (entry 4). The ratio 
of hydroacylation to isomerization products can be further improved by conducting the 
reaction of 1a with a rhodium(I) complex of the more electron-rich (R)-DTBM-Segphos L5 
(entry 5).[51-52] In the presence of this rhodium(I) catalyst, the hydroacylation of 1a occurs 
with a 10.7:1 ratio of hydroacylation to isomerization, and ketone 2a is isolated in 85% yield. 
The absolute configuration of 2a was determined to be (R) by comparison of optical rotation 
data with literature values.[53-54]  
Additional rhodium(I) precursors were evaluated for the hydroacylation of 1a using 
the electron-rich (R)-DTBM-Segphos ligand L5. A significant decrease in the yield of 2a and 
the ratio of hydroacylation to isomerization products is observed when [Rh(COD)2]BF4 is 
employed as the catalyst precursor for the hydroacylation of 1a (63% yield, 6.5:1) (compare 
entries 5 and 6). Conducting the reaction of 1a in the presence of a catalyst generated from 
[Rh(COD)2]BARF results in a 10:1 ratio of hydroacylation to isomerization products. 
However, the yield of 2a was comparatively low (compare entries 5 and 7). Thus, we chose 
to evaluate the scope of hydroacylations of additional ortho-allylbenzaldehydes using the 
reaction conditions from entry 5. 
During our efforts to improve catalyst activity through modification of the steric and 
electronic properties of the bisphosphine ligand we speculated that bulky, electron-rich 
bisphosphine ligands would facilitate turnover-limiting reductive elimination. We identified 
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(R)-DTBM-Segphos as the optimal bisphosphine ligand of those assessed and conducted a 
kinetics study using a cationic rhodium catalyst generated with this ligand to determine if 
reductive elimination is in fact the turnover-limiting step in the rhodium-catalyzed 
hydroacylation of 1a.  
 
Scheme 5: Kinetic isotope experiments for 1a vs. d-1a 
The kinetic isotope effect was determined by measuring the initial rate constants for 
two independent experiments for the hydroacylation of 1a and d-1a (Scheme 5). Figure 5 and 
Figure 6 show [1a] and [d-1a] vs time through the 3rd half-life of the reaction and support 
first order dependence on 1a and d-1a for the overall reaction. The initial rate constants were 
measured based on the slope of the first-order kinetics plots (Figure 7 and Figure 8): kH = 
(1.826 ± 0.10) × 10-4 sec-1 and kD = (1.535 ± 0.06) × 10-4 sec-1. The KIE was found to be 1.19 
based on the initial rate constants kH and kD for the hydroacylation of 1a and d-1a. The 
normal secondary KIE (1.19) suggests that cleavage of the aldehyde C-H bond is not 
involved in the rate-determining step of this reaction. The aldehyde C-H bond is broken 
during oxidative addition so we would expect a primary KIE if this step were turnover-
limiting, thus, this KIE value is inconsistent with oxidative addition as the turnover-limiting 
step in the hydroacylation of 1a. Although these kinetic isotope results do not allow us to 
conclusively rule out migratory insertion as turnover-limiting, the normal secondary KIE 
(kH/kD = 1.19) is consistent with turnover-limiting reductive elimination since the aldehyde 
C-H bond is not involved in this elementary reaction. Furthermore, this data is consistent 
O O[Rh(COD)Cl]2 (2.5 mol %)
(R)-DTBM-Segphos (5 mol %)
NaBARF (5 mol %)
1,4-dioxane-d8, 100 °C
H/D
H/D1a or
d-1a
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d-2a
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with reports of rhodium-catalyzed alkene hydroacylations in which reductive elimination was 
found to be turnover-limiting.[2, 15, 31] 
 
Figure 5: Plot of [1a] vs. time through 3rd half-life of the reaction. 
 
Figure 6: Plot of [d-1a] vs. time through 3rd half-life of the reaction. 
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Figure 7: Plot of ln([1a]) vs. time for the first 5% of total reaction time. 
 
Figure 8: Plot of ln([d-1a]) vs. time for the first 5% of total reaction time. 
We next sought to evaluate an array of ortho-allylbenzaldehydes for the endo- and 
enantioselective rhodium-catalyzed olefin hydroacylation reaction. We synthesized a series 
of ortho-allylbenzaldehydes that contain substitution around the aryl core and on the central 
carbon of the allyl unit. Three different synthetic procedures were required to access a range 
of substrates with this general architecture (Scheme 6). In the first approach, 2-
bromobenzylbromides were obtained by bromination of the corresponding toluene derivative 
with N-bromosuccinimide (NBS) in chloroform. ortho-Allylbromobenzenes 6a-e, 6g-h and 
6o were prepared by coupling the Grignard reagent of the appropriate vinylbromide with an a 
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2-bromobenzylbromide derivative (Scheme 6). ortho-Allylbenzaldehydes 1a-e, 1g-h, 1o and 
d-1a were obtained by lithium-halogen exchange of the corresponding aryl bromide 6a-e, 6g-
h, 6o and quenching with DMF to install the aldehyde moiety. Further synthetic details are 
described in the Experimental section of this chapter. 
 Scheme 6: Synthesis of ortho-allylbenzaldehydes 1a-e, 1g-h, 1o and d-1a. 
 A modified version of this procedure was used for the synthesis of the piperonal-
derived ortho-allylbenzaldehyde 1f (Scheme 7). This substrate was prepared by coupling the 
Grignard reagent of 5-bromo-6-(1,3-dioxolan-2-yl)benzo[d][1,3]dioxole with 3-chloro-2-
methylpropene. Deprotection of the acetal in the presence of PTSA generated 1f. 
  
Scheme 7: Synthesis of 1f 
 The synthesis of ortho-allylbenzaldehydes 1i-n required an alternative synthetic 
approach (Scheme 8). 2-(2-Bromoallyl)benzaldehyde was prepared according to a literature 
procedure, and Suzuki coupling with the appropriate arylboronic acid formed 1i-n without 
significant alkene isomerization.[28]  
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Scheme 8: Synthesis of 1i-n 
With a range of substrates in hand, we evaluated the hydroacylations of a variety of 
ortho-allylbenzaldehydes derivaties (Scheme 9). Hydroacylations of 5-fluoro-2-(2-
methallyl)benzaldehyde 1b and 4-fluoro-2-(2-methallyl)benzaldehyde 1c form the 
corresponding 3,4-dihydronaphthalen-1(2H)-ones 2b and 2c in 88% and 60% yield with 98% 
ee. The hydroacylation of 4-chloro-2-(2-methylallyl)benzaldehyde 1d generated 2d in 
modest yield in the presence of 5 mol % rhodium catalyst.  However, the reaction of 1d in 
the presence of 10 mol % catalyst formed 2d in 91% yield with 96% ee. 
The hydroacylations of electron-rich ortho-allylbenzaldehydes also occur to form 3,4-
dihydronaphthalen-1(2H)-ones in high yields with excellent enantioselectivities. The 
hydroacylations of 4-methoxy-2-(2-methallyl)benzaldehyde 1e and the piperonal-derived 2-
(2-methylallylbenzaldehyde) 1f provide 3,4-dihydronaphthalen-1(2H)-ones 2e and 2f in 84% 
and 85% yields with 99% and 98% ee.  
O
Br
+
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O
Ar
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Pd(PPh3)4 (5 mol%)
Na2CO3 (4 equiv)ArB(OH)2
Ar = 4-Cl-C6H4
        4-CF3-C6H4
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        3-OMe-C6H4
        2-OMe-C6H4
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aYields of 2 are isolated yields after column chromatography on silica gel. Enantiomeric excesses were 
determined by chiral HPLC analysis. Ratios of hydroacylation to alkene isomerization products (2a-o:3a-o) 
were determined by 1H NMR analysis of the crude reaction mixture. bValues in parentheses are for the reaction 
of 1d in the presence of 10 mol % rhodium catalyst. cIsolated as 96:4 mixture of 2h:3h. 
 
Scheme 9: Rh-catalyzed hydroacylation of ortho-allylbenzaldehydes 1a-1o. 
 
Alkyl and aryl substituents on the internal carbon of the allyl moiety are also well 
tolerated. The hydroacylations of ortho-allylbenzaldehydes 1g and 1h (R2 = n-Pr and Ph) 
generate 2g and 2h in 89% and 87% yield with 96% and 97% ee. Hydroacylations of ortho-
allylbenzaldehydes 1j-1m containing substituted aryl groups at the central carbon of the allyl 
moiety generate the 3-aryl-3,4-dihydronaphthalen-1(2H)-one products 2j-2m in good yields 
(70-80%) with excellent enantioselectivies (96-98% ee). In addition, the hydroacylation of 2-
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(2-(thiopheny-3-yl)allyl)benzaldehyde 1n forms 3,4-dihydronaphthalen-1(2H)-one 2n in 
49% yield with 98% ee.   The hydroacylation of 2-allylbenzaldehyde 1o, which lacks 
substitution at the central carbon of the allyl moiety, exclusively forms the 3,4-
dihydronaphthalen-1(2H)-one 2o; the formation of the 5-membered ketone (2-methyl-2,3-
dihydro-1H-inden-1-one) is not observed with the current catalyst system. 
Although we have developed a practical catalyst for enantioselective hydroacylation 
of ortho-allylbenzaldehydes, the catalyst performs poorly for substrates in which the alkene 
and aldehyde units are not conformationally constrained.  For example, the reaction of 5-
phenylhex-5-enal 7 forms alkene isomerization product 8 in 78% yield, and the alkene 
hydroacylation product is not detected by 1H NMR spectroscopy (Scheme 10).  
 
Scheme 10: Rh-catalyzed hydroacylation isomerization of 7 
Conclusion 
In summary, we have developed a rhodium catalyst that promotes the hydroacylation 
of ortho-allylbenzaldehydes to generate 3,4-dihydronaphthalene-1(2H)-ones with excellent 
enantioselectivities. These endo-selective processes are complementary to the recently 
reported exo- and enantioselective NHC-catalyzed hydroacylations of the same substrates.[28] 
Competitive alkene isomerization and ene/dehydration processes are mitigated by a rhodium 
catalyst containing a bulky, electron-rich bisphosphine ligand and a weakly coordinating 
counteranion. This catalyst is prepared from readily available precursors and promotes the 
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desired hydroacylation reactions to form the bicyclic products in good yields and high 
enantioselectivities.  
Experimental 
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques. All reactions were 
performed under nitrogen unless otherwise stated. All glassware for moisture sensitive 
reactions was dried in an oven at 140 °C for at least two hours before use. THF was degassed 
by purging with argon for 45 minutes and dried with a solvent purification system by passing 
through a one-meter column of activated alumina. Anhydrous 1,4-dioxane and DMF were 
purchased from Aldrich and used as received. Flash column chromatography was performed 
on SiliFlash® P60 silica gel (40-63µm, 60Å) using hexanes, hexanes/ethyl acetate, 
hexanes/diethyl ether, or pentane/diethyl ether mixtures. Products were visualized on TLC by 
UV light or by staining with KMnO4, ceric ammonium molybdate (CAM), vanillin or o-
anisaldehyde. 
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer. HPLC analyses 
were carried out on a Waters Alliance HPLC system with an e2695 separations module and a 
2489 dual wavelength detector. Optical rotations were measured on an Atago AP-300 
automatic polarimeter using a 0.5 dm cell. The absolute configuration of compound 2a was 
assigned as R based on comparison of the optical rotation with the literature value,[53-54] and 
the absolute configuration of compounds 2b-n were assigned by analogy. NMR spectra were 
acquired on Varian MR-400 and Bruker Avance III 600 spectrometers at the Iowa State 
University Chemical Instrumentation Facility. Chemical shifts are reported in ppm relative to 
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residual solvent peaks (CDCl3 = 7.26 ppm for 1H and 77.16 ppm for 13C) or an external 
standard (CF3CO2H:CDCl3 = -77.56 ppm for 19F). Coupling constants are reported in hertz. 
Materials. 2-Bromobenzaldehyde, 2-bromobenzylbromide, 2-bromo-5-fluorotoluene, 
2-bromo-5-fluorotoluene, 2-bromo-4-fluorotoluene, 2-bromo-5-chlorotoluene, 4-bromo-3-
methylanisole, and 2,2’-bipyridine were purchased from AK Scientific and used without 
further purification. Ethylene glycol, benzoyl peroxide, α-bromostyrene, δ-valerolactone, 2,3-
dibromopropene, pyridium chlorochromate (PCC), methyltriphenylphosphonium bromide, 6-
bromopiperonal, 5-oxo-5-phenylvaleric acid, 1,5-cyclooctadiene, ethylmagnesium bromide 
(3.0 M in diethyl ether), vinylmagnesium bromide (1.0 M in THF), 1-propenylmagnesium 
bromide (0.5 M in THF), methyllithium (1.6 M in diethyl ether), diisobutylaluminum hydride 
(1.0 M in hexanes) and copper iodide were purchased from Sigma-Aldrich and used as 
received. n-Butyllithium solution (2.5 M in hexanes) was purchased from Sigma-Aldrich and 
titrated with recrystallized diphenylacetic acid.  2-Bromopropene was purchased from GFS 
Chemicals and used without further purification. N-bromosuccinimide (NBS) was purchased 
from Sigma-Aldrich and purified by recrystallization from H2O before use. 2-Bromopent-1-
ene was prepared according to a literature procedure[55] from 2,3-dibromopropene and 
ethylmagnesium bromide. 5-Bromo-6-(1,3-dioxolan-2-yl)benzo[d][1,3]dioxole was prepared 
according to a literature procedure[56-57] from 6-bromopiperonal and ethylene glycol. 5-
Phenylhex-5-enal (5) was prepared according to literature procedures from 5-oxo-5-
phenylvaleric acid.[58] 2-(2-Bromoallyl)benzaldehyde was prepared according to a literature 
procedure from 2-bromobenzaldehyde, ethylene glycol and 2,3-dibromopropene.[28] 
[Rh(COD)Cl]2, [Rh(COD)2]BF4, rac-BINAP (2,2´-bis(diphenylphosphino)-1,1´-
binaphthalene), (R)-BINAP ((R)-2,2´-bis(diphenylphosphino)-1,1´-binaphthalene), (R)-MeO-
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BIPHEP ((R)-2,2´-bis(diphenylphosphino)-1,1´-biphenyl), (R)-DTBM-MeO-Biphep ((R)-
2,2´-bis(di(3,5-di-t-butyl-4-methoxyphenyl)phosphino)-6,6´-dimethoxy-1,1´-biphenyl), (R)-
Segphos ((R)-2,2´-bis(diphenylphosphino)-4,4´-bi-1,3-benzodioxole), (R)-DTBM-Segphos 
((R)-2,2´-bis(di(3,5-di-t-butyl-4-methoxyphenyl)phosphino)-4,4´-bi-1,3-benzodioxole) and 
silver tetrafluoroborate were purchased from Strem Chemicals and used without further 
purification. NaBARF (Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) was prepared 
according to a literature procedure.[35] [Rh(COD)2]BARF was prepared according to a 
literature procedure from [Rh(COD)Cl]2, 1,5-cyclooctadiene and NaBARF.[59]  
General Procedure A: Synthesis of ortho-Bromobenzylbromide 5b-e 
  
To a solution of the appropriate ortho-bromotoluene derivative in CHCl3 was added 
NBS (1.20 equiv) and (PhCO2)2 (0.200 equiv). The reaction mixture was heated to reflux 
under N2 for 6-24 h. The solution was cooled to room temperature and quenched by the 
addition of sat. NaHCO3 solution. The organic layer was washed with NaHCO3 (3x) and 
brine, then dried over Na2SO4 and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography or recrystallization to yield the appropriate 
ortho-bromobenzylbromide 5b-e. 
2-Bromo-1-(bromomethyl)-4-fluorobenzene[60-61] (5b): Prepared 
according to general procedure A from 2-bromo-4-fluorotoluene (5.10 g, 
27.0 mmol), NBS (5.77 g, 32.4 mmol) and Ph(CO2)2 (1.31 g, 5.40 mmol) 
under reflux for 6 h. The crude product was purified by flash column chromatography (95:5 
Hex:EtOAc) to yield 5b (2.99 g, 11.14 mmol, 46%) as a white amorphous solid. m.p. = 50–
Br
BrBr NBS (1.20 equiv)(BzO)2 (0.200 equiv)R R
5b-5e
CHCl3, reflux
R = 4-F, 5-F, 4-Cl, 4-OMe
Br
BrF
5b
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51 °C  (lit = 51–52 °C).  1H NMR (CDCl3, 400 MHz): δ 4.58 (s, 2H), 7.03 (ddd, J = 8.4, 8.0, 
2.4 Hz, 1H), 7.33 (dd, J = 8.0, 2.4 Hz, 1H), 7.44 (dd, J = 8.4, 5.6 Hz, 1H). 13C NMR (CDCl3, 
100 MHz): δ 32.6, 115.4 (d, J = 21.0 Hz), 120.8 (d, J = 24.2 Hz), 124.9 (d, J = 10.0 Hz), 
132.4 (d, J = 8.8 Hz), 133.3 (d, J = 3.4 Hz), 162.3 (d, J = 251.6 Hz). 19F NMR (CDCl3, 376 
MHz): δ -111.4 (m, 1F). 
 1-Bromo-2-(bromomethyl)-4-fluorobenzene[62] (5c): Prepared according 
to general procedure A from 2-bromo-5-fluorotoluene (5.10 g, 27.0 mmol), 
NBS (5.77 g, 32.4 mmol) and Ph(CO2)2 (1.31 g, 5.40 mmol) under reflux for 
24 h. The crude product was purified by flash column chromatography (95:5 Hex:EtOAc) to 
yield 5c (2.36 g, 8.91 mmol, 33%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 4.54 (s, 
2H), 6.91 (ddd, J = 8.8, 8.8, 3.2 Hz, 1H), 7.20 (dd, J = 8.8, 3.2 Hz, 1H), 7.53 (dd, J = 8.8, 5.2 
Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.5, 47.3 (d, J = 22.0 Hz), 48.1 (d, J = 23.0 Hz), 
48.5 (d, J = 3.2 Hz), 64.5 (d, J = 7.8 Hz), 68.8 (d, J = 7.6 Hz), 91.8 (d, J = 246.8 Hz). 19F 
NMR (CDCl3, 376 MHz): δ -114.5 (m, 1F). 
 1-Bromo-2-(bromomethyl)-4-chlorobenzene[61] (5d): Prepared according 
to general procedure A from 2-bromo-5-chlorotoluene (5.55 g, 27.0 mmol), 
NBS (5.77 g, 32.4 mmol) and Ph(CO2)2 (1.31 g, 5.40 mmol) under reflux 
for 18 h. The crude product was purified by flash column chromatography (95:5 Hex:EtOAc) 
to yield 5d (2.74 g, 9.65 mmol, 36%) as a pale orange amorphous solid. 1H NMR (CDCl3, 
400 MHz): δ 4.53 (s, 2H), 7.15 (dd, J = 8.4, 2.4 Hz, 1H), 7.45 (d, J = 2.4 Hz, 1H), 7.50 (d, J 
= 8.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 32.3, 122.2, 130.1, 131.0, 133.7, 134.3, 
138.6.  
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1-Bromo-2-(bromomethyl)-4-methoxybenzene[63] (5e): Prepared 
according to general procedure A from 4-bromo-3-methylanisole (8.04 g, 
40.0 mmol), NBS (8.54 g, 48.0 mmol) and Ph(CO2)2 (1.94 g, 8.00 mmol) under reflux for 24 
h. The crude product was purified by recrystallization from hexanes to yield S2e (3.44 g, 
12.3 mmol, 31%) as a white crystalline solid. m.p = 92-93 °C (lit = 92-93 °C) 1H NMR 
(CDCl3, 400 MHz): δ 3.80 (s, 3H), 4.56 (s, 2H), 6.74 (dd, J = 8.8, 3.0 Hz, 1H), 6.99 (d, J = 
3.0 Hz, 1H), 7.45 (d, J = 8.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 33.6, 55.7, 114.8, 
116.2, 116.7, 134.0, 137.9, 159.3.  
General Procedure B: Synthesis of 6a-e, 6g-h, and 6o 
 
To an oven-dried schlenk flask equipped with a stir bar and under nitrogen 
atmosphere was added Mg turnings (2.20-3.50 equiv), a few crystals of I2 and anhydrous 
THF (4-50 mL). In a separate oven-dried round bottom flask, a solution of the appropriate 
vinyl bromide (1.67-2.50 equiv) in anhydrous THF (4-10 mL) was prepared. An initial 
volume of 1 mL of the vinyl bromide solution was added to the Mg suspension and the 
mixture was heated gently with a heat gun to initiate formation of the Grignard reagent. The 
remaining vinyl bromide solution was added slowly, keeping the solution of Grignard 
reagent at reflux. The reaction mixture was refluxed for an additional 2-4 hours and cooled to 
room temperature. To an oven-dried 100 mL round bottom flask was added the appropriate 
2-bromobenzylbromide (1.00 equiv), CuI (0.200 equiv), 2,2´-bipyridine (0.200 equiv) and 
Br
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dry THF (10 mL), and the mixture was cooled to 0 °C. The solution of Grignard reagent was 
slowly transferred to this mixture via cannula. The combined reaction mixture was stirred 
overnight and allowed to warm to room temperature. The reaction was quenched by the 
addition of sat. NH4Cl solution and extracted with Et2O (3x). The combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography to yield the appropriate ortho-
allylbromobenzene derivative 6a-e, 6g-h, and 6o. As noted with each compound, HRMS 
values for 6b-e were found after loss of a -C3H5 unit. 
1-Bromo-2-(2-methylallyl)benzene[64] (6a): Prepared according to general 
procedure B from 2-bromopropene (2.42 g, 20.0 mmol) and 2-
bromobenzylbromide (2.99 g, 12.0 mmol). The crude product was purified by 
flash column chromatography (100% hexanes) to yield 6a (1.78 g, 8.42 mmol, 70%) as a 
pale yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.76 (s, 3H), 3.46 (s, 2H), 4.59 (s, 1H), 4.86 
(s, 1H), 7.05-7.10 (m, 1H), 7.18-7.29 (m, 2H), 7.55 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 
100 MHz): δ 22.6, 44.0, 112.5, 125.3, 127.3, 127.9, 131.0, 132.9, 139.2, 143.5.  
2-Bromo-4-fluoro-1-(2-methylallyl)benzene (6b): Prepared according to 
general procedure B from 2-bromopropene (1.09 g, 9.00 mmol) and 5b 
(1.45 g, 5.40 mmol). The crude product was purified by flash column 
chromatography (98:2 Hex:EtOAc) to yield 5b (0.794 g, 3.47 mmol, 64%) as a yellow oil 
containing 5% 1-fluoro-4-(2-methylallyl)benzaldehyde. 1H NMR (CDCl3, 400 MHz): δ 1.74 
(s, 3H), 3.42 (s, 2H), 4.57 (s, 1H), 4.86 (s, 1H), 6.98 (ddd, J = 8.4, 8.4, 2.8 Hz, 1H), 7.19 (dd, 
J = 8.4, 6.0 Hz, 1H), 7.30 (dd, J = 8.4, 2.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.5, 
43.2, 112.7, 114.5 (d, J = 20.4 Hz), 119.9 (d, J = 24.0 Hz), 124.9 (d, J = 9.2 Hz), 131.6 (d, J 
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= 8.0 Hz), 135.1 (d, J = 3.4 Hz), 143.4, 161.0 (d, J = 247.4 Hz). 19F NMR (CDCl3, 376 
MHz): δ -115.7 (m, 1F). HRMS (ESI) calcd. for C10H10BrF (M+H+-C3H5) 186.9558, found 
186.9551. 
 1-Bromo-4-fluoro-2-(2-methylallyl)benzene (6c): Prepared according to 
general procedure B from 2-bromopropene (1.09 g, 9.00 mmol) and 5c 
(1.45 g, 5.40 mmol, 0.600 equiv). The crude product was purified by flash 
column chromatography (98:2 Hex:EtOAc) to yield 6c (0.425 g, 1.86 mmol, 34%) as a 
yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.76 (s, 3H), 3.43 (s, 2H), 4.64 (s, 1H), 4.90 (s, 
1H), 6.83 (ddd, J = 9.6, 8.8, 3.2 Hz, 1H), 6.97 (dd, J = 9.6, 3.2 Hz, 1H), 7.50 (dd, J = 8.8, 5.2 
Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.6, 44.1, 113.2, 115.1 (d, J = 22.4 Hz), 117.6 (d, 
J = 22.8 Hz), 119.2 (d, J = 3.0 Hz), 133.9 (d, J = 7.8 Hz), 141.4 (d, J = 7.6 Hz), 142.9, 162.1 
(d, J = 245.2 Hz). 19F NMR (CDCl3, 376 MHz): δ -116.0 (m, 1F). HRMS (ESI) calcd. for 
C7H5BrF (M+H+-C3H5) 186.9558, found 186.9549.  
 1-Bromo-4-chloro-2-(2-methylallyl)benzene (6d): Prepared according 
to general procedure B from 2-bromopropene (2.42 g, 20.0 mmol) and 5d 
(2.28 g, 8.00 mmol). The crude product was purified by flash column 
chromatography (100% hexanes) to yield 6d (1.25 g, 5.10 mmol, 64%) as a yellow oil. 1H 
NMR (CDCl3, 400 MHz): δ 1.75 (s, 3H), 3.41 (s, 2H), 4.62 (s, 1H), 4.89 (s, 1H), 7.06 (dd, J 
= 8.4, 2.8 Hz, 1H), 7.21 (d, J = 2.8 Hz, 1H), 7.47 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 100 
MHz): δ 22.9, 43.8, 113.1, 127.4, 127.9, 130.6, 133.3, 133.8, 140.9, 142.7. HRMS (ESI) 
calcd. for C10H10BrCl (M+H+-C3H5) 202.9263, found 202.9260. 
1-Bromo-4-methoxy-2-(2-methylallyl)benzene (6e): Prepared 
according to general procedure B from 2-bromopropene (2.06 g, 17.0 
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mmol) and 5e (2.86 g, 10.2 mmol). The crude product was purified by flash column 
chromatography (100% hexanes) to yield 6e (1.55 g, 6.41 mmol, 63%) as a yellow oil. 1H 
NMR (CDCl3, 400 MHz): δ 1.78 (s, 3H), 3.43 (s, 2H), 3.78 (s, 3H), 4.65 (s, 1H), 4.89 (s, 
1H), 6.66 (dd, J = 8.8, 3.0 Hz, 1H), 6.81 (d, J = 3.0 Hz, 1H), 7.45 (d, J = 8.8 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 22.6, 44.2, 55.4, 112.6, 113.6, 115.7, 116.5, 133.3, 140.2, 143.4, 
159.0. HRMS (ESI) calcd. for C11H13BrO (M+H+-C3H5) 198.9759, found 198.9753. 
 1-Bromo-2-(2-methylenepentyl)benzene (6g): Prepared according to 
general procedure B from 2-bromopent-1-ene (2.09 g, 14.0 mmol) and 2-
bromobenzylbromide (2.10 g, 8.40 mmol). The crude product was 
purified by flash column chromatography (100% hexanes) to yield 6g (0.681 g, 2.85 mmol, 
34%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 0.94 (t, J = 7.6, 3H), 1.54 (m, 2H), 
2.05 (t, J = 7.6 Hz, 2H), 3.47 (s, 2H), 4.58 (s, 1H), 4.88 (s, 1H), 7.03-7.09 (m, 1H), 7.20-7.26 
(m, 2H), 7.55 (dd, J = 7.2, 0.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 14.0, 21.0, 38.4, 
42.4, 111.6, 125.3, 127.3, 127.8, 131.1, 132.9, 139.4, 147.4. HRMS (ESI) calcd. for C12H15Br 
(M+H+-C5H9) 168.9653, found 168.9645. 
1-Bromo-2-(2-phenylallyl)benzene (6h): Prepared according to general 
procedure B from α-bromostyrene (3.66 g, 20.0 mmol) and 2-
bromobenzylbromide (2.99 g, 12.0 mmol). The crude product was purified 
by flash column chromatography (100% hexanes) to yield 6h (1.70 g, 6.23 mmol, 52%) as a 
pale yellow oil which contained 10% of prop-2-ene-1,2-diyldibenzene. 1H NMR (CDCl3, 400 
MHz): δ 3.93 (s, 2H), 4.86 (s, 1H), 5.52 (s, 1H), 7.07 (ddd, J = 8.0, 2.4, 1.6 Hz, 1H), 7.18-
7.34 (m, 5H), 7.47 (m, 2H), 7.56 (dd, J = 8.0, 1.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 
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41.5, 114.8, 125.3, 126.1, 127.5, 127.8, 128.0, 128.5, 131.1, 132.9, 139.1, 140.8, 145.6. 
HRMS (ESI) calcd. for C15H13Br (M+H+-C8H7) 168.9653, found 168.9647. 
1-Allyl-2-bromobenzene[64-65] (6o): Prepared according to a modified version of 
general procedure B from vinylmagnesium bromide (12.0 mL of a 1.00 M 
solution, 12.00 mmol) and 2-bromobenzylbromide (1.80 g, 7.20 mmol). The 
crude product was purified by flash column chromatography (100% hexanes) to yield 6o 
(0.880 g, 4.46 mmol, 37%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 3.52 (d, J = 6.4 
Hz, 2H), 5.05-5.14 (m, 2H), 5.98 (ddt, J = 16.8, 10.0, 6.4 Hz, 1H), 7.05 – 7.11 (m, 1H), 7.15-
7.32 (m, 2H), 7.55 (dd, J = 8.4, 0.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 40.3, 116.7, 
124.7, 127.6, 128.0, 130.6, 132.9, 135.7, 139.6.  
General Procedure C: Synthesis of ortho-Allylbenzaldehydes 1a-e, 1g-h, 1o, and d-1a 
  
To a solution of the appropriate ortho-allylbromobenzene derivative 6a-e, 6g-h, and 
6o (1.00 equiv) in THF at -78 °C was added n-BuLi (1.00-1.10 equiv of 1.10-1.80M 
solutions in hexanes), dropwise. This solution was kept at -78 °C for 1 hour, warmed to room 
temperature for 30 minutes, and then cooled back to -78 °C for 10 minutes before DMF 
(1.50-3.00 equiv) was added dropwise. The solution was allowed to warm to room 
temperature overnight before it was quenched by the addition of a sat. NH4Cl solution. The 
reaction mixture was extracted with Et2O (3x). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified 
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by flash column chromatography (hexanes:EtOAc) to yield the appropriate ortho-
allylbenzaldehyde 1a-e, 1g-h, 1o, and d-1a. 
2-(2-Methylallyl)benzaldehyde[64-65] (1a): Prepared according to general 
procedure C from 6a (1.27 g, 6.00 mmol), n-BuLi (5.08 mL of a 1.30 M 
solution in hexanes, 1.10 equiv) and DMF (1.34 mL, 3.00 equiv). The crude 
product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1a (0.779 
g, 4.86 mmol, 81%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.78 (s, 3H), 3.73 (s, 2H), 
4.45 (s, 1H), 4.84 (s, 1H), 7.28 (dd, J = 7.6, 1.2 Hz, 1H), 7.40 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 
7.53 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.87 (dd, J = 7.6, 1.6 Hz, 1H), 10.25 (s, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 23.1, 40.3, 112.6, 127.1, 130.7, 131.8, 134.0, 134.4, 142.2, 145.4, 
192.2.  
5-Fluoro-2-(2-methylallyl)benzaldehyde (1b): Prepared according to 
general procedure C from 6b (0.401 g, 1.75 mmol), n-BuLi (1.41 mL of a 
1.30 M solution in hexanes, 1.05 equiv) and DMF (0.20 mL, 1.50 equiv). 
The crude product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 
1b (0.093 g, 0.522 mmol, 30%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.78 (s, 3H), 
3.68 (s, 2H), 4.44 (s, 1H), 4.86 (s, 1H), 7.20-7.28 (m, 2H), 7.57 (dd, J = 8.8, 1.2 Hz, 1H), 
10.2 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.9, 39.5, 112.9, 115.8 (d, J = 35.7), 121.0 (d, 
J = 21.6 Hz), 133.5 (d, J = 7.0 Hz), 135.8 (d, J = 6.0 Hz), 137.9 (d, J = 3.2 Hz), 145.2, 161.8 
(d, J = 246.0), 190.5. 19F NMR (CDCl3, 376 MHz): δ -115.9 (m, 1F). HRMS (ESI) calcd. for 
C11H11FO (M+H+) 179.0867, found 179.0860. 
4-Fluoro-2-(2-methylallyl)benzaldehyde (1c): Prepared according to 
general procedure C from 6c (0.401 g, 1.75 mmol), n-BuLi (1.41 mL of a 
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1.30 M solution in hexanes, 1.05 equiv) and DMF (0.20 mL, 1.50 equiv). The crude product 
was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1c (0.164 g, 0.92 
mmol, 53%) as a yellow oil.1H NMR (CDCl3, 400 MHz): δ 1.78 (s, 3H), 3.73 (s, 2H), 4.50 (s, 
1H), 4.88 (s, 1H), 6.99 (dd, J = 9.6, 2.8 Hz, 1H), 7.07 (ddd, J = 9.6, 8.4, 2.8 Hz, 1H), 7.89 
(dd, J = 8.4, 6.0 Hz, 1H), 10.17 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.9, 40.1, 113.2, 
114.4 (d, J = 22.0 Hz), 118.4 (d, J = 22.0 Hz), 131.0 (d, J = 2.6 Hz), 133.6 (d, J = 10.0 Hz), 
144.4, 145.6 (d, J = 9.0 Hz), 166.0 (d, J = 255.0 Hz), 190.4. 19F NMR (CDCl3, 376 MHz): δ -
104.9 (m, 1F). HRMS (ESI) calcd. for C11H11FO (M+H+) 179.0867, found 179.0863. 
4-Chloro-2-(2-methylallyl)benzaldehyde (1d): Prepared according to 
general procedure C from 6d (0.908 g, 3.70 mmol), n-BuLi (3.13 mL of a 
1.30 M solution in hexanes, 1.10 equiv) and DMF (0.86 mL, 3.00 equiv). 
The crude product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 
1d (0.219 g, 1.12 mmol, 30%) as a yellow oil.1H NMR (CDCl3, 400 MHz): δ 1.78 (s, 3H), 
3.70 (s, 2H), 4.48 (s, 1H), 4.88 (s, 1H), 7.28 (d, J = 2.0 Hz, 1H), 7.37 (dd, J = 8.2, 2.0 Hz, 
1H), 7.81 (d, J = 8.2 Hz, 1H), 10.18 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 23.0, 40.0, 
113.3, 127.5, 131.6, 132.0, 132.8, 140.3, 144.0, 144.5, 190.8. HRMS (ESI) calcd. for 
C11H11ClO (M+H+) 195.0571, found 195.0568. 
4-Methoxy-2-(2-methylallyl)benzaldehyde (1e): Prepared according to 
general procedure C from 6e (1.09 g, 4.50 mmol), n-BuLi (3.46 mL of a 
1.30 M solution in hexanes, 1.00 equiv) and DMF (0.520 mL, 1.50 
equiv). The crude product was purified by flash column chromatography (90:10 Hex:EtOAc) 
to yield 1e (0.703 g, 3.70 mmol, 82%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.70 (s, 
3H), 3.64 (s, 2H), 3.79 (s, 3H), 4.44 (s, 1H), 4.77 (s, 1H), 6.70 (d, J = 2.4 Hz, 1H), 6.80 (dd, 
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J = 8.8, 2.4 Hz, 1H), 7.75 (d, J = 8.8 Hz, 1H), 10.01 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 
22.9, 40.4, 55.5, 112.1, 112.5, 116.8, 128.0, 133.5, 144.7, 144.9, 163.6, 190.6. HRMS (ESI) 
calcd. for C12H14O2 (M+H+) 191.1067, found 191.1065. 
2-(2-Methylenepentyl)benzaldehyde (1g): Prepared according to 
general procedure C from 6g (0.957 g, 4.00 mmol), n-BuLi (2.33 mL of a 
1.80 M solution in hexanes, 1.05 equiv) and DMF (0.93 mL, 3.00 equiv). 
The crude product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 
1g (0.296 g, 1.57 mmol, 39%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 0.89 (t, J = 7.6 
Hz, 3H), 1.41 – 1.53 (m, 2H), 2.01 (t, J = 7.2 Hz, 2H), 3.68 (s, 2H), 4.36 (s, 1H), 4.80 (s, 
1H), 7.22 (dd, J = 7.6, 1.0 Hz, 1H), 7.33 (ddd, J = 7.6, 7.6, 1.0 Hz, 1H), 7.46 (ddd, J = 7.6, 
7.6, 1.2 Hz, 1H), 7.82 (dd, J = 7.6, 1.2 Hz, 1H), 10.18 (s, 1H). 13C NMR (CDCl3, 100 MHz): 
δ 13.8, 20.9, 38.7, 38.7, 111.7, 126.9, 130.4, 131.8, 133.8, 134.4, 142.2, 149.3, 192.0. HRMS 
(ESI) calcd. for C13H16O (M+H+) 189.1274, found 189.1271. 
2-(2-Phenylallyl)benzaldehyde[26, 28] (1h): Prepared according to general 
procedure C from 6h (1.09 g, 4.00 mmol), n-BuLi (2.33 mL of a 1.80 M 
solution in hexanes, 1.05 equiv) and DMF (0.93 mL, 3.00 equiv). The crude 
product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1h (0.332 
g, 1.49 mmol, 37%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 4.18 (s, 2H), 4.66 (d, J = 
1.2 Hz, 1H), 5.41 (d, J = 1.2 Hz, 1H), 7.16-7.34 (m, 5H), 7.40-7.44 (m, 3H), 7.80 (dd, J = 
6.4, 1.2 Hz, 1H), 10.16 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.6, 114.9, 126.0, 127.0, 
127.8, 128.4, 131.5, 131.6, 133.9, 134.2, 140.9, 141.7, 147.5, 192.3. HRMS (ESI) calcd. for 
C16H14O (M+Na+) 245.0937, found 245.0935. 
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 2-Allylbenzaldehyde[64-65] (1o): Prepared according to general procedure C 
from 6o (0.788 g, 4.00 mmol), n-BuLi (4.00 mL of a 1.10 M solution in 
hexanes, 1.10 equiv) and DMF (0.93 mL, 3.00 equiv). The crude product was 
purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1o (0.344 g, 2.36 
mmol, 59%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 3.82 (d, J = 6.4 Hz, 2H), 4.98 
(dd, J = 17.2, 1.8 Hz, 1H), 5.09 (dd, J = 10.2, 1.8 Hz, 1H), 6.05 (ddt, J = 17.2, 10.2, 6.4, 1H), 
7.30 (dd, J = 7.6, 0.8 Hz, 1H), 7.40 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.55 (ddd, J = 7.6, 7.6, 0.8 
Hz, 1H), 7.85 (dd, J = 7.6, 0.8 Hz 1H), 10.26 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 36.5, 
116.4, 126.9, 131.6, 131.6, 133.8, 133.9, 136.9, 142.2, 192.3.  
 d1-2-(2-Methylallyl)benzaldehyde (d-1a): Prepared according to a modified 
version of general procedure C from 6a (0.866 g, 4.10 mmol), n-BuLi (1.87 mL 
of a 2.30 M solution in hexanes, 1.05 equiv) and DMF-d7 (0.957 mL, 3.00 
equiv). The crude product was purified by flash column chromatography (90:10 
Hex:EtOAc) to yield d-1a (0.414 g, 2.57 mmol, 63%) as a pale yellow oil. 1H NMR (CDCl3, 
400 MHz): δ 1.78 (s, 3H), 3.72 (s, 2H), 4.45 (s, 1H), 4.84 (s, 1H), 7.28 (dd, J = 7.6, 0.8 Hz, 
1H), 7.39 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.53 (ddd, J = 8.0, 7.6, 0.8 Hz, 1H), 7.87 (dd, 8.0, 
0.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 23.0, 40.3, 112.6, 127.1, 130.6, 131.7, 134.0, 
134.3 (t, J = 3.0 Hz), 142.2, 145.4, 191.9 (t, J = 26.4 Hz). HRMS (ESI) calcd. for C11H11DO 
(M+H+) 162.1024, found 162.1021. 
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Synthesis of 6-(2-Methylallyl)benzo[d][1,3]dioxole-5-carbaldehyde 1f 
 
 6-(2-Methylallyl)benzo[d][1,3]dioxole-5-carbaldehyde (1f): To an 
oven-dried schlenk flask equipped with a stir bar and under nitrogen 
atmosphere was added Mg turnings (0.182 g, 7.50 mmol, 1.50 equiv), a 
few crystals of I2 and anhydrous THF (20 mL). In a separate oven-dried round bottom flask, 
a solution of 5-bromo-6-(1,3-dioxolan-2-yl)benzo[d][1,3]dioxole (1.37 g, 5.00 mmol, 1.00 
equiv) in anhydrous THF (8 mL) was prepared. An initial volume of 1 mL of the solution of 
5-bromo-6-(1,3-dioxolan-2-yl)benzo[d][1,3]dioxole was added to the Mg suspension via 
syringe and the mixture was heated gently with a heat gun to initiate the formation of the 
Grignard reagent. The remaining solution of 5-Bromo-6-(1,3-dioxolan-2-
yl)benzo[d][1,3]dioxole  was added slowly while keeping the solution of the Grignard 
reagent at reflux. The reaction mixture was refluxed for an additional 2 hours and cooled to 
room temperature. To an oven-dried 100 mL round bottom flask was added 3-chloro-2-
methylprop-1-ene (0.734 mL, 7.50 mmol, 1.50 equiv), CuI (0.143 g, 0.750 mmol, 0.100 
equiv) and dry THF (10 mL), and the mixture was cooled to 0 °C. The solution of the 
Grignard reagent was slowly transferred to this mixture via cannula. The combined reaction 
mixture was stirred overnight and allowed to warm to room temperature. The reaction was 
quenched by the addition of sat. NH4Cl solution and extracted with CH2Cl2 (3x).  The 
Br
O
O
O
O THF, reflux MgBr
O
O
O
O Cl
+
THF, 0° C to rt
O
O
O
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combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. 
The crude product was refluxed for 2 h following the addition of 20 mL H2O, 20 mL acetone 
and PTSA (150 mg). Upon cooling to room temperature, the product was extracted with 
CH2Cl2 (3x), dried over Na2SO4 and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1f (0.209 g, 1.02 
mmol, 20%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 1.76 (s, 3H), 3.63 (s, 2H), 4.52 
(s, 1H), 4.86 (s, 1H), 6.03 (s, 2H), 6.71 (s, 1H), 7.35 (s, 1H), 10.1 (s, 1H). 13C NMR (CDCl3, 
100 MHz): δ 22.8, 40.0, 102.0, 108.0, 111.1, 112.9, 129.1, 139.8, 145.2, 147.2, 152.6, 189.6. 
HRMS (ESI) calcd. for C12H12O3 (M+H+) 205.0859, found 205.0859. 
General Procedure D: Synthesis of ortho-Allylbenzaldehydes 1i-n 
  
Compounds 1i-n were prepared according to a procedure reported by Glorius et al.[28] 
To an oven dried Schlenk flask was added Pd(PPh3)4 (0.050-0.100 mmol, 0.05 equiv), the 
appropriate arylboronic acid (1.20-3.00 mmol, 1.50 equiv), 1.6-4.0 mL of a 2M solution of 
aqueous Na2CO3, 2-(2-bromoallyl)benzaldehyde (0.800-2.00 mmol, 1.00 equiv) and 4-10 mL 
of 1,4-dioxane. The flask was evacuated and backfilled with nitrogen three times and stirred 
for 16 hours at 60 °C. The reaction was quenched with 10 mL of water and extracted with 20 
mL EtOAc (3x). The combined organic layers were dried over Na2SO4 and concentrated 
under reduced pressure. The crude product was purified by flash column chromatography 
(Hex:EtOAc) to yield ortho-allylbenzaldehydes 1i-n. 
O
Br
+
1,4-dioxane, 60 °C
O
Ar
1i-n
Pd(PPh3)4 (5 mol%)
Na2CO3 (4 equiv)ArB(OH)2
Ar = 4-Cl-C6H4
        4-CF3-C6H4
        4-OMe-C6H4
        3-OMe-C6H4
        2-OMe-C6H4
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2-(2-(4-Chlorophenyl)allyl)benzaldehyde (1i): Prepared according 
to general procedure D from Pd(PPh3)4 (116 mg, 0.100 mmol, 0.05 
equiv), 4-chlorophenylboronic acid (469 mg, 3.00 mmol, 1.50 equiv), 
4 mL of a 2M aqueous Na2CO3 solution, 2-(2-bromoallyl)benzaldehyde (450 mg, 2.00 mmol, 
1.00 equiv) and 10 mL 1,4-dioxane. The crude product was purified by flash column 
chromatography (90:10 Hex:EtOAc) to yield 1i (0.378 g, 1.47 mmol, 74%) as a pale yellow 
oil. 1H NMR (CDCl3, 400 MHz): δ 4.23 (s, 2H), 4.75 (s, 1H), 5.44 (s, 1H), 7.27-7.31 (m, 
3H), 7.38-7.45 (m, 3H), 7.52 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.84 (dd, J = 7.6, 1.6 Hz, 1H), 
10.2 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.8, 115.4, 127.3, 127.5, 128.6, 131.6, 132.5, 
133.6, 134.0, 134.2, 139.4, 141.4, 146.4, 192.6. HRMS (ESI) calcd. for C16H13ClO (M+H+) 
257.0728, found 257.0723. 
2-(2-(4-(Trifluoromethyl)phenyl)allyl)benzaldehyde[28] (1j): 
Prepared according to general procedure D from Pd(PPh3)4 (116 mg, 
0.100 mmol, 0.05 equiv), 4-(trifluoromethyl)phenylboronic acid 
(570 mg, 3.00 mmol, 1.50 equiv), 4 mL of a 2M aqueous Na2CO3 
solution, 2-(2-bromoallyl)benzaldehyde (450 mg, 2.00 mmol, 1.00 equiv) and 10 mL 1,4-
dioxane. The crude product was purified by flash column chromatography (90:10 
Hex:EtOAc) to yield 1j (0.432 g, 1.49 mmol, 74%) as a yellow oil. 1H NMR (CDCl3, 400 
MHz): δ 4.26 (s, 2H), 4.83 (s, 1H), 5.50 (s, 1H), 7.31 (dd, J = 7.6, 0.8 Hz, 1H), 7.40 (ddd, J = 
7.6, 7.2, 0.8 Hz, 1H), 7.53 (ddd, J = 7.6, 7.2, 1.2 Hz, 1H), 7.58 (s, 4H), 7.87 (dd, J = 7.6, 1.2 
Hz, 1H), 10.2 (s, 1H).13C NMR (CDCl3, 100 MHz): δ 37.8, 116.6, 124.3 (q, J = 270.5 Hz), 
125.5 (q, J = 3.8 Hz), 126.5, 127.4, 129.8 (q, J = 32.4 Hz), 131.7, 133.0, 134.0, 134.2, 141.0, 
O
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144.6 (q, J = 1.4 Hz), 146.5, 192.7.19F NMR (CDCl3, 376 MHz): δ -62.5 (s, 1F). HRMS 
(ESI) calcd. for C17H13F3O (M+H+) 291.0991, found 291.0995. 
2-(2-(4-Methoxyphenyl)allyl)benzaldehyde[28] (1k): Prepared 
according to general procedure D from Pd(PPh3)4 (116 mg, 0.100 
mmol, 0.05 equiv), 4-methoxyphenylboronic acid (456 mg, 3.00 
mmol, 1.50 equiv), 4 mL of a 2M aqueous Na2CO3 solution, 2-(2-
bromoallyl)benzaldehyde (450 mg, 2.00 mmol, 1.00 equiv) and 10 mL 1,4-dioxane. The 
crude product was purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1k 
(0.324 g, 1.28 mmol, 64%) as a yellow oil. 1H NMR (CDCl3, 400 MHz): δ 3.81 (s, 3H), 4.22 
(s, 2H), 4.64 (s, 1H), 5.41 (s, 1H), 6.86 (d, J = 8.8 Hz, 2H), 7.32 (dd, J = 7.6, 0.8 Hz, 1H), 
7.37 – 7.44 (m, 3H), 7.51 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.87 (dd, J = 7.6, 1.6 Hz, 1H), 10.2 
(s, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.8, 55.4, 113.6, 113.8, 127.1, 127.2, 131.5, 131.6, 
133.3, 134.0, 134.2, 142.0, 146.7, 159.4, 192.5. HRMS (ESI) calcd. for C17H16O2 (M+H+) 
253.1223, found 253.1228. 
 2-(2-(3-Methoxyphenyl)allyl)benzaldehyde (1l): Prepared 
according to general procedure D from Pd(PPh3)4 (116 mg, 0.100 
mmol, 0.05 equiv), 3-methoxyphenylboronic acid (456 mg, 3.00 
mmol, 1.50 equiv), 4 mL of a 2M aqueous Na2CO3 solution, 2-(2-bromoallyl)benzaldehyde 
(450 mg, 2.00 mmol, 1.00 equiv) and 10 mL 1,4-dioxane. The crude product was purified by 
flash column chromatography (90:10 Hex:EtOAc) to yield 1l (0.278 g, 1.10 mmol, 55%) as a 
yellow oil. 1H NMR (CDCl3, 400 MHz): δ 3.84 (s, 3H), 4.26 (s, 2H), 4.76 (s, 1H), 5.50 (s, 
1H), 6.86 (ddd, J = 8.0, 2.4, 0.8 Hz, 1H), 7.03 (dd, J = 2.4, 2.4 Hz, 1H), 7.10 (ddd, J = 8.0, 
1.2, 0.8 Hz, 1H), 7.28 (dd, J = 2.4, 1.2 Hz, 1H), 7.35 (dd, J = 7.6, 0.8 Hz, 1H), 7.44 (ddd, J = 
O
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8.0, 7.6, 0.8 Hz, 1H), 7.55 (ddd, J = 8.0, 7.6, 1.6 Hz, 1H), 7.90 (dd, J = 7.6, 1.6 Hz, 1H), 10.3 
(s, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.8, 55.4, 112.1, 113.1, 115.3, 118.6, 127.2, 129.5, 
131.6, 131.7, 134.0, 134.2, 141.8, 142.5, 147.5, 159.7, 192.5. HRMS (ESI) calcd. for 
C17H16O2 (M+H+) 253.1223, found 253.1229. 
 2-(2-(2-Methoxyphenyl)allyl)benzaldehyde (1m): Prepared according 
to general procedure D from Pd(PPh3)4 (116 mg, 0.100 mmol, 0.05 
equiv), 2-methoxyphenylboronic acid (456 mg, 3.00 mmol, 1.50 equiv), 
4 mL of a 2M aqueous Na2CO3 solution, 2-(2-bromoallyl)benzaldehyde (450 mg, 2.00 mmol, 
1.00 equiv) and 10 mL 1,4-dioxane. The crude product was purified by flash column 
chromatography (90:10 Hex:EtOAc) to yield 1m (0.272 g, 1.08 mmol, 54%) as a yellow oil. 
1H NMR (CDCl3, 400 MHz): δ 3.86 (s, 3H), 4.17 (s, 2H), 4.81 (q, J = 1.6 Hz, 1H), 5.12 (q, J 
= 1.6 Hz, 1H), 6.84-6.92 (m, 2H), 7.08 (dd, J = 7.6, 2.0 Hz, 1H), 7.23 – 7.32 (m, 2H), 7.34 
(ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.50 (ddd, J = 7.6, 7.2, 1.6 Hz, 1H), 7.80 (dd, J = 7.6, 1.6 Hz, 
1H), 10.3 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 38.5, 55.5, 110.7, 116.6, 120.8, 127.1, 
128.96, 129.03, 130.2, 131.6, 132.0, 133.9, 134.5, 142.5, 148.9, 156.5, 192.4. HRMS (ESI) 
calcd. for C17H16O2 (M+Na+) 275.1043, found 275.1046. 
 2-(2-(Thiophen-3-yl)allyl)benzaldehyde (1n): Prepared according to a 
modified version of general procedure D from Pd(PPh3)4 (46.0 mg, 0.050 
mmol, 0.063 equiv), 3-thienylboronic acid (154 mg, 1.20 mmol, 1.50 
equiv), 1.6 mL of a 2M aqueous Na2CO3 solution, 2-(2-bromoallyl)benzaldehyde (180 mg, 
0.800 mmol, 1.00 equiv) and 4 mL 1,4-dioxane. The crude product was purified by flash 
column chromatography (90:10 Hex:EtOAc) to yield 1n (94.2 mg, 0.413 mmol, 52%) as a 
yellow oil. 1H NMR (CDCl3, 400 MHz): δ 4.19 (s, 2H), 4.63 (s, 1H), 5.51 (s, 1H), 7.22-7.27 
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(m, 3H), 7.31 (dd, J = 7.6, 0.8 Hz, 1H), 7.40 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.50 (ddd, J = 
7.6, 7.6, 1.6 Hz, 1H), 7.86 (dd, J = 7.6, 1.6 Hz, 1H), 10.2 (s, 1H). 13C NMR (CDCl3, 100 
MHz): δ 37.6, 113.8, 120.9, 125.7, 125.8, 127.2, 131.60, 131.63, 134.0, 134.3, 141.5, 142.0, 
142.3, 192.5. HRMS (ESI) calcd. for C14H12OS (M+H+) 229.0682, found 229.0685. 
General Procedure E: Hydroacylation of ortho-Allylbenzaldehydes 2a-o 
 
In a nitrogen-filled dry box, the appropriate ortho-allylbenzaldehyde 1a-1o (0.200 
mmol, 1.00 equiv), [Rh(COD)Cl]2 (2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos 
(11.8 mg, 0.010 mmol, 0.050 equiv), NaBARF (8.9 mg, 0.010 mmol, 0.050 equiv), and 
anhydrous 1,4-dioxane (1 mL) were added to a 1-dram vial. The vial was sealed with a 
PFTE/silicone-lined septum cap and removed from the dry box. The reaction mixture was 
heated to 100 °C and allowed to stir at this temperature until the reaction was judged to be 
complete by TLC analysis. The mixture was cooled to rt, filtered through a pad of silica gel 
(eluting with EtOAc), and concentrated under reduced pressure. CDCl3 (0.7 mL) was added 
to dissolve the crude mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an internal 
standard. Conversion and hydroacylation/alkene isomerization ratio were determined by 1H 
NMR spectroscopy of the crude reaction mixture. The crude reaction mixture was purified by 
flash column silica gel chromatography (hexanes:EtOAc or hexanes:Et2O) to yield 2a-o. 
Enantiomeric excess was determined by chiral HPLC analysis. 
 (R)-3-Methyl-3,4-dihydronaphthalen-1(2H)-one[53, 66-67] (2a): Prepared 
according to general procedure E from 1a (32.0 mg, 0.200 mmol) (reaction 
O
R2
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O
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(R)-DTBM-Segphos (5 mol%)
NaBARF (5 mol%)
O
2a
 85 
time = 12 h). The crude product (hydroacylation:isomerization = 10.7:1) was purified by 
flash column chromatography (90:10 hexanes:EtOAc) to yield 2a (27.1 mg, 0.169 mmol, 
85%) as a colorless oil. The enantiomeric excess was determined by HPLC analysis (254 nm, 
25 °C) tR 20.9 min (major); tR 22.1 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 93:7, 0.3 mL/min] to be 98% ee. Lit:1,2 [α]D25 = -
32.2° (c 6.10, EtOH), found [α]D25= -36.7° (c 0.98, EtOH), [α]D25 = -32.9° (c 0.85, CHCl3). 
1H NMR (CDCl3, 400 MHz): δ 1.14 (d, J = 6.0 Hz, 3H), 2.27-2.34 (m, 2H), 2.65-2.75 (m, 
2H), 2.97 (dd, J = 16.4, 3.2 Hz, 1H), 7.24 (dd, J = 7.6, 0.8 Hz, 1H), 7.30 (ddd, J = 7.6, 7.6, 
0.8 Hz, 1H), 7.47 (ddd, J = 8.0, 7.6, 0.8 Hz, 1H), 8.02 (dd, J = 8.0, 0.8 Hz, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 21.5, 30.6, 38.2, 47.3, 126.7, 127.1, 129.0, 132.3, 133.6, 143.9, 198.7.  
 (R)-7-Fluoro-3-methyl-3,4-dihydronaphthalen-1(2H)-one (2b): 
Prepared according to general procedure E from 1b (35.6 mg, 0.200 mmol) 
(reaction time = 24 h). The crude product (hydroacylation:isomerization = 
9:1) was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 2b (21.3 
mg, 0.120 mmol, 60%) as a yellow oil that solidified on standing. The enantiomeric excess 
was determined by HPLC analysis (254 nm, 25 °C) tR 31.5 min (major); tR 32.8 min (minor) 
[Chiracel AS-H+OJ-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
99:1, 0.5 mL/min] to be 98% ee. [α]D25= -32.4° (c 0.68, CHCl3) 1H NMR (CDCl3, 400 MHz): 
δ 1.15 (d, J = 6.4 Hz, 3H), 2.25-2.39 (m, 2H), 2.64 (dd, J = 16.4, 9.2 Hz, 1H), 2.74 (dd, J = 
13.2, 2.0 Hz, 1H), 2.96 (dd, J = 16.4, 3.2 Hz, 1H), 7.18 (ddd, J = 9.2, 8.4, 2.8 Hz, 1H), 7.23 
(dd, J = 8.4, 5.2 Hz, 1H), 7.68 (dd, J = 9.2, 2.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 
21.4, 30.7, 37.4, 46.9, 113.0 (d, J = 22.0, Hz), 120.9 (d, J = 22.0 Hz), 130.7 (d, J = 7.0 Hz), 
133.9 (d, J = 6.0 Hz), 139.6 (d, J = 3.0 Hz), 161.7 (d, J = 244.6 Hz), 197.6. 19F NMR 
O
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(CDCl3, 376 MHz): δ -116.2 (m, 1F). HRMS (ESI) calcd. for C11H11FO (M+H+) 179.0867, 
found 179.0863.  
(R)-6-Fluoro-3-methyl-3,4-dihydronaphthalen-1(2H)-one (2c): Prepared 
according to general procedure E from 1c (35.6 mg, 0.200 mmol) (reaction 
time = 24 h). The crude product (hydroacylation:isomerization = >20:1) 
was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 2c (31.6 mg, 
0.177 mmol, 88%) as a yellow oil. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 12.0 min (major); tR 15.0 min (minor) [Chiracel AS-H (0.46cm x 
25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 99:1, 0.5 mL/min] to be 98% ee. 
[α]D25= -16.4° (c 1.46, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.14 (d, J = 6.4 Hz, 3H), 2.23-
2.39 (m, 2H), 2.67 (dd, J = 16.0, 10.0 Hz, 1H), 2.72 (dd, J = 9.6, 1.6 Hz, 1H), 2.95 (dd, J = 
16.0, 3.6 Hz, 1H), 6.91 (dd, J = 9.2, 2.4 Hz, 1H), 6.97 (ddd, J = 9.2, 8.8, 2.4, 1H), 8.04 (dd, J 
= 8.8, 6.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 21.4, 30.5, 38.2, 47.0, 114.4 (d, J = 22.2), 
115.2 (d, J = 21.2 Hz), 129.0 (d, J = 2.8 Hz), 130.2 (d, J = 10.0 Hz), 146.5 (d, J = 9.0 Hz), 
165.9 (d, J = 254.4 Hz), 197.1. 19F NMR (CDCl3, 376 MHz): δ -105.8 (m, 1F). HRMS (ESI) 
calcd. for C11H11FO (M+H+) 179.0867, found 179.085.  
 (R)-6-Chloro-3-methyl-3,4-dihydronaphthalen-1(2H)-one (2d): 
Prepared according to general procedure E from 1d (38.9 mg, 0.200 
mmol) using 10 mol% catalyst loading (reaction time = 24 h). The crude 
product (hydroacylation:isomerization = >20:1) was purified by flash column 
chromatography (90:10 hexanes: EtOAc) to yield 2d (35.4 mg, 0.182 mmol, 91%) as a 
yellow oil. The enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 
14.0 min (major); tR 15.6 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel 
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Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 97% ee. [α]D25= -68.3° (c 0.82, 
CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.14 (d, J = 6.0 Hz, 3H), 2.26-2.39 (m, 2H), 2.67 (dd, 
J = 16.8, 10.4 Hz, 1H), 2.73 (dd, J = 13.2, 2.0 Hz, 1H), 2.95 (dd, J = 16.8, 3.6 Hz, 1H), 7.25 
(d, J = 0.8 Hz, 1H), 7.27 (dd, J = 8.8, 0.8 Hz, 1H), 7.96 (d, J = 8.8 Hz, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 21.4, 30.5, 37.9, 47.0, 127.3, 128.81, 128.80, 130.8, 139.8, 145.4, 
197.4. HRMS (ESI) calcd. for C11H11ClO (M+H+) 195.0571, found 195.0566.  
(R)-6-Methoxy-3-methyl-3,4-dihydronaphthalen-1(2H)-one (2e): 
Prepared according to general procedure E from 1e (38.1 mg, 0.200 
mmol) (reaction time = 12 h). The crude product 
(hydroacylation:isomerization = 19:1) was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield 2e (32.0 mg, 0.168 mmol, 84%) as a white amorphous solid. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 23.5 min (major); 
tR 25.8 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 90:10, 0.5 mL/min] to be 99% ee. [α]D25 = -49.4° (c 0.77, CHCl3) 1H NMR 
(CDCl3, 400 MHz): δ 1.12 (d, J = 6.4 Hz, 3H), 2.19-2.34 (m, 2H), 2.60-2.70 (m, 2H), 2.92 
(dd, J = 16.4, 3.6 Hz, 1H), 3.84 (s, 3H), 6.68 (d, J = 2.4 Hz, 1H), 6.81 (dd, J = 8.4, 2.4 Hz, 
1H), 7.98 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 21.5, 30.7, 38.6, 47.0, 55.5, 
112.8, 113.1, 126.0, 129.5, 145.4, 163.7, 197.4. HRMS (ESI) calcd. for C12H14O2 (M+H+) 
191.1067, found 191.1063.  
(R)-7-Methyl-7,8-dihydronaphtho[2,3-d][1,3]dioxol-5(6H)-one (2f): 
Prepared according to general procedure E from 1f (40.8 mg, 0.200 mmol) 
(reaction time = 24 h). The crude product (hydroacylation:isomerization = 
9.8:1) was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 2f (35.0 
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mg, 0.171 mmol, 85%) as a colorless oil. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 26.0 min (major); tR 28.4 min (minor) [Chiracel AS-H (0.46cm x 
25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 99% ee. 
[α]D25= -61.3° (c 1.24, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.12 (d, J = 6.0 Hz, 3H), 2.18-
2.35 (m, 2H), 2.59 (dd, J = 16.0, 10.4 Hz, 1H), 2.67 (dd, J = 12.8, 1.6 Hz, 1H), 2.87 (dd, J = 
16.0, 3.6, 1H), 6.00 (s, 2H), 6.65 (s, 1H), 7.45 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 21.4, 
30.8, 38.4, 46.8, 101.7, 106.2, 108.1, 127.1, 140.8, 147.0, 152.2, 196.9. HRMS (ESI) calcd. 
for C12H12O3 (M+H+) 205.0859, found 205.0853.  
 (R)-3-Propyl-3,4-dihydronaphthalen-1(2H)-one[68] (2g): Prepared 
according to general procedure E from 1g (37.7 mg, 0.200 mmol) 
(reaction time = 24 h). The crude product (hydroacylation:isomerization = 
>20:1) was purified by flash column chromatography (90:10 hexanes:Et2O) to yield 2g (33.3 
mg, 0.177 mmol, 89%) as a yellow oil. The enantiomeric excess was determined by HPLC 
analysis (254 nm, 25 °C) tR 11.3 min (major); tR 12.5 min (minor) [Chiracel AS-H (0.46cm x 
25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 96% ee. 
[α]D25 = -28.1° (c 1.21, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 0.88-0.96 (m, 3H), 1.35-1.48 
(m, 4H), 2.16-2.25 (m, 1H), 2.31 (dd, J = 16.8, 12.0 Hz, 1H), 2.69 (dd, J = 16.4, 10.4 Hz, 
1H), 2.77 (ddd, J = 16.8, 3.2, 1.6 Hz, 1H), 2.96-3.05 (m, 1H), 7.24 (dd, J = 7.6, 0.8 Hz, 1H), 
7.30 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.46 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 8.01 (dd, J = 7.6, 1.2 
Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 14.2, 19.8, 35.2, 36.3, 38.1, 45.6, 126.7, 127.1, 
129.0, 132.6, 133.6, 144.0, 198.9. HRMS (ESI) calcd. for C13H16O (M+H+) 189.1274, found 
189.1270.  
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 (R)-3-Phenyl-3,4-dihydronaphthalen-1(2H)-one[26] (2h): Prepared 
according to general procedure E from 1h (44.5 mg, 0.200 mmol) (reaction 
time = 24 h). The crude product (hydroacylation:isomerization = >20:1) was 
purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 2h (37.0 mg, 
0.166 mmol, 83%) as a pale brown oil which contained 4% of 2-(2-phenylprop-1-en-1-
yl)benzaldehyde 3h (E:Z = 1:1). The enantiomeric excess was determined by HPLC analysis 
(254 nm, 25 °C) tR 10.3 min (major); tR 22.9 min (minor) [Chiracel AS-H (0.46cm x 25cm) 
(from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 97% ee. [α]D25 = -
5.71° (c 1.40, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 2.82 (dd, J = 16.4, 12.8 Hz, 1H), 2.93-
2.99 (ddd, J = 16.4, 4.0, 1.6 Hz, 1H), 3.12-3.27 (m, 2H), 3.40-3.49 (m, 1H), 7.40-7.42 (m, 
7H), 7.50 (ddd, J = 8.0, 7.6, 1.2 Hz, 1H), 8.07 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 100 
MHz): δ 37.8, 41.2, 46.1, 126.8, 127.0, 127.1, 127.3, 128.9, 129.0, 132.2, 133.9, 143.4, 
143.5, 197.9. HRMS (ESI) calcd. for C16H14O (M+Na+) 245.0937, found 245.0934. 
(R)-3-(4-Chlorophenyl)-3,4-dihydronaphthalen-1(2H)-one (2i): 
Prepared according to general procedure E from 1i (51.3 mg, 0.200 
mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = >20:1) was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 2i (38.0 mg, 0.148 mmol, 74%) as a pale yellow oil. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 31.9 min (major); 
tR 42.9 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 95:5, 0.5 mL/min] to be 98% ee. [α]D25 = -4.21° (c 1.9, CHCl3) 1H NMR 
(CDCl3, 400 MHz): δ 2.79 (dd, J = 16.4, 12.8 Hz, 1H), 2.93 (ddd, J = 16.8, 4.4, 1.2 Hz, 1H), 
3.10-3.24 (m, 2H), 3.36-3.49 (m, 1H), 7.23 (d, J = 8.4 Hz, 2H), 7.28 (dd, J = 7.6, 0.8 Hz, 
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1H), 7.31 (d, J = 8.4 Hz, 2H), 7.37 (dd, J = 7.6, 0.8 Hz, 1H), 7.52 (ddd, J = 7.6, 7.6, 1.2 Hz, 
1H), 8.07 (dd, J = 7.6, 1.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.7, 40.6, 46.0, 127.2, 
127.4, 128.2, 128.97, 129.04, 132.1, 132.8, 134.0, 142.0, 143.1, 197.5. HRMS (ESI) calcd. 
for C16H13ClO (M+H+) 257.0728, found 257.0731. 
(R)-3-(4-(Trifluoromethyl)phenyl)-3,4-dihydronaphthalen-1(2H)-
one (2j): Prepared according to general procedure E from 1j (58.1 
mg, 0.200 mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = >20:1) was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield 2j (45.6 mg, 0.157 mmol, 79%) as a yellow oil. The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 9.75 min (major); tR 13.5 min 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 1.0 mL/min] to be 96% ee. [α]D25 = -2.89° (c 2.09, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 2.85 (dd, J = 16.8, 12.8 Hz, 1H), 2.98 (ddd, J = 16.8, 4.0, 1.6 Hz, 1H), 3.14-3.29 (m, 
2H), 3.46-3.60 (m, 1H), 7.29 (dd, J = 7.6, 0.8 Hz, 1H), 7.37 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 
7.42 (d, J = 8.0 Hz, 2H), 7.53 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.63 (d, J = 8.0 Hz, 2H), 8.09 
(dd, J = 7.6, 1.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.4, 41.0, 45.7, 125.9 (q, J = 3.7 
Hz), 126.9 (q, J = 270.4 Hz), 127.26, 127.30, 127.4, 129.0, 129.4 (q, J = 32.4 Hz), 132.1, 
134.1, 142.9, 147.4, 197.1. 19F NMR (CDCl3, 376 MHz): δ -63.46 (s, 1F). HRMS (ESI) 
calcd. for C17H13F3O (M+H+) 291.0991, found 291.0995.  
 (R)-3-(4-Methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one 
(2k): Prepared according to general procedure E from 1k (50.5 mg, 
0.200 mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = >20:1) was purified by flash column chromatography (95:5 
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hexanes:EtOAc) to yield 2k (40.4 mg, 0.160 mmol, 80%) as a pale yellow oil. The 
enantiomeric excess was determined by HPLC analysis (254 nm, 25 °C) tR 20.5 min (major); 
tR 29.5 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) 
hexane/iPrOH, 90:10, 1.0 mL/min] to be 98% ee. [α]D25 = -7.14° (c 1.12, CHCl3) 1H NMR 
(CDCl3, 400 MHz): δ 2.80 (dd, J = 16.4, 12.8 Hz, 1H), 2.95 (ddd, J = 16.4, 4.4, 1.2 Hz, 1H), 
3.11-3.23 (m, 2H), 3.36-3.47 (m, 1H), 3.81 (s, 3H), 6.90 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 
Hz, 2H), 7.28 (dd, J = 7.6, 0.8 Hz, 1H), 7.35 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.51 (ddd, J = 
7.6, 7.6, 1.2 Hz, 1H), 8.08 (dd, J = 7.6, 1.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 38.1, 
40.4, 46.3, 55.4, 114.2, 127.0, 127.3, 127.8, 129.0, 132.2, 133.9, 135.7, 143.6, 158.6, 198.1. 
HRMS (ESI) calcd. for C17H16O2 (M+H+) 253.1223, found 253.1231. 
(R)-3-(3-Methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one (2l): 
Prepared according to general procedure E from 1l (50.5 mg, 0.200 
mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = >20:1) was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 2l (36.2 mg, 0.143 mmol, 72%) as a yellow oil. The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 13.8 min (major); tR 16.9 min 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 1.0 mL/min] to be 98% ee. [α]D25 = -10.5° (c 1.72, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 2.79 (dd, J = 16.4, 13.2 Hz, 1H), 2.94 (ddd, J = 16.4, 4.0, 1.6 Hz, 1H), 3.09-3.24 (m, 
2H), 3.35-3.46 (m, 1H), 3.79 (s, 3H), 6.76-6.84 (m, 2H), 6.87 (dd, J = 8.0, 0.8 Hz, 1H), 7.22-
7.29 (m, 2H), 7.32 (ddd, J = 8.0, 7.6, 0.8 Hz, 1H), 7.48 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 8.05 
(dd, J = 7.6, 1.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 37.7, 41.2, 46.1, 55.3, 112.0, 
O
2l
OMe
 92 
113.0, 119.1, 127.1, 127.3, 129.0, 130.0, 132.2, 134.0, 143.5, 145.2, 160.0, 197.9. HRMS 
(ESI) calcd. for C17H16O2 (M+H+) 253.1223, found 253.1227. 
(R)-3-(2-Methoxyphenyl)-3,4-dihydronaphthalen-1(2H)-one (2m): 
Prepared according to general procedure E from 1m (50.5 mg, 0.200 
mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = 18:1) was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 2m (35.4 mg, 0.140 mmol, 70%) as a yellow oil. The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 21.4 min (major); tR 27.6 min 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 0.5 mL/min] to be 97% ee. [α]D25 = -6.02° (c 1.66, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 2.89 (dd, J = 16.4, 12.4 Hz, 1H), 2.97 (ddd, J = 16.4, 4.0, 1.6 Hz, 1H), 3.17 (ddd, J 
= 16.4, 2.8, 0.8 Hz, 1H), 3.27 (dd, J = 12.4, 0.8 Hz, 1H), 3.80-3.93 (m, 4H), 6.94 (dd, J = 8.4, 
0.8 Hz, 1H), 7.00 (ddd, J = 8.0, 7.2, 0.8 Hz, 1H), 7.24-7.34 (m, 3H), 7.37 (ddd, J = 7.6, 7.2, 
0.8 Hz, 1H), 7.53 (ddd, J = 7.6, 7.2, 1.2 Hz, 1H), 8.12 (dd, J = 7.6, 1.2 Hz, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 35.1, 36.0, 44.8, 55.4, 110.7, 120.8, 126.79, 126.83, 127.3, 128.0, 
129.0, 131.6, 132.3, 133.7, 144.3, 157.1, 198.7. HRMS (ESI) calcd. for C17H16O2 (M+H+) 
253.1223, found 253.1225. 
 (R)-3-(Thiophen-3-yl)-3,4-dihydronaphthalen-1(2H)-one (2n): 
Prepared according to general procedure E from 1n (45.7 mg, 0.200 
mmol) (reaction time = 24 h). The crude product 
(hydroacylation:isomerization = >20:1) was purified by flash column chromatography (95:5 
hexanes:EtOAc) to yield 2n (22.6 mg, 0.099 mmol, 49%) as a yellow oil. The enantiomeric 
excess was determined by HPLC analysis (254 nm, 25 °C) tR 13.5 min (major); tR 17.3 min 
O
2m
OMe
O
2n S
 93 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 1.0 mL/min] to be 98% ee. [α]D25 = -17.6° (c 1.02, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 2.80 (dd, J = 16.4, 12.4 Hz, 1H), 3.05 (ddd, J = 16.4, 3.6, 1.6 Hz, 1H), 3.17 (dd, J = 
16.4, 10.8 Hz, 1H), 3.28 (ddd, J = 16.4, 2.8, 1.6 Hz, 1H), 3.52-3.62 (m, 1H), 7.07 (m, 2H), 
7.26-7.40 (m, 3H), 7.51 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 8.07 (dd, J = 7.6, 0.8 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 36.4, 37.2, 45.8, 120.0, 126.2, 126.4, 127.0, 127.2, 128.9, 132.1, 
133.8, 143.1, 144.5, 197.6. HRMS (ESI) calcd. for C14H12OS (M+H+) 229.0682, found 
229.0685. 
3,4-Dihydronaphthalen-1(2H)-one[69] (2o): Prepared according to general 
procedure E from 1o (29.2 mg, 0.200 mmol) (reaction time = 10 h). The crude 
product (hydroacylation:isomerization = >20:1) was purified by flash column 
chromatography (90:10 hexanes:Et2O) to yield 2o (21.2 mg, 0.145 mmol, 73%) as a pale 
yellow oil. 1H NMR (CDCl3, 400 MHz): δ 2.14 (m, 2H), 2.66 (t, J = 6.4 Hz, 2H), 2.97 (t, J = 
6.0 Hz, 2H), 7.25 (dd, J = 8.0 Hz, 0.8 Hz, 1H), 7.31 (ddd, J = 8.0, 7.6, 0.8 Hz, 1H), 7.47 
(ddd, J = 8.0, 7.6, 1.0 Hz, 1H), 8.03 (dd, J = 8.0, 1.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz): 
δ 23.4, 29.8, 39.3, 126.8, 127.3, 128.9, 132.7, 133.5, 144.6, 198.5.  
Rh-catalyzed Hydroacylation of d-1a 
 
[Rh(COD)Cl]2 (2.5 mol %)
rac-BINAP (5 mol %)
NaBARF (5 mol %)
1,4-dioxane, 100 °C
O
+
D
d-1a d-2a
79 % yield
d-3
21% yield
>98% D
>98% D
>98% D
O
not observed
D
O
D
O
D
O
2o
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 d1-3-Methyl-3,4-dihydronaphthalen-1(2H)-one-3 (d-2a): Prepared 
according to a modified version of general procedure E using rac-BINAP 
from d-1a (32.2 mg, 0.200 mmol) (reaction time = 16 h). The crude product 
was purified by flash column chromatography (95:5 hexanes:EtOAc) to yield d-2a (25.2 mg, 
0.156 mmol, 79%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.13 (s, 3H), 2.30 (d, J = 
16.8 Hz, 1H), 2.68 (d, J = 16.4 Hz, 1H), 2.72 (d, J = 16.8 Hz, 1H), 2.96 (d, J = 16.4, 1H), 
7.24 (dd, J = 7.6, 0.8 Hz, 1H), 7.30 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.47 (ddd, J = 7.6, 7.2, 0.8 
Hz, 1H), 8.01 (dd, J = 7.2, 0.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 21.4, 30.2 (t, J = 
19.4 Hz), 38.0, 47.2, 126.7, 127.1, 129.0, 132.3, 133.6, 143.9, 198.8. HRMS (ESI) calcd. for 
C11H11DO (M+H+) 162.1024, found 162.1020. 
d1-2-(2-Methylprop-1-en-1-yl)benzaldehyde (d-3): Prepared according to a 
modified version of general procedure D using rac-BINAP from d-1a (32.2 mg, 
0.200 mmol) (reaction time = 16 h). The crude product was purified by flash 
column chromatography (95:5 hexanes:EtOAc) to yield d-3 (5.9 mg, 0.037 
mmol, 19%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.65 (s, 3H), 1.96 (s, 3H), 6.58 
(s, 1H), 7.23 (dd, J = 7.6, 0.8 Hz, 1H), 7.36 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.54 (ddd, J = 7.6, 
7.6, 0.8 Hz, 1H), 7.89 (dd, J = 7.6, 0.8 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 19.6, 26.2, 
121.3, 126.9, 128.1, 130.9, 133.7, 133.8 (t, J = 3.7 Hz), 139.5, 142.4, 192.6 (t, J = 26.6). 
HRMS (ESI) calcd. for C11H11DO (M+H+) 162.1024, found 162.1023. 
Kinetic Isotope Effect for 1a vs. d-1a 
 
O O[Rh(COD)Cl]2 (2.5 mol %)
(R)-DTBM-Segphos (5 mol %)
NaBARF (5 mol %)
1,4-dioxane-d8, 100 °C
H/D
H/D1a or
d-1a
2a or
d-2a
d-3
O
D
O
D
d-2a
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The kinetic isotope effect was determined by measuring the initial rate constants for 
two independent experiments for the hydroacylation of 1a and d-1a. The reactions were 
monitored by 1H NMR spectroscopy (T = 373K) using 1,3,5-trimethoxybenzene as an 
internal standard. Reaction mixtures were prepared as follows: In a nitrogen-filled dry box, 
1a or d-1a (16.0 mg, 0.100 mmol, 1.00 equiv), [Rh(COD)Cl]2 (1.23 mg, 0.0025 mmol, 0.025 
equiv), (R)-DTBM-Segphos (5.90 mg, 0.005 mmol, 0.050 equiv), NaBARF (4.43 mg, 0.005 
mmol, 0.050 equiv), 1,3,5-trimethoxybenzene (5.61 mg, 0.033 mmol, 0.333 equiv), and 
anhydrous 1,4-dioxane-d8 (0.5 mL) were added to a 1-dram vial. The vial was agitated to 
dissolve all solids and the solution was transferred to a dry J-Young NMR tube, sealed and 
immediately subjected to 1H NMR analysis (T = 373K). Data points were collected every 3 
minutes and the initial rate constants were determined from the first 5% of the reaction data. 
Rh-Catalyzed Hydroacylation of 5-Phenylhex-5-enal 7 
 
In a nitrogen-filled dry box, 5-phenylhex-5-enal 7 (0.200 mmol, 1.00 equiv), 
[Rh(COD)Cl]2 (2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos (11.8 mg, 0.010 
mmol, 0.050 equiv), NaBARF (8.9 mg, 0.010 mmol, 0.050 equiv), and anhydrous 1,4-
dioxane (1 mL) were added to a 1-dram vial. The vial was sealed with a PFTE/silicone-lined 
septum cap and removed from the dry box. The reaction mixture was heated to 100 °C and 
allowed to stir at this temperature until the reaction was judged to be complete by TLC 
analysis. The mixture was cooled to rt, filtered through a pad of silica gel (eluting with 
EtOAc), and concentrated under reduced pressure. CDCl3 (0.7 mL) was added to dissolve the 
O
Ph
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O
Ph
H
[Rh(COD)Cl]2 (2.5 mol %)
(R)-DTBM-Segphos (5 mol %)
NaBARF (5 mol %)
1,4-dioxane
100 °C, 24 h7 8
78% NMR yield
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crude mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an internal standard. Compound 8 
was not isolated. The 1H NMR spectrum of the crude reaction mixture is shown below, 
integrated relative to the CH2Br2 standard. 
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Abstract 
We report studies toward the intramolecular hydroacylation of 1,2-disubstituted 
alkenes as well as the first examples of catalytic, enantioselective alkene hydroacylation of 
1,1,2-trisubstituted alkenes. The intramolecular hydroacylation of 1,2-disubstituted alkenes is 
facilitated by a cationic rhodium complex and generates the indanone products in high yields 
(up to 94%). However, the α-center is prone to epimerization and results in racemic mixtures 
of the bicyclic products. In contrast, the rhodium-catalyzed intramolecular hydroacylation of 
1,1,2-trisubstituted alkenes generates highly enantioenriched, polycyclic architectures. DFT 
and mechanistic studies are consistent with a reaction pathway for these processes that 
includes intramolecular alkene hydroacylation and α-epimerization. This reaction sequence 
enables the hydroacylation of 2-(cyclohex-1-en-1-yl)benzaldehydes to form hexahydro-9H-
fluoren-9-ones in moderate to high yields (68-91%) with high enantioselectivities (up to 99% 
ee) and diastereoselectivities (typically >20:1). 
Introduction 
Over forty years of investigation has established transition metal-catalyzed alkene 
hydroacylation as a powerful method for the formation of carbon-carbon bonds.[1-3] 
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Intramolecular alkene hydroacylations enable the synthesis of a variety of carbocyclic and 
heterocyclic ketones from substrates containing terminal and 1,1-disubstituted alkenes.[4-33] 
However, intramolecular alkene hydroacylation reactions that employ higher order alkenes 
remain rare.[17, 19, 22, 32-33]  
Terminal and 1,1-disubstituted alkenes are excellent substrates for a variety of 
intramolecular alkene hydroacylation reactions catalyzed by rhodium and cobalt complexes 
(Scheme 1a). Rhodium-catalyzed hydroacylations of 4-pentenals are established methods to 
form cyclopentanone derivatives, in many cases with high diastereoselectivity and/or 
enantioselectivity.[4-15, 18, 20] In addition, rhodium- and cobalt-catalyzed hydroacylations of 
1,1-disubstituted 2-vinylbenzaldehydes occur to generate 3-substituted indan-1-ones with 
high enantioselectivities.[17, 28]  
 
Scheme 1: Intramolecular alkene hydroacylations. 
 
Intramolecular hydroacylation reactions of 1,2-disubstituted alkenes are far less 
common than hydroacylations of 1,1-disubstituted alkenes (Scheme 1b). In 2005, Morehead 
reported a single example of the endo-selective rhodium-catalyzed hydroacylation of ethyl 
(E)-3-(2-formylphenyl)acrylate (R = CO2Et) that required 5 days to reach 90% conversion.[17] 
Douglas observed the formation of a product resulting from hydroacylation of a 1,2-
disubstituted alkene upon isomerization of 2-homoallylbenzaldehyde in the presence of a 
R
O
H
(a) Hydroacylation of Terminal and 1,1-Disubstituted Alkenes
O
R
O
H
O
R
R
Rh or Co catalyst
(b) Hydroacylation of Higher Order Alkenes
Rh catalyst
Many enantioselective 
examples
Three examples
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rhodium catalyst.[22] In 2009, Dong and co-workers reported the only enantioselective 
example of intramolecular hydroacylation of a 1,2-disubstituted alkene.[19] This exo-selective 
reaction forms a seven-membered ring and is facilitated by a chiral, cationic rhodium 
catalyst, but requires a coordinating sulfur atom to stabilize the key catalytic intermediate.  
 Several examples of transition metal-catalyzed intermolecular hydroacylation of 1,2-
disubstituted alkenes have been reported, but these reactions typically require chelation-
assistance strategies and selectivities are often highly substrate dependent.[34-39] To our 
knowledge there are no examples of transition metal-catalyzed alkene hydroacylation 
reactions with trisubstituted alkenes as substrates.[40-43]  
We report studies toward the development of a rhodium catalyst for the 
hydroacylation of 1,2-disubstituted alkenes and efforts made to address challenges in the 
enantioselective hydroacylation of these substrates. We also report the first examples of 
catalytic, enantioselective hydroacylations of 1,1,2-trisubstituted alkenes. DFT and 
mechanistic studies are consistent with an intramolecular alkene hydroacylation/α-
epimerization sequence for these catalytic processes and a series of hexahydro-9H-fluoren-9-
ones were synthesized by this method.  
Results and Discussion 
 
Chapter III of this thesis discusses the development of a rhodium catalyst for the 
endo- and enantioselective hydroacylation of ortho-allylbenzaldehydes.[29] We envisioned 
that the same cationic, rhodium catalyst could facilitate the endo-selective hydroacylation of 
ortho-allylbenzaldehyde derivatives containing substitution at the terminal end of the allyl 
unit (Scheme 2). 
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Scheme 2: Proposed reaction scheme for the endo-selective hydroacylation of 1,2-
disubstituted alkenes. 
 
However, the reaction of a 1.3:1 E:Z mixture of 2-(but-2-en-1-yl)benzaldehyde 1 
forms 2-ethyl-2,3-dihydro-1H-inden-1-one 2 in 38% yield as a racemic mixture and 
formation of the six-membered ring was not observed (Scheme 3).  
 
Scheme 3: Rh-catalyzed hydroacylation of  2-(but-2-en-1-yl)benzaldehyde 1 
 
We hypothesized that the formation of 2 results from endo-selective hydroacylation 
of alkene isomerization product 3. Thus, 3 was independently prepared and isolated as a 
mixture of isomers (1:2.6 E:Z). The reaction of 2-(but-1-en-1-yl)benzaldehyde 3 generated 2 
in 94% yield as a racemic mixture in the presence of a catalyst generated from 
[Rh(COD)Cl]2, (R)-DTBM-Segphos and NaBARF (Scheme 4). Although it is clear from this 
result that the cationic rhodium complex enables the hydroacylation of 1,2-disubstituted 
alkenes, we cannot conclusively rule out exo-selective hydroacylation of 1 to form 2 for the 
reaction shown in Scheme 3. 
O [Rh(COD)Cl]2 (2.5 mol %)(R)-DTBM-Segphos (5.0 mol %)
NaBARF (5.0 mol %)
1,4-dioxane, 100 °C, 24 h
R
O
R
O [Rh(COD)Cl]2 (2.5 mol %)
(R)-DTBM-Segphos (5.0 mol %)
NaBARF (5.0 mol %)
1,4-dioxane, 100 °C, 24 h
1
1.3:1 E:Z
O
2
38% yield
racemic
O
3
O
not observed
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Scheme 4: Rh-catalyzed hydroacylation of 2-(but-1-en-1-yl)benzaldehyde 3. 
 
Lower yields of 2-ethyl-2,3-dihydro-1H-inden-1-one 2 can be isolated after shorter 
reaction times (6-12 h) and some degree of enantioenrichment is observed in these cases (30-
59% ee). However, compound 2 is isolated as a racemic mixture after reexposure to the 
hydroacylation reaction conditions. We propose that a racemization event occurs at the α-
center following enantioselective, rhodium-catalyzed hydroacylation of the 1,2-disubstituted 
alkene. In an attempt to prevent this racemization reaction, we evaluated the hydroacylation 
of 3 at lower reaction temperatures, but found a significant loss of reactivity toward alkene 
hydroacylation below 100 °C; the reaction of 3 at 60 °C formed 2-ethyl-2,3-dihydro-1H-
inden-1-one in only 35% yield after 24h. However, 1H NMR analysis of the crude reaction 
mixture revealed that alkene isomerization occurs in the presence of the cationic rhodium 
catalyst to form exclusively the E isomer after 24 hours. Alkene isomerization is observed for 
the reaction of 3 at 60 °C and 40 °C, and a room temperature experiment led to an increased 
ratio of the E isomer relative to the Z isomer for the starting 2-(but-1-en-1-yl)benzaldehyde 3 
(Table 1). Based on this observation we propose that the cationic rhodium complex serves as 
an alkene isomerization catalyst and one isomer of 3 undergoes the rhodium-catalyzed 
hydroacylation reaction preferentially.  
 
 
 
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5 mol%)
NaBARF (5 mol%)
1,4-dioxane, 100 °C, 24 h
O
2
94% yield
racemic
O
3
1:2.6 E:Z
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Table 1: Rh-catalyzed hydroacylation of 3 
 
Entry Temperature (°C) NMR yield 2a Isomeric ratio 3 (E:Z)a 
1 rt 0 1.1:1 
2 40 14 >20:1 
3 60  35 >20:1 
aDetermined by 1H NMR analysis of the crude reaction mixture with dibromomethane 
as an internal standard. 
 
Despite the wide range of potential synthetic applications for the hydroacylation of 
1,2-disubstituted alkenes, the racemization process that occurs at the α-center in the presence 
of the cationic rhodium complex presents a catch-22; the highly cationic rhodium catalyst is 
critical for the alkene hydroacylation reaction to proceed, but this same complex significantly 
erodes the enantioselectivity before appreciable yields of the hydroacylation product can be 
obtained. This dilemma remains an unsolved problem and has prevented practical 
enantioselective hydroacylations of these substrates at this time.  
We instead turned our attention to investigation of the rhodium-catalyzed 
hydroacylation of trisubstituted alkenes. The hydroacylation of a 1,1,2-trisubstituted alkene 4 
occurs in the presence of the chiral rhodium catalyst (Scheme 5). However, the 
hydroacylation of ortho-vinylbenzaldehyde 4 generated 2,3-dimethylindanone 5 as a mixture 
of diastereomers (1.6:1 trans:cis) with a high level of enantiocontrol at the β-center (94% ee 
for each diastereomer). The observed enantioselectivities suggest that the β-center is stable to 
the catalytic conditions, but that the α-center is again prone to the racemization process. 
O
3
Z:E = 2.6:1
O[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5 mol%)
NaBARF (5 mol%)
1,4-dioxane, Temp, 24 h
4
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Scheme 5: Rh-catalyzed hydroacylation of (E)-2-(but-2-en-2-yl)benzaldehyde 4. 
 
To assess the viability of 1,1,2-trisubstituted alkenes as substrates for intramolecular 
hydroacylation, we instead evaluated reactions of ortho-vinylbenzaldehyde derivatives 
containing alkene units fixed within rings of increasing size in the presence of a catalyst 
generated from [Rh(COD)Cl]2, (R)-DTBM-Segphos and NaBARF (Scheme 6).  
The size of the cycloalkene ring was found to have a significant impact on the 
reactivity and selectivity of the rhodium-catalyzed hydroacylation reactions. 2-(Cyclopent-1-
en-1-yl)benzaldehyde 6a did not undergo the desired hydroacylation reaction. The 
hydroacylation of 2-(cyclohex-1-en-1-yl)benzaldehyde 6b generated 7b as the cis 
diastereomer in high yield and enantioselectivity (88% yield, 97% ee), and the 
hydroacylation of 2-(cyclohept-1-en-1-yl)benzaldehyde 6c formed 7c as a mixture of 
diastereomers (1.7:1 cis:trans) in moderate yield (56%). 
  
Scheme 6: Rhodium-catalyzed hydroacylation of 6a-c. 
The distinct difference in reactivity observed for substrates containing cycloalkenes 
of varied size, and the unexpected formation of cis-7b rather than trans-7b, led us to probe 
O [Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
O
4
1.6:1 dr (trans:cis)
cis-5: 94% ee
trans-5: 94% ee
5
35% yield
O
n
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
n % yield
0
1
2
0   (quant. recovery 6a)
88 (cis-7b, 97% ee)
56 (1.7:1 cis:trans-7c)
      cis-7c = 82% ee
      trans-7c = 70% ee
H
H
O
n
7a
7b
7c
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H
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O
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+
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the mechanism of this transformation. We conducted a kinetic isotope incorporation 
experiment to confirm where the aldehyde hydrogen resides in 7b (Scheme 7). The reaction 
of d-6b in the presence of the same rhodium catalyst generated d-7b in 78% yield with 
deuterium incorporation exclusively at the β-position and only a small loss in the total 
deuterium content of the material. This result is consistent with the mechanism for alkene 
hydroacylation described in Chapter III of this thesis.[1] 
 
Scheme 7: Rh-catalyzed hydroacylation of d-6b. 
 
We conducted DFT studies to model the reaction pathway for hydroacylation of both 
6a and 6b (Figure 1).[44-51] In these studies, coordination of the substrate to the rhodium(I) 
catalyst through both the ketone oxygen and cycloalkene unit is highly exothermic (ΔH = -
19.5 and -23.2 kcal/mol) and occurs to form I1. A conformational change of the substrate 
around the Rh-center occurs to preorganize the aldehyde C-H bond for oxidative addition and 
generates I2. Oxidative addition of the rhodium(I) catalyst to the aldehyde C-H bond leads to 
I3 in which the key acylrhodium(III) hydride is stabilized by the C=C bond of the 
cycloalkene ring (ΔH = -10.8 and -13.3 kcal/mol). Migratory insertion generates intermediate 
I4 in which the acylrhodium(III) unit and the β-hydrogen reside on the same face of the 
cycloalkane in a cis orientation. Reorientation of the substrate occurs to form complex I5 and 
this species undergoes reductive elimination to generate the polycyclic ketone product as the 
trans diastereomer. 
O
D
H
O
D
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
78% yield
90% D
85% D
d-6b
d-7b
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Figure 1. Potential energy surface for the rhodium-catalyzed hydroacylation of 6a and 6b 
and structures of intermediates I1-5 for the reaction of 6b.  Enthalpies computed as sums of 
M06-L/6-31G(d) thermal contributions, M05-2X/6-311+G(2d,p)//M06-L/6-31G(d) 
electronic energies, and a solvation correction with the SMD model (THF) and M05-2X/6-
31G(d). 
 
The modeled transition state energies for the alkene hydroacylation reaction sequence 
are consistent with reductive elimination from I5 as the turnover-limiting step for this 
catalytic process and offer support for the marked difference in reactivity between 6a and 6b. 
Consistent with the high transition state energy for turnover-limiting reductive elimination to 
generate trans-7a (ΔH≠ = +15.6 kcal/mol), formation of trans-7a is not observed in the 
presence of this rhodium catalyst. However, reductive elimination to generate trans-7b 
corresponds to a much lower transition state energy (ΔH≠ = +10.7 kcal/mol) and trans-7b is 
observed as an intermediate in the overall reaction sequence leading to cis-7b.  
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Figure 2 shows that two potential pathways exist for the formation of I2: 1) 
coordination of the substrate to generate I1 and formation of I2 via reorientation of the 
substrate to preorganize the aldehyde C-H bond for oxidative addition, or 2) coordination of 
the substrate to the cationic rhodium complex to generate I2 directly.  
   
Figure 2: Proposed catalytic cycle for the Rh-catalyzed hydroacylation of 6b. 
Furthermore, comparison of initial rates for independent reactions of 6b and d-6b at 
100 °C gave a kinetic isotope effect (KIE) of 0.60 (Scheme 8).[52-55] The KIE was calculated 
based on the initial rates kH = (2.002 ± 0.04) x 10-5 sec-1 and kD = (3.358 ± 0.09) x 10-5 sec-1 
measured from the slope of the first-order kinetics plots (Figure 3 and Figure 4). We propose 
that the inverse KIE observed is an equilibrium isotope effect that arises from a 
preequilibrum to generate I3 followed by turnover-limiting reductive elimination.[56-62] The 
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greater strength of the Rh-D bond relative to the Rh-H bond leads to an increased 
concentration of intermediate I3 from d-6b relative to 6b.[63-64] The larger equilibrium 
concentration of d-I3 will lead to a higher concentration of d-7b relative to 7b and the 
observed inverse KIE. The combination of inverse KIE and high transition state energy for 
reductive elimination are consistent with reductive elimination as the turnover-limiting step 
for this process. 
 
Scheme 8: Kinetic isotope experiments for 6b vs. d-6b. 
 
Figure 3: Plot of ln([6b]) with time for the first 1.5 h of the total reaction time. 
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Figure 4: Plot of ln([d-6b]) with time for the first 1.5 h of the total reaction time. 
 
We hypothesized that the rhodium-catalyzed hydroacylation of 6b generates trans-7b 
and this intermediate undergoes epimerization at the α-stereocenter to yield cis-7b.[65-69] We 
conducted a series of control experiments to evaluate the proposed α-epimerization pathway 
leading from trans-7b to cis-7b. When a mixture of diastereomers of 7b (1.3:1 cis:trans) was 
re-exposed to the rhodium catalyst, exclusive formation of cis-7b was observed with high 
enantioselectivity (Scheme 9a). We hypothesized that the α-epimerization process could 
occur through Lewis acid-catalyzed activation of the ketone, deprotonation of the  α-
hydrogen and diastereoselective protonation directed by the fixed β-stereocenter. To evaluate 
this hypothesis, a mixture of cis-7b and trans-7b was exposed to an achiral Lewis acid and 
quantitative formation of cis-7b was observed without loss of enantiomeric excess (98% ee) 
(Scheme 9b).  
y	=	-3.36E-05x	-	2.95E+00	
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Scheme 9: Lewis acid-catalyzed α-epimerization of cis:trans-7b. 
 
 Table 2 summarizes additional control experiments to ascertain which catalytic 
components contribute to the α-epimerization reaction. [Rh(COD)Cl]2,  (R)-DTBM-Segphos 
and NaBARF each facilitate the α-epimerization reaction, although no single component 
generates the cis-7b as a single diastereomer (entries 1-3). 
Table 2: α-Epimerization experiments for the reaction of 7b 
   
Entry SM dr  
(trans:cis) 
Conditions Product dr 
(trans:cis) 
cis-7b 
ee (%)a,b 
1 3.0:1.0 [Rh(COD)Cl]2 (2.5 mol%) 1.5:1.0 89(94) 
2 3.0:1.0 (R)-DTBM-Segphos (5.0 mol%) 1.0:1.3 92(94) 
3 1.2:1.0 NaBARF (5.0 mol%) 1.0:2.9 94(98) 
4 1.2:1.0 1,4-dioxane only 1.2:1.0 97(98) 
5 1.0:1.3 [Rh(COD)Cl]2 (2.5 mol%) 
(R)-DTBM-Segphos (5.0 mol%) 
NaBARF (5.0 mol%) 
<1:20 97(97) 
6 1.2:1.0 AlCl3 (5.0 mol%) <1:20 98(98) 
aDetermined by chiral HPLC analysis. bEnantiomeric excess  of the starting material is given 
in parentheses for comparison. 
 
The α-epimerization reaction is not thermally driven; no change in dr was observed 
when 7b was heated in 1,4-dioxane at 100 °C for 24 h in the absence of other catalyst 
O [Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
H
H
O
cis-7b
77% yield
98% ee
H
H
O
cis:trans-7b
1:1.2 dr
AlCl3 (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
H
H
O
cis-7b
quant. yield
98% ee
H
H
cis:trans-7b
1.3:1 dr
(a)
(b)
O
H
H
cis-7b + trans-7b
94-98% ee
O
H
H
7b
Conditions
1,4-dioxane
100 °C, 24 h
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components (entry 4). As shown in Scheme 8a, exposing a mixture of diastereomers of 7b to 
the standard hydroacylation reaction conditions led to complete epimerization at the α-center 
after 24h (entry 5). AlCl3, an achiral Lewis acid unrelated to the rhodium-catalyzed 
hydroacylation reaction conditions, also promotes the α-epimerization to generate the cis 
diastereomer in quantitative yield and high enantioselectivity (entry 6 and Scheme 9b). These 
results support the viability of the proposed α-epimerization reaction to generate the cis-
diastereomer of 7b following enantioselective rhodium-catalyzed hydroacylation that forms 
the trans-diastereomer of 7b. 
We conducted DFT studies to model this proposed α-epimerization sequence in an 
effort to understand the marked difference in diastereoselectivity for the hydroacylations of 
6b and 6c. In these calculated results, coordination of the cationic rhodium species occurs at 
the ketone oxygen and deprotonation via chloride anion at the  α-center generates the 
corresponding rhodium enolate I7 (Figure 5). This species is stabilized by the enolate C=C 
bond, and diastereoselective protonation occurs to produce the cis diastereomer. The 
calculated ground state energy difference between the coordinated forms of the two 
diastereomers (ΔG = -14.5 kcal/mol), and a low ground state energy for rhodium enolate of 
7b (ΔG = -6.8 kcal/mol) are consistent with exclusive formation of cis-7b in the overall 
reaction sequence However, the high ground state energy for the rhodium enolate 7c (ΔG = 
+14.7 kcal/mol) disfavors complete epimerization at the α-center and leads to a mixture of 
diastereomers of the ketone product.  
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Figure 5. Reaction profile for the rhodium-catalyzed hydroacylation of 6b and 6c. Gibbs 
energies computed as sum of M06-L/6-31G(d) thermal contributions, M05-2X/6-
311+G(2d,p)//M06-L/6-31G(d) electronic energies, and a solvation correction with the SMD 
model (THF) and M05-2X/6-31G(d). 
 
In addition to the theoretical mechanistic investigations, we evaluated a range of 
ligands for the Rh-catalyzed hydroacylation of 6a to identify the best conditions for this 
catalytic process (Table 3). Ligands L1-L4 generated 7b in low yields (23-28%), but the 
observed enantioselectivities were high (79-86% ee) (entries 1-4). (R)-DTBM-MeO-Biphep 
L5, which contains a bulky aryl unit, generated hexahydro-9H-fluoren-9-one 7b in an 
improved yield of 49% with high enantioselectivity (98% ee) (entry 5). As shown earlier in 
this chapter, (R)-DTBM-Segphos L6 generated 7b in 88% yield with 97% ee (entry 6) and 
was the most effective bisphosphine ligand evaluated for the rhodium-catalyzed 
hydroacylation of 6b.  
 
 
 
 
 
 
 
O
H
H
Rh
trans-7b
0.0 kcal/mol
cis-7b
-14.5 kcal/mol
P
P O
H
H
Rh
P
P
O
H
H
Rh
trans-6c
0.0 kcal/mol
cis-6c
-3.4 kcal/mol
P
P O
H
H
Rh
P
P
O
H
Rh
P
P
O
H
Rh
P
P
I7
-6.8 kcal/mol
I7
+14.7 kcal/mol
Cl
HCl
HCl
Cl
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Table 3: Catalyst identification for the hydroacylation of 6aa 
 
 
Entry Rh precursor Ligand Yield 2bb,c (%) ee (%)d 
1 [Rh(COD)Cl]2 L1 20(23) 79 
2 [Rh(COD)Cl]2 L2 32(27) 84 
3 [Rh(COD)Cl]2 L3 28(27) 87 
4 [Rh(COD)Cl]2 L4 32(28) 86 
5 [Rh(COD)Cl]2 L5 48(49) 98 
6 [Rh(COD)Cl]2 L6 88(88) 96 
7e Rh(COD)2BF4 L6 84(79) 46 
8e Rh(COD)2BARF L6 79(72) 96 
qReactions were conducted on a 0.200 mmol scale and further details are given in the 
experimental section of this thesis chapter. bYield determined by 1H NMR spectroscopy with 
dibromomethane as an internal standard. cIsolated yield shown in parentheses. dDetermined 
by chiral HPLC analysis. e5.0 mol% of Rh precursor used and NaBARF was excluded. 
 
We evaluated alternative rhodium catalyst precursors for the hydroacylation of 6b 
(entries 7 and 8). Although Rh(COD)2BF4 facilitates the desired hydroacylation reaction, the 
enantioselectivity of the hexahydro-9H-fluoren-9-one product was significantly lower in the 
presence of the BF4
- counteranion. Rh(COD)2BARF also promoted the hydroacylation of 6b 
O [Rh(COD)Cl]2 (2.5 mol%)
Ligand (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
H
H
O
PAr2
PAr2
L1: (R)-Tol-BINAP (Ar = Tolyl)
L2: (R)-Xyl-BINAP (Ar = Xylyl)
PPh2
PPh2
O
O
O
O
PPh2
PPh2
MeO
MeO
L4: 
(R)-Segphos
L3: 
(R)-MeO-Biphep
PAr2
PAr2
O
O
O
O
PAr2
PAr2
MeO
MeO
L6: 
(R)-DTBM-Segphos
L5: 
(R)-DTBM-MeO-Biphep
tBu
OMe
tBu
Ar =
6a 7a
n
n
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and 7b was isolated with 96% ee. However, the yield of 7b was noticeably lower (72% yield) 
with this catalyst precursor than when each catalyst component was separately weighed out 
(compare entries 6 and 8). 
With suitable catalytic conditions at hand for the hydroacylation of substrates 
containing a six-membered cycloalkene unit, we synthesized a series of compounds with this 
general architecture. The following procedures were also used for the synthesis of 
compounds 1a-c and the substrates that did not undergo the desired hydroacylation reaction. 
First a series of 1-bromocycloalkenes were synthesized using an enolizable ketone and a 
complex generated in situ from P(OPh)3 and Br2 (Scheme 10a). A variety of 1-bromoalkenes 
were isolated in moderate-to-high yields and spectral data for these compounds (9a-f) 
matches previous reports.[70-72] Vinyl triflates containing S (9g) and NBoc (9h) units within 
the cycloalkene were also prepared using known procedures (Scheme 10b).[73-74] 
 
Scheme 10: Synthesis of 1-bromocycloalkenes and vinyl triflates. 
Suzuki coupling of the 1-bromocycloalkenes with a variety of 2-formylphenylboronic 
acid derivatives formed compounds 6a-k and 4 (Scheme 11a). Modified conditions were 
used for the Suzuki coupling of the vinyl triflates with 2-formylphenylboronic acid to 
generate 2-(cyclohex-1-en-yl)benzaldehydes 6l-m (Scheme 11b). Further discussion of these 
reaction conditions is included in the Experimental section of this thesis chapter. 
P(OPh)3 (1.2 equiv)
Br2 (1.3 equiv)
NEt3 (1.4 equiv)
DCM, - 60 °C to reflux
X
Br
nX
O
n
n = 0,1 or 2
R = CH2, O, CMe2
1) LHMDS or LDA
2) PhNTf2
THF, - 78 °C
X
OTf
X
O
X = S or NBoc
(a)
(b)
9a-f
9g-h
 118 
 
Scheme 11: Synthesis of 6a-m and 4. 
 
Cycloalkene 6n was synthesized by a reported literature procedure according to 
Scheme 12. Spectral data for all isolated compounds is consistent with previous reports.[75] 
 
Scheme 12: Synthesis of 6n. 
 
X
n
O
X
Br
n
O
B(OH)2
RR +
Pd(PPh3)4 (2.5 mol%)
Na2CO3 (2 equiv)
Toluene:EtOH (3:1), 80 °C
6a-k, 4
n = 0,  1 or 2
R = 4-OMe, 5-OMe, 4,5-OCH2O-, 4-F
X = CH2, O, CMe2
X
O
X
OTfO
B(OH)2
+
PdCl2(PPh3)2 (4.0 mol%)
NaHCO3
6l-m
THF, 60 °C
X = S or NBoc
9a-f
9g-h
(a)
(b)
OOH
PCC (2.0 equiv)
DCM, rt
OAc
KOH (2 equiv)
MeOH/H2O
Cl
OAc
HO
SOCl2 (1.5 equiv)
pyridine, -15 °C
OH
HO
Pyr (3.8 equiv)
Ac2O (1.3 equiv)
DCM, rt, 1.5 h
HO 1) BH3THF
2) H2O2, NaOH
THF, 0 °C
O
BrMg
Et2O, 0°C
6n
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Scheme 13: Rh-catalyzed hydroacylation of 6b-k 
With a variety of substrates in hand, we conducted hydroacylations of compounds 6d-
n (Scheme 13). Electron-rich substrates are well suited to the enantioselective, rhodium-
catalyzed hydroacylation reactions. The hydroacylations of 6d (R = 5-OMe) and 6e (R = 4-
OMe) occur to form the corresponding hexahydro-9H-fluoren-9-ones 7d and 7e in high 
yields (80 and 89%) and enantioselectivities (89 and 99% ee). The hydroacylation of 6f (R = 
4-F), which contains a weak electron-withdrawing group, occurs to form 7f in moderate yield 
(74%) with excellent enantioselectivity (97% ee). The reaction of 6g proceeds to form the 
tetracyclic hexahydro-9H-fluoren-9-one 7g in 89% yield with 85% ee. Single crystal X-ray 
O
X
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h X
H
H
O
R R
H
H
O
H
H
O
H
H
O
MeO
MeO
O
H
H
O
O
H
H
O
H
H
O
F
H
H
O
O
O
MeO
7b
88% yield
97% ee
7d
80% yield
89% ee
7e
89% yield
99% ee
7f
74% yield
97% ee
7g
89% yield
85% ee
7h
91% yield
97% ee
7i
68% yield
97% ee
O
NBoc
Unsuccessful Substrates:
O
7j
77% yield 
(2.7:1 trans:cis)
cis-7j:  10% ee
O
7k
49% yield
0% ee
O
H
H
H
H
O
S
H
H
O
7c
56% yield (1.7:1 dr)
cis-7c 82% ee
n
n6b-k 7b-kn = 1 or 2
6l 6m 6n
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structure determination was performed using Cu radiation to determine the relative and 
absolute configurations of 7g to be cis-(4bS,8aR) (Figure 6).  
 
Figure 6: Absolute stereochemistry and structure of (4bS,8aR)-4b,5,6,7,8,8a-Hexahydro-9H-
fluoreno[2,3-d][1,3]dioxol-9-one (7g) 
 
Substrates containing an oxygen atom within the cyclohexene ring were also 
amenable to the rhodium-catalyzed hydroacylation reaction. The hydroacylation of 6h and 6i 
occurred to form 7h and 7i in moderate to high yield (68-91%) with excellent 
enantioselectivity (97% ee).  
We evaluated the rhodium-catalyzed hydroacylation of substrates with substituted 
cycloalkene units and found that this substitution can significantly impact the diastereo- and 
enantioselectivity of the overall hydroacylation/α-epimerization sequence. The 
hydroacylation of 6j which contains two methyl groups on the cyclohexene ring led to a 
mixture of diastereomers of 7j (2.7:1 trans:cis) and cis diastereomer was found to have only 
10% ee. Determination of the enantiomeric excess of the trans-diastereomer proved 
challenging because we were unable to obtain a pure sample of trans-7j; various conditions 
for the hydroacylation of 6j yielded only traces of trans-7j that were isolated in a mixture 
with cis-7j. However, HPLC studies using these mixtures of cis- and trans-7j suggest that the 
rhodium-catalyzed hydroacylation reaction is enantioselective and that another catalytic 
 121 
process may occur at a faster rate than the α-epimerization reaction to produce cis-7j as a 
racemic product. Formation of racemic cis-7j by such a background reaction would lead to 
poor enantioselectivity in the final product. Therefore, we conducted a deuterium isotope 
experiment to confirm that the rhodium-catalyzed hydroacylation is enantioselective and to 
probe the lack of enantioselectivity observed for trans-7j. The hydroacylation of d-6j 
generated trans-d-7j with 99% ee and 86% deuterium incorporation at the β-position after 24 
hours. Re-exposure of this product to the reaction conditions yielded cis-d-7j with the same 
level of enantioenrichment (99% ee) and deuterium incorporation (86% D) (Scheme 14).  
 
Scheme 14: Rh-catalyzed hydroacylation of d-6j 
We propose that a potential reaction pathway leading to racemic product includes β-
hydride elimination from the rhodium-enolate species I7 to generate the α,β-unsaturated 
ketone I8 (Scheme 15). Insertion of the alkene into the rhodium-hydride bond and 
reprotonation of the resulting rhodium-enolate leads to racemic cis-7j and a significant loss 
of enantioselectivity in the overall formation of cis-7j. In contrast, the rhodium-enolate of d-
7j does not undergo β-hydride elimination to generate I8 and a high level of selectivity is 
preserved in the formation of cis-d-7j.  
 
O
D
H
O
D
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos 
(5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane
100 °C, 24 h
O
D
H
91% D
86% Dd-6j d-7j
7:1 dr
cis-d-7j
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos 
(5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane 
100 °C, 24 h
86% D
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Scheme 15: Proposed mechanism for the formation of cis-7j with low enantioselectivity. 
Poor enantioselectivity was also observed for the hydroacylation of 6k in which the 
cycloalkene moiety contains an aryl backbone. We propose that the planar orientation of the 
cycloalkene unit in this substrate prevents any facial selectivity for alkene coordination in I3. 
Alternatively, the increased acidity of the bis-benzylic hydrogen atom at the β-center may 
lead to epimerization of the β-stereogenic center at elevated temperatures on the same time 
scale as the hydroacylation reaction. Substrates that contain a sulfur (6l) or nitrogen atom 
(6m) in the cycloalkene ring, or that lack a rigid aryl backbone for the aldehyde moieties 
(6n), do not undergo the desired hydroacylation reaction.  
Conclusions 
In summary, we have developed the first examples of catalytic, enantioselective 
intramolecular hydroacylations of 1,1,2-trisubstituted alkenes. DFT and experimental studies 
support a reaction sequence in which rhodium-catalyzed alkene hydroacylation forms the 
trans-diastereomer of the ketone product, and Lewis acid-catalyzed α-epimerization is 
facilitated by the same rhodium complex to subsequently generate the cis diastereomer. 
These highly enantioselective processes offer a snapshot into the mechanistic challenges at 
play in the hydroacylation of higher order alkenes. Further investigation to improve catalyst 
H
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H
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P
P
O
H
H
O
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enantioenriched
I7 I8
cis-7j
10% ee
β-hydride
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[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
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enolate
formation
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P
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activity and to expand the scope of trisubstituted alkenes that undergo alkene hydroacylation 
are ongoing in our laboratory. 
Experimental  
General synthetic details. All air-sensitive procedures were conducted under inert 
atmosphere in a nitrogen-filled dry box or by standard Schlenk techniques. All reactions were 
performed under nitrogen unless otherwise stated. All glassware for moisture sensitive 
reactions was dried in an oven at 140 °C for at least two hours before use. THF, Et2O, and 
DCM were degassed by purging with argon for 45 minutes and dried with a solvent 
purification system by passing through a one-meter column of activated alumina. Anhydrous 
1,4-dioxane and DMF were purchased from Sigma-Aldrich and used as received. Flash 
column chromatography was performed on SiliFlash® P60 silica gel (40-63µm, 60 Å) using 
hexanes, hexanes/ethyl acetate or hexanes/diethyl ether mixtures. Products were visualized 
on TLC by UV light or by staining with KMnO4. 
Instrumentation. HRMS (ESI) analysis was performed at the Iowa State University 
Chemical Instrumentation Facility on an Agilent 6540 QTOF spectrometer. HPLC analyses 
were carried out on a Waters Alliance HPLC system with an e2695 separations module and a 
2489 dual wavelength detector. Optical rotations were measured on an Atago AP-300 
automatic polarimeter using a 0.5 dm cell. NMR spectra were acquired on Varian MR-400 
and Bruker Avance III 600 spectrometers at the Iowa State University Chemical 
Instrumentation Facility. Chemicals shifts are reported in ppm relative to residual solvent 
peaks (CDCl3 = 7.26 ppm for 1H and 77.16 ppm for 13C) or an external standard 
(CF3CO2H:CDCl3 = -77.56 ppm for 19F). Coupling constants are reported in hertz. 
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Materials. Triphenylphosphite, bromine, α-tetralone, p-toluenesulfonic acid, 
ethylene glycol, 6-bromopiperonal, lithium bis(trimethylsilyl)amide, diisopropylamine, m-
anisaldehyde, trimethyl borate, triisopropyl borate, cyclopentanone, cycloheptanone, (E)-2-
bromo-2-butene, and propyltriphenylphosphium bromide were purchased from Sigma 
Aldrich and used without further purification. n-Butyllithium (2.5M in hexanes) was 
purchased from Sigma-Aldrich and titrated with recrystallized diphenylacetic acid prior to 
use. Tetrahydro-4H-pyran-4-one and 4,4-dimethylcyclohexanone were purchased from 
Oakwood Chemicals and used without further purification. Cyclohexanone, triethylamine 
and p-toluenesulfonic acid were purchased from Fisher Scientific and used without further 
purification. 1-Methylpiperidine-4-one was purchased from TCI Chemicals and used without 
further purification. 2-Formylphenylboronic acid, N-phenyl-
bis(trifluoromethanesulfonimide), tetrahydro-4H-thiopyran-4-one and tert-butyl 4-
oxopiperidine-1-carboxylate were purchased from AK Scientific and used without further 
purification. (2-Formyl-5-methoxyphenyl)boronic acid and (5-fluoro-2-
formylphenyl)boronic acid were purchased from Frontier Scientific and used without further 
purification. 
Pd(PPh3)4, [Rh(COD)Cl]2, [Rh(COD)2]BF4, rac-Tol-BINAP (2,2´-bis(di-p-
tolylphosphino)-1,1´-binaphthalene), (R)-Tol-BINAP ((R)-2,2´-bis(di-p-tolylphosphino)-1,1´-
binaphthalene), (R)-Xyl-BINAP ((R)-2,2´-bis(di-3,5-dimethylphenylphosphino)-1,1´-
binaphthalene), (R)-MeO-Biphep ((R)-2,2´-bis(diphenylphosphino)-1,1´-biphenyl), (R)-
Segphos ((R)-2,2´-bis(diphenylphosphino)-4,4´-bi-1,3-benzodioxole), (R)-DTBM-
MeOBiphep ((R)-2,2´-bis(di(3,5-di-t-butyl-4-methoxyphenyl)phosphino)-6,6´-dimethoxy-
1,1´-biphenyl), and (R)-DTBM-Segphos ((R)-2,2´-bis(di(3,5-di-t-butyl-4-
 125 
methoxyphenyl)phosphino)-4,4´-bi-1,3-benzodioxole) were purchased from Strem 
Chemicals and used without further purification.  
NaBARF (Sodium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) was prepared 
according to a literature procedure.[76] [Rh(COD2]BARF was prepared according to a 
literature procedure from [Rh(COD)Cl]2 and NaBARF.[77] 1-Bromocyclopent-1-ene, 1-
bromocyclohex-1-ene and 1-bromocyclohept-1-ene were prepared according to a literature 
procedure from cyclopentanone, cyclohexanone or cycloheptanone.[71] 4-Bromo-1,2-
dihydronapthalene was prepared according to a literature procedure from α-tetralone.[70] 4-
Bromo-3,6-dihydro-2H-pyran was prepared according to a literature procedure from 
tetrahydro-4H-pyran-4-one.[72] 3,6-Dihydro-2H-thiopyran-4-yl trifluoromethanesulfonate 
was prepared according to a literature procedure from tetrahydro-4H-thiopyran-4-one.[74] 
tert-Butyl-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate was 
prepared according to a literature procedure from tert-butyl 4-oxopiperidine-1-
carboxylate.[73] tert-Butyl-4-(2-formylphenyl)-3,6-dihydropyridine-1-(2H)-carboxylate was 
prepared according to a literature procedure.[78] 3-(Cyclohex-1-en-1-yl)propanal was 
prepared according to a literature procedure starting from cyclohexanone and 
allylmagnesium bromide.[75] (2-Formyl-4-methoxyphenyl)boronic acid was prepared 
according to literature procedure from m-anisaldehyde.[79] (6-formylbenzo[d][1,3]dioxol-5-
yl)boronic acid was prepared according to a literature procedure from 6-bromopiperonal.[80] 
Preparation of 1-Bromo-2-(but-2-en-1-yl)benzene 8a 
 
Br
8a
Br
Br
THF, 0° C to rt
CuI (0.200 equiv)
2,2ʹ-bipyridine (0.200 equiv)
BrMg+
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To an oven-dried 100 mL round bottom flask was added 2-bromobenzylbromide 
(1.80 g, 7.20 mmol, 1.00 equiv), CuI (0.200 equiv), 2,2´-bipyridine (0.200 equiv) and dry 
THF (10 mL) and the mixture was cooled to 0 °C. Then, 1-propenylmagnesium bromide 
(24.0 mL of a 0.5 M solution, 12.00 mmol) was added dropwise via syringe and the 
combined reaction mixture was stirred overnight and allowed to warm to room temperature. 
The reaction was quenched by the addition of sat. NH4Cl solution and extracted with Et2O 
(3x). The combined organic layers were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The crude product was purified by flash column chromatography (100% 
hexanes) to yield 8 as a mixture of isomers (E:Z = 1.6:1.0) (1.38 g, 6.53 mmol, 54%) as a 
colorless oil. Spectral data is consistent with previous reports.[81] 
Preparation of 1-Bromo-2-(but-1-en-1-yl)benzene 8b 
 
To a solution of propyltriphenylphosphonium bromide (6.16 g, 16.00 mmol, 2.00 
equiv) in anhydrous THF at -78 °C under N2 was added n-BuLi (8.04 mL of a 1.99M 
solution in hexanes, 2.00 equiv), dropwise. This mixture was allowed to stir at -78 °C for 10 
minutes, warmed to room temperature for 30 minutes then cooled to 0 °C and 2-
bromobenzaldehyde (0.934 mL, 8.00 mmol, 1.00 equiv) was added via syringe. The 
combined reaction mixture was let stir at 0 °C for 30 minutes before slowly warming to 
reflux and allowing to stir overnight (16 h). The reaction mixture was cooled to room 
temperature quenched by the addition of NH4Cl (sat. solution). The solution was extracted 
with Et2O (3x) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated under reduced pressure. The crude product was purified by flash column 
Br
8b
O
Br
H
Ph3P Br + nBuLi THF, - 78 °C to reflux
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chromatography (100% hexanes) to yield 8b as a mixture of isomers (E:Z = 1.0:2.4) (1.19 g, 
5.63 mmol, 70%) as a colorless oil.[82] 
Preparation of 1 and 3 
 
2-(But-2-en-1-yl)benzaldehyde (1): To a solution of 8a (1.37 g, 6.50 mmol, 1.00 equiv) in 
THF at -78 °C was added n-BuLi (2.83 mL of a 2.30 M solution in hexanes, 
1.00 equiv) dropwise. The solution was kept at -78 °C for 1 hour, warmed to 
room temperature for 30 minutes, and then cooled back to -78 °C for 10 minutes 
before DMF (1.50 mL, 3.00 equiv) was added. The solution was allowed to warm to room 
temperature overnight and extracted with Et2O (3x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (90:10 Hex:EtOAc) to yield 1 (0.797 g, 4.97 
mmol, 76%) as a yellow oil (E:Z = 1.3:1). Spectral data is consistent with previous 
reports.[83] 
2-(But-1-en-1-yl)benzaldehyde (3): To a solution of 8b (1.06 g, 5.00 mmol, 1.00 equiv) in 
THF at -78 °C was added n-BuLi (2.51 mL of a 1.99 M solution in hexanes, 
1.00 equiv) dropwise. The solution was kept at -78 °C for 2 hours and DMF 
(1.16 mL, 3.00 equiv) was added. The solution was allowed to warm to room 
temperature overnight and extracted with Et2O (3x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated under reduced pressure. The crude product was 
purified by flash column chromatography (90:10 Hex:EtOAc) to yield 3 (0.502 g, 3.14 
mmol, 63%) as a colorless oil (E:Z = 1:2.6). Spectral data reported for major (cis) 
regioisomer: 1H NMR (CDCl3, 400 MHz): δ 0.995 (t, J = 7.6 Hz, 3H), 2.04-2.13 (dq, J = 7.6, 
Br
O
THF, -78 °C to rt
1)  n-BuLi (1.00 equiv)
2) DMF (3.00 equiv)
8a-b 1 or 3
O
3
O
1
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7.2 Hz, 2H), 5.93 (dt, J = 11.2, 7.6 Hz, 1H), 6.78 (d, J = 11.2 Hz, 1H), 7.27 (dd, J = 8.4 Hz, 
1H), 7.39 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.55 (ddd, J = 8.4, 7.6, 0.8 Hz, 1H), 7.89 (dd, J = 
7.6, 0.8 Hz, 1H), 10.26 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 14.1, 22.0, 124.8, 127.1, 
127.4, 128.7, 130.6, 133.7, 133.8, 137.9, 192.6. HRMS (ESI) calcd. for C11H13O (M+H+) 
161.0961, found 161.0960. 
Preparation of 4-bromo-4,4-dimethylcyclohex-1-ene (9e) 
 
 
To a solution of triphenylphosphite (5.96 g, 19.2 mmol, 1.2 equiv) in DCM at -60 °C 
was added Br2 (1.07 mL, 20.8 mmol, 1.30 equiv) and the mixture was let stir at this 
temperature for 15 minutes. 4,4-Dimethylcyclohexanone (2.02 g, 16.0 mmol, 1.00 equiv) was 
added as a solution in CH2Cl2 via syringe followed by NEt3 (3.12 mL, 22.4 mmol, 1.40 
equiv) and the evolution of white vapor was observed. The combined reaction mixture was 
allowed to warm to room temperature and stirred overnight (16 h). The reaction mixture was 
then heated to reflux for 2h and cooled to room temperature. The mixture was diluted with 
hexanes (some precipitation was observed) and ~½ of the solvent volume was removed under 
reduced pressure. The mixture was diluted to the original volume with hexanes, and ~½ of 
the total solvent volume was once again removed under reduced pressure. The mixture was 
filtered to remove resulting precipitate (triphenylphosphite oxide and triethylammonium 
salts) and the filtrate was concentrated under reduced pressure. The crude product was 
purified by flash column chromatography on silica gel (100% hexanes) to yield 1-bromo-4,4-
dimethylcyclohex-1-ene 9e (2.21 g, 11.7 mmol, 73%) as a colorless oil. 1H NMR (CDCl3, 
400 MHz): δ 0.93 (s, 6H), 1.47 (t, J = 6.4 Hz, 2H), 1.86 (m, 2H), 2.41 (m, 2H), 5.93 (m, 1H). 
O BrP(OPh)3 (1.2 equiv)
Br2 (1.3 equiv)
NEt3 (1.4 equiv)
DCM, - 60 °C to reflux
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13C NMR (CDCl3, 100 MHz): δ 28.0 (2C), 28.2, 33.2, 37.3, 41.3, 121.2, 127.9. HRMS (ESI) 
calcd. for C8H14Br (M+H+) 189.0273, found 189.0274.  
 
Compounds 9a-d and 9f were synthesized by the same synthetic procedure as 9e from 
the corresponding ketones and spectral data for those compounds is consistent with previous 
reports.[70-72]  
General Procedure A: Synthesis of ortho-vinylbenzaldehydes 6a-6k, 4 
 
 
In a nitrogen-filled dry box, Pd(PPh3)4 (0.025 equiv) was weighed into dry round 
bottom flask and anhydrous toluene was added. The flask was sealed with a rubber septum 
and removed from the dry box. The appropriate bromoalkene (1.00 equiv) was added via 
syringe, followed by a solution of the appropriate boronic acid (1.10-1.20 equiv) in EtOH, 
then Na2CO3 (2.0 M solution, 2.00 equiv). This mixture was heated to 80 °C, monitored by 
TLC for consumption of the bromoalkene (16 h) then cooled to room temperature. The 
reaction mixture was diluted with EtOAc, washed with Na2CO3 sat. solution and extracted 
with EtOAc (x3). The combined organic layers were washed with brine, dried over Na2SO4, 
filtered and the filtrate was concentrated under reduced pressure. The crude product was 
P(OPh)3 (1.2 equiv)
Br2 (1.3 equiv)
NEt3 (1.4 equiv)
DCM, - 60 °C to reflux
9a-d, 9f
X
Br
nX
O
n
n = 0,1 or 2
X = CH2 or O
X
n
O
X
Br
n
O
B(OH)2
RR +
Pd(PPh3)4 (2.5 mol%)
Na2CO3 (2 equiv)
Toluene:EtOH (3:1), 80 °C
6a-k, 4
n = 0,  1 or 2
R = 4-OMe, 5-OMe, 4,5-OCH2O-, 4-F
X = CH2, O, CMe2
9a-f
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purified by flash column chromatography on silica gel (90:10 hexanes:EtOAc) to yield the 
corresponding ortho-vinylbenzaldehyde 6a-k or 4.  
2-(Cyclopent-1-en-1-yl)benzaldehyde (6a): Prepared according to general procedure A 
from 1-bromocyclopent-1-ene (0.294 g, 2.00 mmol), 2-formylphenylboronic 
acid (0.360 g, 2.40 mmol, 1.20 equiv), Pd(PPh3)4 (57.8 mg, 0.050 mmol, 0.025 
equiv), Na2CO3 (2.0 mL of a 2.0 M solution, 2.00 equiv), toluene (6.0 mL) and 
EtOH (2.0 mL). The crude product was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield 6a (0.256 g, 1.48 mmol, 74%) as a colorless oil. 1H NMR (CDCl3, 
400 MHz): 1H NMR (CDCl3, 400 MHz): δ 2.09 (tt, J = 7.6, 7.2 Hz, 2H), 2.60 (tdt, J = 7.2, 
5.2, 2.4 Hz, 2H), 2.76 (tdt, J = 7.6, 5.2, 2.4 Hz, 2H), 5.72-5.75 (m, 1H), 7.33-7.39 (m, 2H), 
7.54 (ddd, J = 8.0, 7.2, 1.6 Hz, 1H), 7.90 (dd, J = 8.0, 1.6 Hz, 1H), 10.2 (s, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 24.0, 34.1, 37.1, 127.1, 127.7, 128.4, 133.4, 134.3, 135.3, 139.8, 142.6, 
192.5. HRMS (ESI) calcd. for C12H13O (M+H+) 173.0961, found 173.0962. 
2-(Cyclohex-1-en-1-yl)benzaldehyde (6b): Prepared according to general procedure A from 
1-bromocyclohex-1-ene (3.14 g, 19.5 mmol), 2-formylphenylboronic acid 
(3.51 g, 23.4 mmol, 1.20 equiv), Pd(PPh3)4 (563 mg, 0.488 mmol, 0.025 
equiv), Na2CO3 (19.5 mL of a 2.0 M solution, 2.00 equiv), toluene (60.0 mL) 
and EtOH (19.5 mL). The crude product was purified by flash column chromatography 
(90:10 hexanes:EtOAc) to yield 6b (1.87 g, 10.1 mmol, 52%) as a colorless oil. 1H NMR 
(CDCl3, 400 MHz): δ 1.67-1.75 (m, 2H), 1.77-1.85 (m, 2H), 2.20-2.26 (m, 2H), 2.32-2.38 
(m, 2H), 5.61-5.65 (m, 1H), 7.31 (dd, J = 7.6, 0.8 Hz, 1H), 7.36 (ddd, J = 7.6, 7.6, 0.8 Hz, 
1H), 7.25 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.90 (dd, J = 7.6, 1.2 Hz, 1H), 10.15 (d, J = 0.4 Hz, 
1H). 13C NMR (CDCl3, 100 MHz): δ 22.0, 23.0, 25.8, 31.1, 127.0, 127.6, 128.8, 131.4, 
O
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133.5, 133.9, 135.0, 148.9, 192.8. HRMS (ESI calcd. for C13H15O (M+H+) 187.1117, found 
187.1119. 
2-(Cyclohept-1-en-1-yl)benzaldehyde (6c): Prepared according to general procedure A 
from 1-bromocyclohept-1-ene (1.75 g, 10.0 mmol), 2-formylphenylboronic 
acid (1.80 g, 12.0 mmol, 1.20 equiv), Pd(PPh3)4 (289 mg, 0.250 mmol, 0.025 
equiv), Na2CO3 (10.0 mL of a 2.0 M solution, 2.00 equiv), toluene (30.0 mL) 
and EtOH (10.0 mL). The crude product was purified by flash column chromatography 
(90:10 hexanes:EtOAc) to yield 6c (0.943 g, 4.71 mmol, 47%) as a colorless oil. 1H NMR 
(CDCl3, 400 MHz): δ 1.57-1.72 (m, 4H), 1.83-1.91 (m, 2H), 2.31-2.38 (m, 2H), 2.57-2.62 
(m, 2H), 5.77 (t, J = 6.4 Hz, 1H), 7.28-7.36 (m, 2H), 7.51 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 
7.87 (dd, J = 7.6, 1.2 Hz, 1H), 10.17 (d, J = 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 
26.9, 27.0, 29.3, 32.6, 35.8, 126.7, 127.7, 128.8, 133.4, 133.5, 136.8, 141.6, 150.3, 192.8. 
HRMS (ESI) calcd. for C14H17O (M+H+) 201.1274, found 201.1276. 
4-Methoxy-2´,3´,4´,5´-tetrahydro-[1,1´-biphenyl]-2-carbaldehyde (6d): Prepared 
according to general procedure A from 1-bromocyclohex-1-ene (0.306 g, 
1.90 mmol), (2-formyl-4-methoxyphenyl)boronic acid (0.410 g, 2.28 
mmol, 1.20 equiv), Pd(PPh3)4 (55.0 mg, 0.048 mmol, 0.025 equiv), 
Na2CO3 (1.9 mL of a 2.0 M solution, 2.00 equiv), toluene (6.0 mL) and EtOH (1.9 mL). The 
crude product was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 
6d (0.158 g, 0.730 mmol, 38%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.65-1.74 
(m, 2H), 1.75-1.84 (m, 2H), 2.17-2.25 (m, 2H), 2.27-2.34 (m, 2H), 3.86 (s, 3H), 5.62-5.68 
(m, 1H), 6.72 (d, J = 2.4 Hz, 1H), 6.86 (dd, J = 8.0, 2.4 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 
10.0 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.0, 23.0, 25.6, 31.2, 55.6, 113.28, 113.31, 
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127.4, 130.0, 130.5, 135.1, 151.5, 163.7, 191.3. HRMS (ESI) calcd. for C14H17O2 (M+H+) 
217.1223, found 217.1218. 
5-Methoxy-2´,3´,4´,5´-tetrahydro-[1,1´-biphenyl]-2-carbaldehyde (6e): Prepared 
according to general procedure A from 1-bromocyclohex-1-ene (0.805 g, 
5.00 mmol), (2-formyl-5-methoxyphenyl)boronic acid (0.990 g, 5.50 
mmol, 1.10 equiv), Pd(PPh3)4 (144 mg, 0.125 mmol, 0.025 equiv), 
Na2CO3 (5.0 mL of a 2.0 M solution, 2.00 equiv), toluene (15.0 mL) and EtOH (5.0 mL). 
The crude product was purified by flash column chromatography (90:10 hexanes:EtOAc) to 
yield 6e (0.490 g, 2.26 mmol, 45%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.66-
1.75 (m, 2H), 1.76-1.84 (m, 2H), 2.18-2.25 (m, 2H), 2.28-2.36 (m, 2H), 3.87 (s, 3H), 5.64-
5.69 (m, 1H), 6.73 (d, J = 2.4 Hz, 1H), 6.87 (dd, J = 8.8, 2.4 Hz, 1H), 7.89 (d, J = 8.8 Hz, 
1H), 10.0 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.0, 23.0, 25.7, 31.2, 55.6, 113.29, 
113.32, 127.4, 130.1, 130.6, 135.1, 151.6, 163.8, 191.3. HRMS (ESI) calcd. for C14H17O2 
(M+H+) 217.1223, found 217.1219. 
5-Fluoro-2´,3´,4´,5´-tetrahydro-[1,1´-biphenyl]-2-carbaldehyde (6f): Prepared according 
to general procedure A from 1-bromocyclohex-1-ene (0.805 g, 5.00 mmol), 
(5-fluoro-2-formylphenyl)boronic acid (0.924 g, 5.50 mmol, 1.10 equiv), 
Pd(PPh3)4 (144 mg, 0.250 mmol, 0.025 equiv), Na2CO3 (5.0 mL of a 2.0 M 
solution, 2.00 equiv), toluene (15.0 mL) and EtOH (5.0 mL). The crude product was purified 
by flash column chromatography (90:10 hexanes:EtOAc) to yield 6f (0.741 g, 3.62 mmol, 
72%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.66-1.75 (m, 2H), 1.76-1.84 (m, 
2H), 2.18-2.27 (m, 2H), 2.28-2.36 (m, 2H), 5.67 (m, 1H), 6.97 (dd, J = 9.6, 2.4 Hz, 1H), 7.03 
(dd, J = 8.4, 2.4 Hz, 1H), 7.92 (dd, J = 8.4, 6.4 Hz, 1H), 10.1 (s, 1H). 13C NMR (CDCl3, 100 
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MHz): δ 21.9, 22.9, 25.7, 30.8, 114.6 (d, J = 21.8 Hz), 115.4 (d, J = 21.2 Hz), 130.4 (d, J = 
2.6 Hz), 130.6 (d, J = 10.0 Hz), 132.0, 134.1 (d, J = 1.9 Hz), 151.7 (d, J = 9.2 Hz), 165.7 (d, 
J = 254.2 Hz), 191.0. 19F NMR (CDCl3, 376 MHz): δ -104.3 (m, 1F). HRMS (ESI) calcd. 
for C13H14FO (M+H+) 205.1023, found 205.1022. 
6-(Cyclohex-1-en-1-yl)benzo[d][1,3]dioxole-5-carbaldehyde[84] (6g): Prepared according 
to general procedure A from 1-bromocyclohex-1-ene (0.483 g, 3.00 
mmol), (6-formylbenzo[d][1,3]dioxol-5-yl)boronic acid (0.698 g, 3.60 
mmol, 1.20 equiv), Pd(PPh3)4 (87.0 mg, 0.075 mmol, 0.025 equiv), 
Na2CO3 (3.0 mL of a 2.0 M solution, 2.00 equiv), toluene (9.0 mL) and EtOH (3.0 mL). The 
crude product was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 
6g (0.437 g, 1.90 mmol, 63%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.62-1.70 
(m, 2H), 1.71-1.80 (m, 2H), 2.14-2.21 (m, 2H), 2.22-2.29 (m, 2H), 5.59 (m, 1H), 5.99 (s, 
2H), 6.68 (s, 1H), 7.31 (s, 1H), 9.92 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 21.9, 22.9, 
25.6, 31.2, 101.9, 106.1, 108.2, 128.7, 131.3, 134.4, 146.7, 147.1, 152.1, 190.7. HRMS (ESI) 
calcd. for C14H15O3 (M+H+) 231.1016, found 231.1018.  
2-(3,6-Dihydro-2H-pyran-4-yl)benzaldehyde (6h): Prepared according to general 
procedure A from 4-bromo-3,6-dihydro-2H-pyran (0.815 g, 5.00 mmol), 2-
formylphenylboronic acid (0.732 g, 6.00 mmol, 1.20 equiv), Pd(PPh3)4 (144 
mg, 0.125 mmol, 0.025 equiv), Na2CO3 (5.0 mL of a 2.0 M solution, 2.00 
equiv), toluene (15.0 mL) and EtOH (5.0 mL). The crude product was purified by flash 
column chromatography (90:10 hexanes:EtOAc) to yield 6h (0.567 g, 3.01 mmol, 60%) as a 
colorless oil. 1H NMR (CDCl3, 400 MHz): δ 2.44-2.51 (m, 2H), 3.92-3.99 (m, 2H), 4.29-4.36 
(m, 2H), 5.69 (m, 1H), 7.32 (dd, J = 7.6, 0.8 Hz, 1H), 7.41 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 
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7.56 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.91 (dd, J = 7.6, 1.2 Hz, 1H), 10.2 (s, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 30.7, 64.4, 65.6, 127.7, 128.4, 128.7, 129.0, 133.1, 133.8, 133.9, 146.2, 
192.2. HRMS (ESI) calcd. for C12H12O2Na (M+Na+) 211.0730, found 211.0731. 
2-(3,6-Dihydro-2H-pyran-4-yl)-5-methoxybenzaldehyde (6i): Prepared according to 
general procedure A from 4-bromo-3,6-dihydro-2H-pyran (0.489 g, 
3.00 mmol), (2-formyl-4-methoxyphenyl)boronic acid (0.648 g, 3.60 
mmol, 1.20 equiv), Pd(PPh3)4 (87.0 mg, 0.075 mmol, 0.025 equiv), 
Na2CO3 (3.0 mL of a 2.0 M solution, 2.00 equiv), toluene (9.0 mL) and EtOH (3.0 mL). The 
crude product was purified by flash column chromatography (80:20 hexanes:Et2O) to yield 6i 
(0.396 g, 1.81 mmol, 60%) as a light yellow oil. 1H NMR (CDCl3, 400 MHz): δ 2.39-2.47 
(m, 2H), 3.82 (s, 3H), 3.93 (t, J = 5.2 Hz, 2H), 4.30 (q, J = 2.4 Hz, 2H), 5.61 (m, 1H), 7.10 
(dd, J = 8.4, 2.8 Hz, 1H), 7.23 (d, J = 8.4 Hz, 1H), 7.38 (d, J = 2.8 Hz, 1H), 10.1 (s, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 30.8, 55.6, 64.4, 65.6, 110.4, 121.4, 129.0, 129.9, 132.3, 134.8, 
139.4, 158.9, 191.9. HRMS (ESI) calcd. for C13H15O3 (M+H+) 219.1016, found 219.1016.  
4,4´-Dimethyl-2´,3´,4´,5´-tetrahydro-[1,1´-biphenyl]-2-carbaldehyde (6j): Prepared 
according to general procedure A from 1-bromocyclohex-1-ene (0.946 g, 
5.00 mmol), 2-formylphenylboronic acid (0.900 g, 6.00 mmol, 1.20 equiv), 
Pd(PPh3)4 (144 mg, 0.125 mmol, 0.025 equiv), Na2CO3 (5.0 mL of a 2.0 M 
solution, 2.00 equiv), toluene (15.0 mL) and EtOH (5.0 mL). The crude product was purified 
by flash column chromatography (95:5 hexanes:EtOAc) to yield 6j (0.831 g, 3.88 mmol, 
78%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.01 (s, 6H), 1.56 (t, J = 6.4 Hz, 2H), 
2.02 (q, J = 2.4 Hz, 2H), 2.34-2.41 (m, 2H), 5.54-5.58 (m, 1H), 7.32 (dd, J = 7.6, 0.8 Hz, 
1H), 7.36 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.53 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.90 (dd, J = 
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7.6, 1.2 Hz, 1H), 10.1 (s, 1H). 13C NMR (CDCl3, 100 MHz): δ 28.36, 28.38 (2C), 28.8, 35.8, 
39.8, 127.1, 127.7, 128.9, 130.6, 133.5, 133.7, 134.0, 148.6, 192.7.  HRMS (ESI) calcd. for 
C15H18ONa (M+Na+) 237.1250, found 237.1254.  
2-(3,4-Dihydronaphthalen-1-yl)benzaldehyde (6k): Prepared according to general 
procedure A from 4-bromo-1,2-dihydronapthalene (2.09 g, 10.0 mmol), 2-
formylphenylboronic acid (1.80 g, 12.0 mmol, 1.20 equiv), Pd(PPh3)4 (289 
mg, 0.250 mmol, 0.025 equiv), Na2CO3 (10.0 mL of a 2.0 M solution, 2.00 
equiv), toluene (30.0 mL) and EtOH (10.0 mL). The crude product was 
purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 6k (2.07 g, 8.83 
mmol, 88%) as an light yellow oil that solidified on standing. 1H NMR (CDCl3, 400 MHz): δ 
2.46-2.56 (m, 2H), 2.94 (t, J = 8.0 Hz, 2H), 6.04 (t, J = 4.4 Hz, 1H), 6.66 (dd, J = 7.6, 0.8 Hz, 
1H), 7.07 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.16 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.22 (dd, J = 
7.6, 0.8 Hz, 1H), 7.35 (dd, J = 7.6, 0.8 Hz, 1H), 7.49 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.62 
(ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 8.01 (dd, J = 7.6, 1.2 Hz, 1H), 9.99 (d, J = 0.4 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 23.7, 28.1, 125.6, 126.9, 127.3, 127.7, 127.9, 128.0, 131.1, 
131.2, 134.0, 134.7, 135.7, 135.9, 136.1, 144.7, 192.5. HRMS (ESI) calcd. for C17H14ONa 
(M+Na+) 257.0937, found 257.0942. 
2-(But-2-en-2-yl)benzaldehyde (4): Prepared from (E)-2-bromo-2-butene (0.405 g, 3.00 
mmol), 2-formylphenylboronic acid (0.540 g, 3.60 mmol, 1.20 equiv), 
Pd(PPh3)4 (86.7 mg, 0.075 mmol, 0.025 equiv), Na2CO3 (3.0 mL of a 2.0 M 
solution, 2.00 equiv), toluene (9.0 mL) and EtOH (3.0 mL). The crude product 
was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 4 (0.246 g, 
1.53 mmol, 51%) as a colorless oil. 1H NMR (CDCl3, 400 MHz): δ 1.84 (dd, J = 6.8, 0.8 Hz, 
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3H), 2.05-2.08 (dd, J = 1.6, 1.2 Hz, 3H), 5.41 (qq, J = 6.8, 1.6 Hz, 1H), 7.31 (dd, J = 7.6, 1.2 
Hz, 1H), 7.35 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.52 (ddd, J = 8.0, 7.6, 1.6 Hz, 1H), 7.89 (dd, J 
= 8.0, 1.2 Hz, 1H), 10.1 (d, J = 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 14.5, 18.7, 
127.0, 128.9, 129.18, 129.23, 133.0, 133.5, 133.9, 149.9, 192.8. HRMS (ESI) calcd. for 
C11H13O (M+H+) 161.0961, found 161.0962. 
Synthesis of 2-(3,6-Dihydro-2H-thiopyran-4-yl)benzaldehyde 6l 
 
 
 
In a nitrogen-filled dry box, PdCl2(PPh3)2 (84.0 mg, 0.120 mmol, 0.040 equiv), and 2-
formylphenylboronic (0.450 g, 3.00 mmol, 1.00 equiv) were weighed into dry round bottom 
flask. The flask was sealed with a rubber septum and removed from the dry box. Anhydrous 
THF (30.0 mL) was added via syringe followed by 3,6-dihydro-2H-thiopyran-4-yl 
trifluoromethanesulfonate (0.596 g, 2.40 mmol, 0.800 equiv) and NaHCO3 sat. solution (6.0 
mL) . This mixture was heated to 60 °C and monitored by TLC for consumption of 3,6-
dihydro-2H-thiopyran-4-yl trifluoromethanesulfonate (3 h) then cooled to room temperature. 
H2O was added and the reaction mixture was extracted with Et2O (x3). The combined 
organic layers were washed with brine, dried over MgSO4, filtered then concentrated under 
reduced pressure. The crude product was purified by flash column chromatography (90:10 
hexanes:EtOAc) to yield 6l (0.374 g, 1.83 mmol, 61%) as a colorless oil. 1H NMR (CDCl3, 
400 MHz): δ 2.58-2.65 (m, 2H), 2.91 (t, J = 5.6 Hz, 2H), 3.35 (dt, J = 4.0, 2.4 Hz, 2H), 5.78-
5.83 (m, 1H), 7.29 (dd, J = 7.6, 0.8 Hz, 1H), (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.56 (ddd, J = 
7.6, 7.6, 1.2 Hz, 1H), 7.91 (dd, J = 7.6, 1.2 Hz, 1H), 10.2 (s, 1H). 13C NMR (CDCl3, 100 
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MHz): δ 25.3, 26.0, 31.8, 126.7, 127.7, 128.4, 129.2, 133.77, 133.82, 136.5, 147.9, 192.2. 
HRMS (ESI) calcd. for C12H13SO (M+H+) 205.0682, found 205.0689. 
Rh-catalyzed hydroacylation of 1 
 
In a nitrogen-filled dry box, 2-(but-2-en-1-yl)benzaldehyde 1 (0.200 mmol, 1.00 
equiv), [Rh(COD)Cl]2 (2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos (11.8 mg, 
0.010 mmol, 0.050 equiv), NaBARF (8.9 mg, 0.010 mmol, 0.050 equiv), and anhydrous 1,4-
dioxane (1 mL) were added to a 1-dram vial. The vial was sealed with a PFTE/silicone-lined 
septum cap and removed from the dry box. The reaction mixture was heated to 100 °C and 
allowed to stir at this temperature until the reaction was judged to be complete by TLC 
analysis. The mixture was cooled to rt, filtered through a pad of silica gel (eluting with 
EtOAc), and concentrated under reduced pressure. CDCl3 (0.7 mL) was added to dissolve the 
crude mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an internal standard. The crude 
product was purified by flash column chromatography (90:10 hexanes:EtOAc) to yield 2 
(12.3 mg, 0.077 mmol, 38%) as a light yellow oil. The enantiomeric excess was determined 
by HPLC analysis (254 nm, 25 °C) tR 15.3 min; tR 19.7 min [Chiracel AS-H (0.46cm x 
25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 0% ee.  1H 
NMR (CDCl3, 400 MHz): δ 1.01 (t, J = 7.2 Hz, 1H), 1.47 – 1.58 (m, 1H), 1.91-2.04 (m, 1H), 
2.57 – 2.67 (m, 1H), 2.83 (dd, J = 17.2, 4.0 Hz, 1H), 3.32 (dd, J = 17.2, 8.0 Hz, 1H), 7.36 
(ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.46 (dd, J = 7.6, 0.8 Hz, 1H), 7.58 (ddd, J = 7.6, 7.6, 1.2 Hz, 
1H), 7.75 (dd, J = 7.6, 1.2 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 11.8, 24.6, 32.5, 48.9, 
O [Rh(COD)Cl]2 (2.5 mol %)
(R)-DTBM-Segphos (5.0 mol %)
NaBARF (5.0 mol %)
1,4-dioxane, 100 °C, 24 h
1
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124.0, 126.7, 127.4, 134.8, 137.1, 154.0, 209.2. Spectral data for 2 is consistent with previous 
reports.[22, 85] 
General Procedure B: Hydroacylation of 1,1,2-Trisubstituted Alkenes 6b-k, 4 
 
 
In a nitrogen-filled dry box, the appropriate ortho-vinylbenzaldehyde 6b-k or 4 
(0.200 mmol, 1.00 equiv), [Rh(COD)Cl]2 (2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-
Segphos (11.8 mg, 0.010 mmol, 0.050 equiv), NaBARF (8.9 mg, 0.010 mmol, 0.050 equiv) 
and anhydrous 1,4-dioxane (1.0 mL) were added to a 1-dram vial. The vial was sealed with a 
PFTE/silicone-lined septum cap and removed from the dry box. The reaction mixture was 
heated to 100 °C and allowed to stir at this temperature until the reaction was judged to be 
complete by TLC analysis. The mixture was cooled to room temperature, filtered through a 
pad of silica gel (eluting with EtOAc), and concentrated under reduced pressure. CDCl3 (0.7 
mL) was added to dissolve the crude mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an 
internal standard. Conversion was determined by 1H NMR spectroscopy of the crude reaction 
mixture. The crude product was purified by flash column chromatography on silica gel 
(hexanes/Et2O) to yield 7b-k or 5. The enantiomeric excess was determined by chiral HPLC 
analysis.  
 (4aS,9aR)-1,2,3,4,4a,9a-Hexahydro-9H-fluoren-9-one[86-87] (7b): Prepared according to 
general procedure B from 6b (37.3 mg, 0.200 mmol). The crude product was 
purified by flash column chromatography (90:10 hexanes:Et2O) to yield 7b 
(32.7 mg, 0.175 mmol, 88%) as a white solid. The enantiomeric excess was 
X
n
O [Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h X
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determined by chiral HPLC analysis (254 nm, 25 °C) tR 20.3 min (major); tR 18.6 min 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 0.5 mL/min] to be 97% ee. [α]D25= -23.5° (c 0.68, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 1.15-1.30 (m, 2H), 1.33-1.45 (m, 1H), 1.46-1.63 (m, 2H), 1.70-1.82 (m, 1H), 2.05-
2.17 (m, 2H), 2.77 (ddd, J = 7.2, 6.8, 5.2 Hz, 1H), 3.39 (ddd, J = 8.8, 6.8, 6.4 Hz, 1H), 7.36 
(ddd, J = 7.2, 7.2, 0.4 Hz, 1H), 7.46 (dd, J = 7.2, 0.8 Hz, 1H), 7.57 (ddd, J = 7.6, 7.2, 0.8 Hz, 
1H), 7.76 (dd, J = 7.6, 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.5, 22.8, 23.3, 31.5, 
39.0, 48.7, 124.1, 125.0, 127.4, 134.4, 135.8, 158.5, 208.0. HRMS (ESI) calcd. for C13H15O 
(M+H+) 187.1117, found 187.1115. 
 (4bS,9aR)-5,6,7,8,9,9a-Hexahydrobenzo[a]azulen-10(4bH)-one[88-89] (7c): Prepared 
according to general procedure B from 6c (40.1 mg, 0.200 mmol). The crude 
product was purified by flash column chromatography (95:5 hexanes:Et2O) 
to yield 7c (23.7 mg, 0.118 mmol, 59%) as a mixture of diastereomers (3.3:1 
cis:trans) a clear oil. The enantiomeric excess was approximated by chiral HPLC analysis 
(254 nm, 20 °C) tR 20.3 min (cis-major); tR 27.4 min (cis-minor), tR 20.9 min (trans-major); 
tR 30.2 min (trans-minor)  [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., 
Ltd.) hexane/iPrOH, ratio, rate mL/min] to be 82% ee for the cis diastereomer and 70% ee for 
the trans diastereomer. Note: Chiral HPLC separation conditions for the four diastereomers 
of 2c were evaluated on Chiracel AD-H, AS-H, OD-H and OJ-H columns, but baseline 
separation conditions could not be identified for all four peaks. The enantioselectivities 
reported were approximated using the tangent line integration method for the cis-major and 
trans-major isomer peaks that overlap in the best separation conditions found.[90-92] 1H NMR 
(CDCl3, 400 MHz): δ 1.24-1.87 (m, 8H), 2.11-2.22 (m, 2H), 2.85 (ddd, J = 10.4, 8.0, 4.4 Hz, 
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1H), 3.57 (ddd, J = 10.2, 8.0, 4.0 Hz, 1H), 7.36 (ddd, J = 7.2, 7.2, 0.4 Hz, 1H), 7.49 (dd, J = 
7.6, 0.4 Hz, 1H), 7.60 (ddd, J = 7.2, 7.2, 0.4 Hz, 1H), 7.73 (dd, J = 7.6, 0.4 Hz, 1H). 
Representative trans-2c peaks: 1.24-1.87 (m, 8H), 2.31-2.56 (m, 3H), 3.03-3.10 (m, 1H) 13C 
NMR (CDCl3, 100 MHz): δ cis-2c peaks: 28.2, 28.50, 28.7, 31.4, 32.6, 44.5, 53.1, 123.7, 
125.7, 127.5, 134.6, 134.9, 158.7, 209.4. Representative trans-2c peaks: 25.8, 27.1, 28.46, 
29.4, 32.2, 44.6, 55.3, 123.5, 124.6, 127.4, 136.4, 136.5. HRMS (ESI) calcd. for C14H17O 
(M+H+) 201.1274, found 201.1274. 
 (4aS,9aR)-7-Methoxy-1,2,3,4,4a,9a-hexahydro-9H-fluoren-9-one[93-94] (7d): Prepared 
according to general procedure B from 6d (43.3 mg, 0.200 mmol). 
The crude product was purified by flash column chromatography 
(90:10 hexanes:Et2O) to yield 7d (34.4 mg, 0.159 mmol, 89%) as an 
off-white amorphous solid. The enantiomeric excess was determined by chiral HPLC 
analysis (254 nm, 25 °C) tR 13.1 min (major); tR 12.3 min (minor) [Chiracel AS-H (0.46cm x 
25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min]  to be 89% ee. 
[α]D25= -116° (c 0.12, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.12-1.29 (m, 2H), 1.32-1.43 
(m, 1H), 1.44-1.60 (m, 2H), 1.69-1.81 (m, 1H), 2.01-2.13 (m, 2H), 2.77 (ddd, J = 6.8, 6.8, 
5.2 Hz, 1H), 3.32 (ddd, J = 8.8, 6.8, 6.4 Hz, 1H), 3.83 (s, 3H), 7.16 (dd, J = 8.4, 2.4 Hz, 1H), 
7.20 (d, J = 2.4 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 22.4, 
22.5, 23.4, 31.4, 38.2, 49.2, 55.7, 105.7, 123.3, 125.8, 137.0, 151.4, 159.4, 208.1. HRMS 
(ESI) calcd. for C14H16O2Na (M+Na+) 239.1043, found 239.1035.  
 (4aS,9aR)-6-Methoxy-1,2,3,4,4a,9a-hexahydro-9H-fluoren-9-one[94-95] (7e): Prepared 
according to general procedure B from 6e (43.3 mg, 0.200 mmol). The 
crude product was purified by flash column chromatography (95:5 
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hexanes:Et2O) to yield 7e (38.5 mg, 0.178 mmol, 89%) as an off-white amorphous solid. The 
enantiomeric excess was determined by chiral HPLC analysis (254 nm, 25 °C) tR 45.5 min 
(major); tR 37.3 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., 
Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 99% ee. [α]D25= -25.7° (c 0.70, CHCl3) 1H 
NMR (CDCl3, 600 MHz): δ 1.19-1.29 (m, 2H), 1.33-1.43 (m, 1H), 1.45-1.58 (m, 2H), 1.69-
1.79 (m, 1H), 1.99-2.11 (m, 2H), 2.73 (ddd, J = 7.2, 6.6, 5.4 Hz, 1H), 3.32 (ddd, J = 9.0, 6.6, 
6.6 Hz, 1H), 3.88 (s, 3H), 6.85-6.90 (m, 2H), 7.68 (d, J = 9.0 Hz, 1H). 13C NMR (CDCl3, 
151 MHz): δ 22.4, 22.6, 23.4, 31.0, 38.8, 48.6, 55.7, 108.8, 114.7, 125.8, 128.9, 161.4, 165.1, 
206.4. HRMS (ESI) calcd. for C14H17O2 (M+H+) 217.1223, found 217.1222.  
 (4aS,9aR)-6-Fluoro-1,2,3,4,4a,9a-hexahydro-9H-fluoren-9-one[93] (7f): Prepared 
according to general procedure B from 6f (40.9 mg, 0.200 mmol). The 
crude product was purified by flash column chromatography (95:5 
hexanes:Et2O) to yield 7f (30.2 mg, 0.148 mmol, 74%) as a colorless oil. 
The enantiomeric excess was determined by chiral HPLC analysis (254 nm, 25 °C) tR 31.7 
min (major); tR 25.1 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical 
Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 97% ee. [α]D25= -38.0° (c 0.79, CHCl3) 1H 
NMR (CDCl3, 600 MHz): δ 1.15-1.27 (m, 2H), 1.34-1.43 (m, 1H), 1.46-1.60 (m, 2H), 1.70-
1.79 (m, 1H), 2.03-2.14 (m, 2H), 2.77 (ddd, J = 6.6, 6.6, 4.8 Hz, 1H), 3.36 (ddd, J = 8.4, 7.2, 
6.6 Hz, 1H), 7.04 (ddd, J = 9.0, 8.4, 2.4 Hz, 1H), 7.10 (dd, J = 8.4, 1.6 Hz, 1H), 7.74 (dd, J = 
8.4, 6.0 Hz, 1H). 13C NMR (CDCl3, 151 MHz): δ 22.4, 22.6, 23.3, 31.2, 38.8, 48.8, 111.9 (d, 
J = 22.0 Hz), 115.5 (d, J = 23.4 Hz), 126.4 (d, J = 10.2 Hz), 132.1 (d, J = 7.8 Hz), 161.4 (d, J 
= 9.2 Hz), 167.1 (d, J = 253.8 Hz), 206.0. 19F NMR (CDCl3, 565 MHz): δ -103.5 (m, 1F) 
HRMS (ESI) calcd. for C13H14FO (M+H+) 205.1023, found 205.1020.  
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 (4bS,8aR)-4b,5,6,7,8,8a-Hexahydro-9H-fluoreno[2,3-d][1,3]dioxol-9-one (7g): Prepared 
according to general procedure B from 6g (46.1 mg, 0.200 mmol). The 
crude product was purified by flash column chromatography (90:10 
hexanes:Et2O) to yield 7g (40.9 mg, 0.178 mmol, 89%) as an off-white 
solid. The enantiomeric excess was determined by chiral HPLC analysis (254 nm, 25 °C) tR 
33.3 min (major); tR 36.2 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel 
Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 85% ee. [α]D25= -14.3° (c 0.44, 
CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.15-1.29 (m, 2H), 1.31-1.42 (m, 1H), 1.43-1.58 (m, 
2H), 1.67-1.80 (m, 1H), 1.95-2.1 (m, 2H), 2.74 (ddd, J = 6.8, 6.8, 5.6 Hz, 1H), 3.26 (ddd, J = 
8.8, 6.8, 6.4 Hz, 1H), 6.04 (m, 2H), 6.82 (s, 1H), 7.10 (s, 1H). 13C NMR (CDCl3, 100 MHz): 
δ 22.1, 22.2, 23.6, 30.9, 38.6, 48.7, 102.2, 102.9, 104.7, 130.3, 148.1, 153.9, 156.1, 206.2. 
HRMS (ESI) calcd. for C14H15O3 (M+H+) 231.1016, found 231.1012.  
 (4aS,9aS)-3,4,4a,9a-Tetrahydroindeno[2,1-c]pyran-9(1H)-one (7h): Prepared according 
to general procedure B from 6h (37.7 mg, 0.200 mmol). The crude product 
was purified by flash column chromatography (80:20 hexanes:Et2O) to yield 
7h (34.2 mg, 0.182 mmol, 91%) as a colorless oil. The enantiomeric excess 
was determined by chiral HPLC analysis (254 nm, 25 °C) tR 40.4 min (major); tR 43.0 min 
(minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 
90:10, 0.5 mL/min] to be 97% ee. [α]D25= -30.8° (c 0.65, CHCl3) 1H NMR (CDCl3, 400 
MHz): δ 1.47-1.60 (m, 1H), 2.17-2.28 (m, 1H), 2.70-2.76 (m, 1H), 3.50-3.63 (m, 2H), 3.65-
3.73 (m, 1H), 3.88 (dd, J = 12.0, 5.6 Hz, 1H), 4.31 (dd, J = 12.0, 3.6 Hz, 1H), 7.41 (ddd, J = 
7.6, 7.6, 0.4 Hz, 1H), 7.49 (dd, J = 7.6, 0.4 Hz, 1H), 7.61 (ddd, J = 7.6, 7.6, 0.4 Hz, 1H), 7.79 
(dd, J = 7.6, 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 30.9, 35.7, 47.9, 64.4, 65.1, 124.5, 
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125.1, 127.9, 134.9, 135.8, 157.5, 205.0. HRMS (ESI) calcd. for C12H13O2 (M+H+) 
189.0910, found 189.0908.  
 (4aS,9aS)-7-Methoxy-3,4,4a,9a-tetrahydroindeno[2,1-c]pyran-9(1H)-one (7i): Prepared 
according to general procedure B from 6i (43.7 mg, 0.200 mmol). The 
crude product was purified by flash column chromatography (80:20 
hexanes:Et2O) to yield 7i (29.5 mg, 0.135 mmol, 68%) as an orange 
amorphous solid. The enantiomeric excess was determined by chiral HPLC analysis (254 nm, 
25 °C) tR 41.8 min (major); tR 45.5 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 97% ee. [α]D25= -28.2° 
(c 0.78, CHCl3) 1H NMR (CDCl3, 400 MHz): δ 1.45-1.57 (m, 1H), 2.15-2.25 (m, 1H), 2.71-
2.79 (m, 1H), 3.48-3.57 (m, 2H), 3.63-3.71 (m, 1H), 3.84 (s, 3H), 3.87 (dd, J = 12.0, 5.6 Hz, 
1H), 4.28 (dd, J = 120, 3.6 Hz, 1H), 7.19 (dd, J = 8.4, 2.8 Hz, 1H), 7.23 (d, J = 2.8 Hz, 1H), 
7.38 (d, J = 8.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 30.8, 35.0, 48.5, 55.8, 64.5, 65.0, 
105.9, 123.9, 125.8, 137.1, 150.4, 159.8, 205.2. HRMS (ESI) calcd. for C13H14O3Na 
(M+Na+) 241.0835, found 241.0831.  
 (4aS,9aR)-2,2-Dimethyl-1,2,3,4,4a,9a-hexahydro-9H-fluoren-9-one (7j): Prepared 
according to general procedure B from 6j (42.9 mg, 0.200 mmol). The 
crude product was purified by flash column chromatography (95:5 
hexanes:Et2O) to yield 7j (33.1 mg, 0.154 mmol, 77%) as mixture of 
diastereomers (2.7:1 trans:cis) a clear oil. Reexposure to the reaction conditions for an 
additional 24h led to exclusive formation of the cis diastereomer. The enantiomeric excess of 
the cis diastereomer was determined by chiral HPLC analysis (254 nm, 25 °C) tR 24.8 min 
(major); tR 19.4 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., 
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Ltd.) hexane/iPrOH, 95:5, 0.5 mL/min] to be 10% ee. Determination of the enantiomeric 
excess of the trans-diastereomer proved challenging because we were unable to obtain a pure 
sample of trans-7j; various conditions for the hydroacylation of 6j yielded only traces of 
trans-7j that were isolated in a mixture with cis-7j. For this reason, retention times and an ee 
value for trans-7j are not reported. 1H NMR (CDCl3, 400 MHz): δ 0.80 (s, 3H), 1.00 (s, 3H), 
1.21-1.33 (m, 2H), 1.49-1.69 (m, 3H), 2.01-2.13 (m, 1H), 2.80 (ddd, J = 7.6, 7.6, 7.2 Hz, 
1H), 3.35 (ddd, J = 7.6, 7.2, 7.2 Hz, 1H), 7.37 (ddd, J = 7.6, 7.6, 0.4 Hz, 1H), 7.47 (dd, J = 
7.6, 0.4 Hz, 1H), 7.59 (ddd, J = 7.6, 7.6, 0.4 Hz, 1H), 7.75 (dd, J = 7.6, 0.4 Hz, 1H). 13C 
NMR (CDCl3, 100 MHz): δ 25.7, 29.0, 29.5, 29.7, 36.5, 37.2, 38.0, 46.9, 124.2, 125.0, 
127.5, 134.6, 135.6, 157.8, 208.9. HRMS (ESI) calcd. for C15H19O (M+H+) 215.1430, found 
215.1426.  
 5,6,6a,11b-Tetrahydro-7H-benzo[c]fluoren-7-one (7k): Prepared according to general 
procedure B from 6k (46.9 mg, 0.200 mmol). The crude product was purified 
by flash column chromatography (90:10 hexanes:Et2O) to yield 7k (23.0 mg, 
0.098 mmol, 49%) as an off-white solid. The enantiomeric excess was 
determined by chiral HPLC analysis (254 nm, 25 °C) tR 21.9 min; tR 25.0 min [Chiracel AS-
H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to 
be 0% ee. 1H NMR (CDCl3, 600 MHz): δ 1.83-1.92 (m, 1H), 2.14-2.23 (m, 1H), 2.49-2.59 
(m, 2H), 3.17-3.22 (m, 1H), 4.69 (d, J  = 7.8 Hz, 1H), 7.05 (dd, J = 7.2, 0.4 Hz, 1H), 7.17 
(ddd, J = 7.2, 7.2, 0.4 Hz, 1H), 7.30 (ddd, J = 7.8, 7.2, 0.4 Hz, 1H), 7.33-7.37 (m, 1H), 7.52-
7.59 (m, 3H), 7.76 (dd, J = 7.8, 0.4 Hz, 1H). 13C NMR (CDCl3, 151 MHz): δ 26.9, 27.4, 
43.2, 47.5, 123.4, 126.5, 126.7, 126.8, 127.8, 128.8, 129.0, 135.3, 136.5, 136.9, 138.7, 157.1, 
209.6. HRMS (ESI) calcd. for C17H15O (M+H+) 235.1117, found 235.1113.  
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 2,3-Dimethyl-2,3-dihydro-1H-inden-1-one (5): Prepared according to general procedure B 
from 4 (32.0 mg, 0.200 mmol). The crude product was purified by flash 
column chromatography (90:10 hexanes:Et2O) to yield 5 (11.1 mg, 0.069 
mmol, 35%) as a colorless oil (dr = 1.6:1 trans:cis). Note: The mass balance 
for this reaction is made up of the isomerized starting material 4 (E:Z = 3.7:1). The 
enantiomeric excess for 5 was determined by chiral HPLC analysis (254 nm, 25 °C) tR 14.3 
min (cis-major); tR 16.7 min (cis-minor) tR 20.1 min (trans-major); tR 17.6 min (trans-minor) 
[Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 95:5, 0.5 
mL/min] to be 94% ee for both the cis and trans diastereomers. Peaks reported for the major 
(trans) diastereomer: 1H NMR (CDCl3, 400 MHz): δ 1.32 (d, J = 7.6 Hz, 3H), 1.45 (d, J = 
7.2 Hz, 3H), 2.24 (dq, J = 7.6, 7.2 Hz, 1H), 2.94 (dq, J = 7.6, 7.2 Hz, 1H), 7.36 (m, 1H), 7.49 
(m, 1H), 7.60 (m, 1H), 7.74 (m, 1H). 13C NMR (CDCl3, 100 MHz): δ 14.3, 19.3, 41.9, 51.6, 
123.8, 125.0, 127.6, 134.8, 134.9, 157.9, 208.5. Representative peaks for the minor (cis) 
diastereomer: 1H NMR (CDCl3, 400 MHz): δ 1.21 (d, J = 7.6 Hz, 3H, cis), 1.23 (d, J = 7.6 
Hz, 3H, cis), 2.82 (dq, J = 7.6, 7.2 Hz, 1H, cis), 3.52 (dq, J = 7.6, 7.2 Hz, 1H, cis). HRMS 
(ESI) calcd. for C11H13O (M+H+) 161.0961, found 161.0960. 
Preparation of a diastereomeric mixture of 7b 
 
 
In a nitrogen-filled dry box, 6b (1.00 mmol, 1.00 equiv), [Rh(COD)Cl]2 (12.3 mg, 
0.025 mmol, 0.025 equiv), (R)-DTBM-Segphos (59.0 mg, 0.050 mmol, 0.050 equiv), 
NaBARF (44.3 mg, 0.050 mmo, 0.050 equiv) and anhydrous 1,4-dioxane (5.0 mL) were 
added to a dry scintillation vial. The vial was sealed, removed from the dry box and the 
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reaction mixture was heated to 100 °C for 4 h. The reaction mixture was cooled to room 
temperature, filtered through a pad of silica gel (eluting with EtOAc), and concentrated under 
reduced pressure. CH2Br2 (35.1 µL, 0.500 mmol) was added as an internal standard and an 
aliquot of this mixture was dissolved in CDCl3. The diastereomeric ratio (trans:cis) was 
determined by 1H NMR spectroscopy of the crude reaction mixture and the crude product 
was purified by flash column chromatography on silica gel (hexanes/Et2O) to yield 7b (58.1 
g, 0.312 mmol, 31%) as a 3.0:1.0 (trans:cis) mixture of diastereomers. The enantiomeric 
excess was determined by chiral HPLC analysis (254 nm, 20 °C) tR 23.2 min (cis-major); tR 
21.4 min (cis-minor); tR 19.9 min (trans-major); tR 26.4 min (trans-minor) [Chiracel AS-H 
(0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 
92% ee for the cis-diastereomer and 94% ee for the trans-diastereomer. Note: Although 
longer reaction times would lead to a higher yield of 7b, the reaction was stopped after 4h to 
generate a mixture of diastereomers favoring the trans product. Longer reaction times lead to 
lower dr’s or a diastereomeric mixture favoring the cis product. Peaks reported for the major 
(trans) diastereomer: 1H NMR (CDCl3, 400 MHz): δ 1.33-1.43 (m, 1H), 1.43-1.75 (m, 3H), 
1.91-2.02 (m, 2H), 2.21 (ddd, J = 11.2, 8.8, 2.8 Hz, 1H), 2.25-2.32 (m, 1H), 2.44-2.53 (m, 
1H), 2.69-2.79 (m, 1H), 7.35 (ddd, J = 7.6, 7.2, 0.8 Hz, 1H), 7.41 (dd, J = 7.6, 0.8 Hz, 1H), 
7.55 (ddd, J = 7.6, 7.2, 0.8 Hz, 1H), 7.70 (dd, J = 7.6, 0.8 Hz, 1H). 13C NMR (CDCl3, 100 
MHz): δ 24.8, 26.3, 26.5, 29.0, 45.6, 58.4, 123.1, 123.5, 127.4, 133.9, 137.0, 153.9, 205.1. 
HRMS (ESI) calcd. for C13H15O (M+H+) 187.1117, found 187.1116. 
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Synthesis of d-6b 
 
 
To a solution of 6b (0.242 g, 1.30 mmol) in MeOH at 0 °C was added NaBD4 (0.082 
g, 1.95 mmol, 1.50 equiv) in one portion. This solution was stirred for 30 minutes and 
monitored by TLC for consumption of 6b. When the reaction was determined to be complete, 
it was quenched by the careful addition of 1M HCl. The reaction mixture was extracted with 
EtOAc (3x) and the combined organic layers were washed with brine, dried over Na2SO4, 
filtered and concentrated. The resulting oil was taken up in CH2Cl2 (5 mL) and MnO2 (0.904 
g, 10.4 mmol, 8.00 equiv) was added. This mixture was heated to 40 °C for 16 h. Once the 
reaction was determined to be complete by TLC analysis, the solution was cooled and 
filtered through celite. The filtrate was concentrated and the crude product was purified by 
flash column chromatography on silica gel (90:10 hexanes/Et2O) to yield d-6b (0.108 g, 
0.581 mmol, 45%) as a colorless oil with 90% incorporation of the deuterium at the aldehyde 
carbon. Note: The large KIE for the oxidation of benzyl alcohol with MnO2 explains the high 
deuterium content observed in d-1b instead of the expected statistical mixture of protio- and 
deuterio-aldehyde.[96-97] 1H NMR (CDCl3, 400 MHz): δ 1.67-1.76 (m, 2H), 1.76-1.86 (m, 
2H), 2.19-2.28 (m, 2H), 2.31-2.39 (m, 2H), 5.59-5.66 (m, 1H), 7.31 (dd, J = 7.6, 0.8 Hz, 1H), 
7.36 (ddd, J = 8.0, 7.6, 0.8 Hz, 1H), 7.53 (ddd, J = 7.6, 1.2 Hz, 1H), 7.90 (dd, J = 8.0, 1.2 Hz, 
1H), 10.1 (s, 0.1H). 13C NMR (CDCl3, 100 MHz): δ 22.0, 23.0, 25.7, 31.0, 127.0, 127.6, 
128.7, 131.4, 133.5, 133.7 (t, J = 3.2 Hz), 134.9, 148.9, 192.4 (t, J = 33.2 Hz). HRMS (ESI) 
calcd. for C13H14OD (M+H+) 188.1180, found 188.1175.  
O
D
90% D
O
H
1) NaBD4 (1.5 equiv)
    MeOH, 0 °C 
2) MnO2 (8 equiv)
    DCM, 40 °C
6b d-6b
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Rhodium-catalyzed Hydroacylation of d-6b 
 
 
In a nitrogen-filled dry box, d-6b (37.5 mg, 0.200 mmol, 1.00 equiv), [Rh(COD)Cl]2 
(2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol, 0.050 
equiv), NaBARF (8.9 mg, 0.010 mmo, 0.050 equiv) and anhydrous 1,4-dioxane (1.0 mL) 
were added to a 1-dram vial. The vial was sealed with a PFTE/silicone-lined septum cap and 
removed from the dry box. The reaction mixture was heated to 100 °C and allowed to stir at 
this temperature until the reaction was judged to be complete by TLC analysis. The mixture 
was cooled to room temperature, filtered through a pad of silica gel (eluting with EtOAc), 
and concentrated under reduced pressure. CDCl3 (0.7 mL) was added to dissolve the crude 
mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an internal standard. Conversion was 
determined by 1H NMR spectroscopy of the crude reaction mixture. The crude product was 
purified by flash column chromatography on silica gel (90:10 hexanes/Et2O) to yield d-7b 
(29.2 g, 0.156 mmol, 78%) as a colorless oil. The enantiomeric excess was determined by 
chiral HPLC analysis (254 nm, 25 °C) tR 20.3 min (major); tR 18.6 min (minor) [Chiracel 
AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] 
to be 97% ee. 1H NMR (CDCl3, 400 MHz): δ 1.12-1.29 (m, 2H), 1.33-1.42 (m, 1H), 1.45-
1.62 (m, 2H), 1.69-1.81 (m, 1H), 2.04-2.15 (m, 2H), 2.75 (app t, J = 6.4 Hz, 1H), 3.38 (ddd, J 
= 6.8, 6.8, 4.4 Hz, 0.15H), 7.35 (dd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.45 (dd, J = 7.6, 0.8 Hz, 1H), 
7.56 (ddd, J = 7.6, 1.2 Hz, 1H), 7.75 (dd, J = 7.6, 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): 
O
D
H
O
D
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane, 100 °C, 24 h
78% yield
90% D
85% D
d-6b
d-7b
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δ 22.5, 22.8, 23.2, 31.4, 38.5 (t, J = 20.6 Hz), 48.6, 124.1, 125.0, 127.4, 134.4, 135.8, 158.4, 
208.0. HRMS (ESI) calcd. for C13H14OD (M+H+) 188.1180, found 188.1176.  
Kinetic isotope effect for the hydroacylation of 6b and d-6b 
 
 
 
The kinetic isotope effect was determined by measuring the initial rate constants for 
two independent experiments for the hydroacylation of 6b and d-6b. The reactions were 
monitored by 1H NMR spectroscopy (T = 373K) using 1,3,5-trimethoxybenzene as an 
internal standard. Reaction mixtures were prepared as follows: In a nitrogen-filled dry box, 
6b or d-6b (18.6 mg, 0.100 mmol, 1.00 equiv), [Rh(COD)Cl]2 (1.23 mg, 0.0025 mmol, 0.025 
equiv), (R)-DTBM-Segphos (5.90 mg, 0.005 mmol, 0.050 equiv), NaBARF (4.43 mg, 0.005 
mmol, 0.050 equiv), 1,3,5-trimethoxybenzene (5.61 mg, 0.033 mmol, 0.333 equiv), and 
anhydrous 1,4-dioxane-d8 (0.5 mL) were added to a 1-dram vial. The vial was agitated to 
dissolve all solids and the solution was transferred to a dry J-Young NMR tube, sealed and 
immediately subjected to 1H NMR analysis (T = 373K). Data points were collected every 3 
minutes and the initial rate constants were determined from the first 5% of the reaction data.  
Synthesis of d-6j 
 
To a solution of 6j (0.386 g, 1.80 mmol) in MeOH at 0 °C was added NaBD4 (0.113 
g, 2.70 mmol, 1.50 equiv) in one portion. This solution was stirred for 30 minutes and 
O
H/D
H
O
H/D
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos (5.0 mol%)
NaBARF (5.0 mol%)
1,3,5-trimethoxybenzene
1,4-dioxane-d8, 100 °C
6b or d-6b 7b or d-7b
O
D
91% D
O
H
1) NaBD4 (1.5 equiv)
    MeOH, 0 °C 
2) MnO2 (8 equiv)
    DCM, 40 °C
6j d-6j
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monitored by TLC for consumption of 6j. When the reaction was determined to be complete, 
it was quenched by the careful addition of 1M HCl. The reaction mixture was extracted with 
EtOAc (3x) and the combined organic layers were washed with brine, dried over Na2SO4, 
filtered and concentrated. The resulting oil was taken up in CH2Cl2 (5 mL) and MnO2 (1.25 
g, 14.4 mmol, 8.00 equiv) was added. This mixture was heated to 40 °C for 16 h. Once the 
reaction was determined to be complete by TLC analysis, the solution was cooled and 
filtered through celite. The filtrate was concentrated and the crude product was purified by 
flash column chromatography on silica gel (90:10 hexanes/Et2O) to yield d-6j (0.252 g, 1.35 
mmol, 75%) as a colorless oil and the deuterium content was determined by 1HNMR 
analysis. 1H NMR (CDCl3, 400 MHz): δ 1.01 (s, 6H), 1.56 (t, J = 6.4 Hz, 2H), 2.00-2.04 (m, 
2H), 2.34-2.42 (m, 2H), 5.54-5.58 (m, 1H), 7.32 (dd, J = 7.6, 1.2 Hz, 1H), 7.36 (ddd, J = 7.6, 
7.6, 1.2 Hz, 1H), 7.53 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H), 7.91 (dd, J = 7.6, 1.2 Hz, 1H), 10.1 (s, 
0.1H). 13C NMR (CDCl3, 100 MHz): δ 28.19. 28.22 (2C), 28.6, 35.6, 39.6, 126.9, 127.5, 
128.7, 130.4, 133.3, 133.5, 133.8 (t, J = 3.6 Hz), 148.4, 192.1 (t, J = 26.6 Hz). HRMS (ESI) 
calcd. for C15H18OD (M+H+) 216.1493, found 216.1492.  
Rhodium-catalyzed Hydroacylation of d-6j 
 
  
In a nitrogen-filled dry box, d-6j (43.1 mg, 0.200 mmol, 1.00 equiv), [Rh(COD)Cl]2 
(2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol, 0.050 
equiv), NaBARF (8.9 mg, 0.010 mmo, 0.050 equiv) and anhydrous 1,4-dioxane (1.0 mL) 
were added to a 1-dram vial. The vial was sealed with a PFTE/silicone-lined septum cap and 
O
D
H
O
D
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos 
(5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane
100 °C, 24 h
O
D
H
91% D
86% Dd-6j d-7j
7:1 dr
cis-d-7j
[Rh(COD)Cl]2 (2.5 mol%)
(R)-DTBM-Segphos 
(5.0 mol%)
NaBARF (5.0 mol%)
1,4-dioxane 
100 °C, 24 h
86% D
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removed from the dry box. The reaction mixture was heated to 100 °C and allowed to stir at 
this temperature until the reaction was judged to be complete by TLC analysis. The mixture 
was cooled to room temperature, filtered through a pad of silica gel (eluting with EtOAc), 
and concentrated under reduced pressure. CDCl3 (0.7 mL) was added to dissolve the crude 
mixture along with CH2Br2 (7.0 µL, 0.100 mmol) as an internal standard. Conversion and 
deuterium content was determined by 1H NMR spectroscopy of the crude reaction mixture. 
The crude product was purified by flash column chromatography on silica gel (90:10 
hexanes/Et2O) to yield d-7j as a mixture of diastereomers (7:1 trans:cis) (40.8 mg, 0.189 
mmol, 95%) an off white solid. Peaks reported for the major diastereomer: 1H NMR (CDCl3, 
400 MHz): δ 0.97 (s, 3H), 1.06 (s, 3H), 1.35-1.47 (m, 2H), 1.58-1.69 (m, 2H), 1.92-1.98 (m, 
1H), 2.29 (ddd, J = 12.0, 3.6. 2.4 Hz, 1H), 2.43-2.51 (m, 1H), 2.79 (app t, J = 7.6 Hz, 0.14H), 
7.35 (ddd, J = 7.6, 7.6, 0.4 Hz, 1H), 7.42 (dd, J = 7.6, 0.4 Hz, 1H), 7.55 (ddd, J = 7.6, 7.6, 0.4 
Hz, 1H), 7.70 (dd, J = 7.6, 0.4 Hz, 1H). 13C NMR (CDCl3, 100 MHz): δ 25.1, 25.4, 31.9, 
33.0, 37.6, 40.0, 45.8 (t, J = 24.2 Hz), 54.4, 123.2, 123.4, 127.4, 133.9, 137.4, 153.4, 205.7. 
HRMS (ESI) calcd. for C15H18OD (M+H+) 216.1493, found 216.1488. The enantiomeric 
excess for trans-7j was determined by chiral HPLC analysis (254 nm, 25 °C) tR 15.8 min 
(major); tR 22.4 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from Daicel Chemical Ind., 
Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 99% ee. 
In a nitrogen-filled dry box, d-7j from above (40.8 mg, 0.189 mmol), [Rh(COD)Cl]2 
(2.5 mg, 0.0050 mmol, 0.025 equiv), (R)-DTBM-Segphos (11.8 mg, 0.010 mmol, 0.050 
equiv), NaBARF (8.9 mg, 0.010 mmo, 0.050 equiv) and anhydrous 1,4-dioxane (1.0 mL) 
were added to a 1-dram vial. The reaction mixture was heated to 100 °C and allowed to stir at 
this temperature for 24 h. The mixture was cooled to room temperature, filtered through a 
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pad of silica gel (eluting with EtOAc), and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography on silica gel (hexanes/Et2O) to yield 
d-7j as a mixture of diastereomers (10:1 cis:trans) (27.6 mg, 0.128 mmol, 64%) as an off 
white solid. The enantiomeric excess for cis-7j was determined by chiral HPLC analysis (254 
nm, 25 °C) tR 20.4 min (major); tR 16.7 min (minor) [Chiracel AS-H (0.46cm x 25cm) (from 
Daicel Chemical Ind., Ltd.) hexane/iPrOH, 90:10, 0.5 mL/min] to be 99% ee. Peaks reported 
for the major diastereomer: 1H NMR (CDCl3, 400 MHz): δ 0.79 (s, 3H), 1.00 (s, 3H), 1.22-
1.36 (m, 2H), 1.44-1.69 (m, 3H), 2.06 (ddd, J = 14.0, 6.4, 4.4 Hz, 1H), 2.79 (app t, J =7.6 Hz, 
1H), 3.35 (app q, J = 7.2 Hz, 0.14H), 7.37 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.47 (dd, J = 7.6, 
0.8 Hz, 1H), 7.58 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 7.75 (dd, J = 7.6, 0.8 Hz, 1H). 13C NMR 
(CDCl3, 100 MHz): δ 25.6, 29.0, 29.5, 29.7, 36.5, 37.2, 37.6 (t, J = 20.8 Hz), 46.8, 124.2, 
125.0, 127.5, 134.6, 135.6, 157.7, 209.0. HRMS (ESI) calcd. for C15H18OD (M+H+) 
216.1493, found 216.1489.  
 
Absolute stereochemistry and structure of (4bS,8aR)-4b,5,6,7,8,8a-Hexahydro-9H-
fluoreno[2,3-d][1,3]dioxol-9-one (7g) 
 
Single crystal X-ray structure determination of 7g was performed using Cu radiation 
to determine the absolute configuration of the molecule. The systematic absences in the 
diffraction data were consistent for the stated space group. The positions of almost all non-
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hydrogen atoms were found by direct methods. The remaining atoms were located on an 
alternating series of least-squares cycles on difference Fourier maps. All non-hydrogen atoms 
were refined in full-matrix anisotropic approximation. All hydrogen atoms were placed in the 
structure factor calculation at idealized positions and were allowed to ride on the neighboring 
atoms with relative isotropic displacement coefficients. Flack,[98-100] Hooft[101] and 
Parsons[102] parameters were calculated with PLATON software.[103] Flack, Hooft and 
Parsons parameters -0.02(14), -0.02(14), and -0.03(12) in combination with the enantiomeric 
purity of 7g are consistent with our assignment of the absolute stereochemistry as cis-
(4bS,8aR). Supplementary X-ray diffraction data and structure refinement for 7g is contained 
in CCDC 1484241. These data can be accessed free of charge from the Cambridge 
Crystallographic Data Center at www.ccdc.cam.ac.uk/data_request/cif. 
 
Computed structures of I1-I5 for hydroacylation reaction with 1b.   
 
Reactant is bolded for clarity and black spheres represent carbon, red for oxygen, white for 
hydrogen, orange for phosphorus, and blue for rhodium.  
 
Computed structure of I1:     Computed structure of I2: 
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Computed structure of I3:   Computed structure of I4:
      
 
Computed structure of I5: 
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CHAPTER V 
CONCLUSION 
  
 
This thesis describes the development of new transition metal-catalyzed N-tert-
prenylation and alkene hydroacylation reactions. The synthesis of a variety of carbocyclic 
and heterocyclic architectures is enabled by new catalytic methods developed for these allylic 
substitution and hydrofunctionalization processes. Experimental and computational 
mechanistic work contributes to the fundamental understanding of the catalytic principles 
that control these reactions.  
The palladium-catalyzed N-tert-prenylation studies provide three distinct protocols 
for the synthesis of the N-tert-prenylindoles. Indoles containing strong electron-withdrawing 
groups readily undergo the allylic substitution reaction and high branched-to-linear ratios are 
observed in the N-tert-prenylindole products. (η6-Indole)Cr(CO)3 complexes facilitate the 
formation of N-tert-prenylindoles containing electron-neutral or electron-donating 
substituents and a variety of new N-tert-prenylindoles are obtained by this method. Indoline 
nucleophiles also undergo the palladium-catalyzed prenylation reaction and oxidation of the 
N-tert-prenylindoline products with MnO2 forms N-tert-prenylindoles. The high branched-to-
linear ratios observed in these reactions are attributed to the use of a wide bite angle 
bisphosphine ligand that facilitates nucleophilic attack at the more substituted end of the 
palladiumprenyl(II) intermediate. 
The rhodium-catalyzed endo- and enantioselective hydroacylation of ortho-
allylbenzaldehydes utilized fundamental principles of catalyst design to identify a catalyst 
that minimizes formation of two distinct byproducts. The use of a counteranion derived from 
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NaBARF eliminates an ene/dehydration pathway that leads to the formation of 2-
methylnaphthalene. An electron-rich bisphosphine ligand containing bulky aryl substitutents 
facilitated turnover-limiting reductive elimination to generate the ketone product with high 
ratios of hydroacylation to alkene isomerization. This rhodium-catalyzed reaction facilitates 
the synthesis of wide range of 3,4-dihydronaphthalen-1(2H)-one proudcts with high 
enantioselectivities (up to 99% ee). 
This thesis presents studies toward the identification of a catalyst for the 
intramolecular hydroacylation of 1,2-disubstituted alkenes. Although the rhodium-catalyzed 
hydroacylation of 1,2-disubstituted alkenes discussed in Chapter IV results in high yields of 
the indanone product, racemization of the α-center has prevented the development of an 
enantioselective variant of this reaction at this time. However, this work demonstrates the 
value of cationic rhodium catalysts for the hydroacylation of higher order alkenes and 
identifies the challenges to address in reactions of this type. Future studies in this area will 
require the identification of a catalyst for the hydroacylation of 1,2-disubstituted alkenes that 
does not promote a Lewis acid-catalyzed racemization process.  
The first hydroacylations of 1,1,2-trisubstituted alkenes are presented along with 
experimental and computational mechanistic studies to elucidate the mechanism by which 
these reactions occur. These studies are consistent with an alkene hydroacylation/α-
epimerization pathway for the rhodium-catalyzed processes. This reaction sequence enables 
the hydroacylation of a series of 2-(cyclohex-1-en-1-yl)benzaldehydes to form hexahydro-
9H-fluoren-9-ones with moderate to high yields (68-91%) and up to 99% ee.  
Overall, the new synthetic methods presented in this thesis occur with low catalyst 
loadings to generate a wide variety of products with high levels of regio-, diastereo- and/or 
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enantiocontrol. Computational studies and mechanistic experiments contribute to a deeper 
understanding of the mechanisms of these transformations and the application of catalyst 
design principles improves catalyst activity and minimizes byproduct formation. These new 
catalytic methods represent significant advancements for prenylation and alkene 
hydroacylation reactions and highlight the power of transition-metal catalysis in modern 
synthetic organic chemistry.   
